<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Dialysis on VitaminDWiki</title><link>/tags/dialysis.html</link><description>Recent content in Dialysis on VitaminDWiki</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Sun, 23 Mar 2025 00:00:00 +0000</lastBuildDate><atom:link href="/tags/dialysis/index.xml" rel="self" type="application/rss+xml"/><item><title>Klotho interactions with Vitamin D</title><link>/posts/klotho-interactions-with-vitamin-d.html</link><pubDate>Sun, 23 Mar 2025 00:00:00 +0000</pubDate><guid>/posts/klotho-interactions-with-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#klotho-interactions-with-vitamin-dhttpswwwperplexityaisearchplease-tell-me-about-klotho-vi-opx6gimaqwueeuuxmgm88a-perplexity-ai---deep-research">&lt;a href="https://www.perplexity.ai/search/please-tell-me-about-klotho-vi-Opx6gImAQWueeUuxMGM88A">Klotho interactions with Vitamin D&lt;/a> Perplexity AI - Deep Research&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#klotho-vitamin-d-and-their-impact-on-health-a-comprehensive-review">Klotho, Vitamin D, and Their Impact on Health: A Comprehensive Review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#discovery-and-function-of-klotho">Discovery and Function of Klotho&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-klotho-vitamin-d-regulatory-axis">The Klotho-Vitamin D Regulatory Axis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-regulation-of-klotho">Vitamin D Regulation of Klotho&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#klotho-regulation-of-vitamin-d">Klotho Regulation of Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#health-implications-of-klotho-deficiency">Health Implications of Klotho Deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mineral-metabolism-disturbances">Mineral Metabolism Disturbances&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#accelerated-aging-phenotype">Accelerated Aging Phenotype&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#neurological-implications">Neurological Implications&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-toxicity-and-its-relationship-with-klotho">Vitamin D Toxicity and Its Relationship with Klotho&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-fgf23-klotho-vitamin-d-axis-in-disease">The FGF23-Klotho-Vitamin D Axis in Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#chronic-kidney-disease-ckd">Chronic Kidney Disease (CKD)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cardiovascular-disease">Cardiovascular Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#aging-and-longevity">Aging and Longevity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#potential-therapeutic-applications">Potential Therapeutic Applications&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#klotho-supplementation">Klotho Supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-management">Vitamin D Management&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lifestyle-interventions">Lifestyle Interventions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#how-individuals-can-increase-klotho-protein-levels-perplexity-aihttpswwwperplexityaisearch3a9c7a80-8980-416b-9e79-4bb130633cf0">How individuals can increase Klotho protein levels &lt;a href="https://www.perplexity.ai/search/3a9c7a80-8980-416b-9e79-4bb130633cf0">Perplexity AI&lt;/a>&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#dietary-interventions">&lt;strong>Dietary Interventions&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#key-nutrients--supplements">Key Nutrients &amp;amp; Supplements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#physical-activity">&lt;strong>Physical Activity&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#exercise-protocols">Exercise Protocols&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#key-considerations">Key Considerations:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#lifestyle--pharmacological-options">&lt;strong>Lifestyle &amp;amp; Pharmacological Options&lt;/strong>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evidence-based-strategies">Evidence-Based Strategies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#experimental-approaches">Experimental Approaches:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#key-limitations--cautions">&lt;strong>Key Limitations &amp;amp; Cautions&lt;/strong>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#klotho-antiaging-protein-molecular-mechanisms-and-therapeutic-potential-in-diseases---march-2025">Klotho antiaging protein: molecular mechanisms and therapeutic potential in diseases - March 2025&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#some-klotho-and-vitamin-d-studies-from-google-scholar">Some Klotho and Vitamin D studies from Google Scholar&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="klotho-interactions-with-vitamin-dhttpswwwperplexityaisearchplease-tell-me-about-klotho-vi-opx6gimaqwueeuuxmgm88a-perplexity-ai---deep-research">&lt;a href="https://www.perplexity.ai/search/please-tell-me-about-klotho-vi-Opx6gImAQWueeUuxMGM88A">Klotho interactions with Vitamin D&lt;/a> Perplexity AI - Deep Research&lt;/h3>
&lt;h4 id="klotho-vitamin-d-and-their-impact-on-health-a-comprehensive-review">Klotho, Vitamin D, and Their Impact on Health: A Comprehensive Review&lt;/h4>
&lt;p>Klotho and vitamin D have emerged as critical players in mineral homeostasis, aging processes, and various health conditions. Their intricate relationship represents a fascinating area of research with significant implications for understanding age-related diseases and developing novel therapeutic approaches. This review explores the biology of Klotho, its relationship with vitamin D metabolism, and how imbalances in this system affect human health.&lt;/p></description></item><item><title>Vitamin D is the 3rd best predictor of bleeding after hemodialysis</title><link>/posts/vitamin-d-is-the-3rd-best-predictor-of-bleeding-after-hemodialysis.html</link><pubDate>Sun, 20 Oct 2024 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-the-3rd-best-predictor-of-bleeding-after-hemodialysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#prediction-of-gastrointestinal-bleeding-hospitalization-risk-in-hemodialysis-using-machine-learning">Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hemodialysis-4-hours-per-session-3-sessons-per-week-costs-80000year">Hemodialysis: 4 hours per session, 3 sessons per week, costs $80,000/year&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="prediction-of-gastrointestinal-bleeding-hospitalization-risk-in-hemodialysis-using-machine-learning">Prediction of gastrointestinal bleeding hospitalization risk in hemodialysis using machine learning&lt;/h4>
&lt;p>BMC Nephrology volume 25, Article number: 366 (2024)&lt;/p>
&lt;p>John W. Larkin, Suman Lama, Sheetal Chaudhuri, Joanna Willetts, Anke C. Winter, Yue Jiao, Manuela Stauss-Grabo, Len A. Usvyat, Jeffrey L. Hymes, Franklin W. Maddux, David C. Wheeler, Peter Stenvinkel &amp;amp; Jürgen Floege on behalf of the INSPIRE Core Group&lt;/p></description></item><item><title>Extended-Release Calcifediol is useful for Hyperparathyroidism</title><link>/posts/extended-release-calcifediol-is-useful-for-hyperparathyroidism.html</link><pubDate>Wed, 09 Oct 2024 00:00:00 +0000</pubDate><guid>/posts/extended-release-calcifediol-is-useful-for-hyperparathyroidism.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#extended-release-calcifediol-a-data-journey-from-phase-3-studies-to-real-world-evidence-highlights-the-importance-of-early-treatment-of-secondaryhyperparathyroidism">Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#asked-chat-gpt-under-what-situations-is-extended-release-calcifediolbeneficialhttpswwwperplexityaisearchunder-what-situations-is-exten-hucvsx0xq7ysp5973f2kka">Asked Chat-GPT: &lt;a href="https://www.perplexity.ai/search/under-what-situations-is-exten-hUCvsx0XQ7ySp5973f2kKA">Under what situations is Extended-Release Calcifediol beneficial?&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="extended-release-calcifediol-a-data-journey-from-phase-3-studies-to-real-world-evidence-highlights-the-importance-of-early-treatment-of-secondaryhyperparathyroidism">Extended-Release Calcifediol: A Data Journey from Phase 3 Studies to Real-World Evidence Highlights the Importance of Early Treatment of Secondary Hyperparathyroidism&lt;/h4>
&lt;p>Nephron. 2024;148(10):657-666. &lt;a href="https://doi.org/10.1159/000538818">doi: 10.1159/000538818&lt;/a>&lt;/p>
&lt;p>Domenico Merante 1, Henrik Schou 1, Isabelle Morin 1, Marius Manu 1, Akhtar Ashfaq 2, Charles Bishop 2, Stephen Strugnell 2&lt;/p></description></item><item><title>Magnesium raised Vitamin D, lowered blood pressure and Ca to Mg ratio – RCT</title><link>/posts/magnesium-raised-vitamin-d-lowered-blood-pressure-and-ca-to-mg-ratio-rct.html</link><pubDate>Wed, 09 Oct 2024 00:00:00 +0000</pubDate><guid>/posts/magnesium-raised-vitamin-d-lowered-blood-pressure-and-ca-to-mg-ratio-rct.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#positive-effects-of-magnesium-supplementation-in-metabolic-syndrome">Positive effects of magnesium supplementation in metabolic syndrome&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="positive-effects-of-magnesium-supplementation-in-metabolic-syndrome">Positive effects of magnesium supplementation in metabolic syndrome&lt;/h4>
&lt;p>Int. Journal of Clinical Pharmacology and Therapeutics DOI 10.5414/CP204677 PDF behind paywall&lt;/p>
&lt;p>Sophia Kisters1, Klaus Kisters &lt;a href="mailto:k.kisters@dialyse-herne.de">k.kisters@dialyse-herne.de&lt;/a> 2,3,4, Tanja Werner4, Jürgen Vormann4, Faruk Tokmak3,4, Timm Westhoff5, Uwe Gröber4,6, Hans-Georg Predel7, Hannes Reuter8,9&lt;/p>
&lt;p>1 University Dental Clinic, Cologne, 2 Medical University Policlinic, Münster, 3 Operasan Dialysis Center, Herne, 4 Society for Magnesium Research, Tutzing, 5 Medical Clinic 1 , Marienhospital, Herne, Ruhr University, Bochum, 6 Academy for Mikronutrients, Essen, 7 Institute of Cardiovascular Research and Sport Medicine, German Sport University, 8 Department of Internal Medicine and Cardiology, EVK Cologne Weyertal, and 9 University Hypertension Center, University of Cologne, Cologne, Germany&lt;/p></description></item><item><title>Body weight not reduced by small doses of calcitriol – meta-analysis</title><link>/posts/body-weight-not-reduced-by-small-doses-of-calcitriol-meta-analysis.html</link><pubDate>Mon, 23 Sep 2024 00:00:00 +0000</pubDate><guid>/posts/body-weight-not-reduced-by-small-doses-of-calcitriol-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-effect-of-active-vitamin-d-supplementation-on-body-weight-and-composition-a-meta-analysis-of-individual-participant-data">The effect of active vitamin D supplementation on body weight and composition: a meta-analysis of individual participant data&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-effect-of-active-vitamin-d-supplementation-on-body-weight-and-composition-a-meta-analysis-of-individual-participant-data">The effect of active vitamin D supplementation on body weight and composition: a meta-analysis of individual participant data&lt;/h4>
&lt;p>Sabrina M. Oussaada1 ∙ Isis Akkermans2,# ∙ Sandeep Chohan1,#∙ … ∙ Johannes A. Romijn8 ∙ Mireille J. Serlie1,9,# ∙ Kasper W. ter Horst1,# &lt;a href="mailto:k.w.terhorst@amsterdamumc.nl">k.w.terhorst@amsterdamumc.nl&lt;/a>…&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/webp/body-weight-calcitriol.webp" alt="image" width="800">
&lt;p>Background &amp;amp; Aims&lt;/p>
&lt;p>Obesity is associated with vitamin D (VitD) deficiency. However, previous studies showed mixed effects of VitD (25-hydroxyVitD/calcidiol) supplementation on body weight. The biological actions of VitD require the hydroxylation of inactive VitD into active VitD (1.25-dihydroxyVitD/calcitriol). This step is highly regulated; therefore, supplementing with inactive VitD might not be sufficient to overcome the potential adverse health effects of VitD deficiency. The objective of this study was to conduct a systematic review and individual participant data (IPD) meta-analysis of data acquired from randomised placebo-controlled calcitriol trials (RCTs) to determine the effects of calcitriol on body weight and weight-related parameters.&lt;/p></description></item><item><title>Vitamin D Update Journal has published free PDFs since 2018</title><link>/posts/vitamin-d-update-journal-has-published-free-pdfs-since-2018.html</link><pubDate>Fri, 03 May 2024 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-update-journal-has-published-free-pdfs-since-2018.html</guid><description>&lt;p>&lt;strong>&lt;a href="https://www.vitamind-journal.it/en/archive/">https://www.vitamind-journal.it/en/archive/&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#2024--1-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfvitamin-d-update-1-2024pdfpdfa">2024 -1 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-update-1-2024.pdf">PDF&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2023-4-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfvitamin-d-update-2023-4-compresspdfpdfpdfa">2023-4 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-update-2023-4-compresspdf.pdf">PDF&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2023-3-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfupdate-2023-3-compresspdfpdfpdfa">2023-3 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/update-2023-3-compresspdf.pdf">PDF&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2023-2-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfupdate-2023-2pdfpdfa">2023-2 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/update-2023-2.pdf">PDF&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2023-1-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfupdate-2023-1-compresspdfpdfpdfa">2023-1 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/update-2023-1-compresspdf.pdf">PDF&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#each-quarter-has-an-editorial-and-bibliographic-updates-often-20-items-for-each-topic">Each quarter has an editorial and bibliographic updates: often 20+ items for each topic&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="2024--1-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfvitamin-d-update-1-2024pdfpdfa">2024 -1 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-update-1-2024.pdf">PDF&lt;/a>&lt;/h4>
&lt;h5 id="vitamin-d-in-cardiovascular-diseases">Vitamin D in cardiovascular diseases&lt;/h5>
&lt;h5 id="vitamin-d-and-mental-disorders-update-on-the-latest-evidence-and-focus-on-autism-and-anorexia">Vitamin D and mental disorders: update on the latest evidence and focus on autism and anorexia&lt;/h5>
&lt;hr>
&lt;h4 id="2023-4-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfvitamin-d-update-2023-4-compresspdfpdfpdfa">2023-4 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vitamin-d-update-2023-4-compresspdf.pdf">PDF&lt;/a>&lt;/h4>
&lt;h5 id="vitamin-d-deficiency-and-osteosarcopenia">Vitamin D deficiency and osteosarcopenia&lt;/h5>
&lt;h5 id="effects-of-vitamin-d-deficiency-on-inflammatory-cytokines">Effects of vitamin D deficiency on inflammatory cytokines&lt;/h5>
&lt;hr>
&lt;h4 id="2023-3-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfupdate-2023-3-compresspdfpdfpdfa">2023-3 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/update-2023-3-compresspdf.pdf">PDF&lt;/a>&lt;/h4>
&lt;h5 id="the-role-of-vitamin-d-in-dermatological-diseases">The role of vitamin D in dermatological diseases&lt;/h5>
&lt;h5 id="cholecalciferol-or-calcifediol-a-question-of-narrative">Cholecalciferol or calcifediol? A question of narrative!&lt;/h5>
&lt;hr>
&lt;h4 id="2023-2-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfupdate-2023-2pdfpdfa">2023-2 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/update-2023-2.pdf">PDF&lt;/a>&lt;/h4>
&lt;h5 id="vitamin-d-deficiency-in-gynaecological-diseases">Vitamin D deficiency in gynaecological diseases&lt;/h5>
&lt;h5 id="the-use-of-vitamin-d-in-chronic-kidney-disease">The use of vitamin D in chronic kidney disease&lt;/h5>
&lt;hr>
&lt;h4 id="2023-1-i-classfas-fa-file-pdf-stylemargin-right-03emia-hrefhttpsd378j1rmrlek7xcloudfrontnetattachmentspdfupdate-2023-1-compresspdfpdfpdfa">2023-1 &lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/update-2023-1-compresspdf.pdf">PDF&lt;/a>&lt;/h4>
&lt;h5 id="vital-study-lights-and-shadows">VITAL Study: lights and shadows&lt;/h5>
&lt;h5 id="2022-recommendations-of-the-italian-society-for-osteoporosis-vitamin-d">2022 recommendations of the Italian Society for Osteoporosis&amp;hellip; Vitamin D&lt;/h5>
&lt;p>Summary of the new 2022 recommendations of the Italian Society for Osteoporosis, Mineral Metabolism and Skeletal Diseases (SIOMMMS) for the management of vitamin D deficiency&lt;/p></description></item><item><title>Calcifediol (semi-activated vitamin D, Calcidiol)</title><link>/posts/calcifediol-semi-activated-vitamin-d-calcidiol.html</link><pubDate>Fri, 20 Oct 2023 00:00:00 +0000</pubDate><guid>/posts/calcifediol-semi-activated-vitamin-d-calcidiol.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#calcifediol-mechanisms-of-action">Calcifediol: Mechanisms of Action&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#study-does-not-appear-to-mention-afinity-of-calcifediol-to-membrane-vdr">Study does not appear to mention afinity of Calcifediol to membrane VDR&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="calcifediol-mechanisms-of-action">Calcifediol: Mechanisms of Action&lt;/h4>
&lt;p>Nutrients 2023, 15, 4409. https:// doi.org/10.3390/nu15204409&lt;/p>
&lt;p>Simone Donati1, Gaia Palmini 1 , Cinzia Aurilia 1, Irene Falsetti1, Francesca Marini 2 , Francesca Giusti 1 , Teresa Iantomasi1 and Maria Luisa Brandi 2,3,*@&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy; &lt;a href="mailto:simone.donati@unifi.it">simone.donati@unifi.it&lt;/a> (S.D.); &lt;a href="mailto:gaia.palmini@umfi.it">gaia.palmini@umfi.it&lt;/a> (G.P.); &lt;a href="mailto:cinzia.aurilia@umfi.it">cinzia.aurilia@umfi.it&lt;/a> (C.A.); &lt;a href="mailto:irene.falsetti@unifi.it">irene.falsetti@unifi.it&lt;/a> (I.F.); &lt;a href="mailto:francesca.giusti@unifi.it">francesca.giusti@unifi.it&lt;/a> (F.G.); &lt;a href="mailto:teresa.iantomasi@unifi.it">teresa.iantomasi@unifi.it&lt;/a> (T.I.)&lt;/p></description></item><item><title>Pancreatic Cancer survival 2.3 X more likely if good level of Vitamin D – meta-analysis</title><link>/posts/pancreatic-cancer-survival-23-x-more-likely-if-good-level-of-vitamin-d-meta-analysis.html</link><pubDate>Fri, 15 Sep 2023 00:00:00 +0000</pubDate><guid>/posts/pancreatic-cancer-survival-23-x-more-likely-if-good-level-of-vitamin-d-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#there-are-2-meta-analyses-on-this-page">There are 2 meta-analyses on this page&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#25-hydroxyvitamin-d-concentration-is-positively-associated-with-overall-survival-in-advanced-pancreatic-cancer-a-systematic-review-and-meta-analysis---2023">25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#40-less-likely-to-die-of-pancreatic-cancer-if-high-vitamin-d---meta-analyis-jan-2024">40% less likely to die of Pancreatic Cancer if high vitamin D - meta-analyis Jan 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="there-are-2-meta-analyses-on-this-page">There are 2 meta-analyses on this page&lt;/h3>
&lt;hr>
&lt;h4 id="25-hydroxyvitamin-d-concentration-is-positively-associated-with-overall-survival-in-advanced-pancreatic-cancer-a-systematic-review-and-meta-analysis---2023">25-hydroxyvitamin D concentration is positively associated with overall survival in advanced pancreatic cancer: A systematic review and meta-analysis - 2023&lt;/h4>
&lt;p>Nutrition Research Vol 117, Sept 2023, Pages 73-82 &lt;a href="https://doi.org/10.1016/j.nutres.2023.07.001">https://doi.org/10.1016/j.nutres.2023.07.001&lt;/a> PDF is behind a paywall&lt;/p></description></item><item><title>Many Chronic Health Diseases and Infections can controlled by 40 ng of Vitamin D – Sunil</title><link>/posts/many-chronic-health-diseases-and-infections-can-controlled-by-40-ng-of-vitamin-d-sunil.html</link><pubDate>Fri, 18 Aug 2023 00:00:00 +0000</pubDate><guid>/posts/many-chronic-health-diseases-and-infections-can-controlled-by-40-ng-of-vitamin-d-sunil.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#controlling-chronic-diseases-and-acute-infections-with-vitamin-dsufficiency">Controlling Chronic Diseases and Acute Infections with Vitamin D Sufficiency&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="controlling-chronic-diseases-and-acute-infections-with-vitamin-dsufficiency">Controlling Chronic Diseases and Acute Infections with Vitamin D Sufficiency&lt;/h4>
&lt;p>Nutrients 2023, 15(16), 3623; &lt;a href="https://doi.org/10.3390/nu15163623">https://doi.org/10.3390/nu15163623&lt;/a>&lt;/p>
&lt;p>by Sunil J. Wimalawansa, Dept of Medicine, CardioMetabolic &amp;amp; Endocrine Institute, North Brunswick, NJ 08902, USA&lt;/p>
&lt;p>&lt;strong>Table of Contents&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/toc-sunil.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/summary.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pathways.jpg" alt="image" width="700">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/benefits.jpg" alt="image" width="700">
&lt;p>Apart from developmental disabilities, the prevalence of chronic diseases increases with age especially in those with co-morbidities: vitamin D deficiency plays a major role in it. Whether vitamin D deficiency initiates and/or aggravates chronic diseases or vice versa is unclear. It adversely affects all body systems but can be eliminated using proper doses of vitamin D supplementation and/or safe daily sun exposure. Maintaining the population serum 25(OH)D concentration above 40 ng/mL (i.e., sufficiency) ensures a sound immune system, minimizing symptomatic diseases and reducing infections and the prevalence of chronic diseases. This is the most cost-effective way to keep a population healthy and reduce healthcare costs. Vitamin D facilitates physiological functions, overcoming pathologies such as chronic inflammation and oxidative stress and maintaining broader immune functions. These are vital to overcoming chronic diseases and infections. Therefore, in addition to following essential public health and nutritional guidance, maintaining vitamin D sufficiency should be an integral part of better health, preventing acute and chronic diseases and minimize their complications. Those with severe vitamin D deficiency have the highest burdens of co-morbidities and are more vulnerable to developing complications and untimely deaths. Vitamin D adequacy improves innate and adaptive immune systems. It controls excessive inflammation and oxidative stress, generates antimicrobial peptides, and neutralizes antibodies via immune cells. Consequently, vitamin D sufficiency reduces infections and associated complications and deaths. Maintaining vitamin D sufficiency reduces chronic disease burden, illnesses, hospitalizations, and all-cause mortality. Vulnerable communities, such as ethnic minorities living in temperate countries, older people, those with co-morbidities, routine night workers, and institutionalized persons, have the highest prevalence of vitamin D deficiency—they would significantly benefit from vitamin D and targeted micronutrient supplementation. At least now, health departments, authorities, and health insurance companies should start assessing, prioritizing, and encouraging this economical, non-prescription, safe micronutrient to prevent and treat acute and chronic diseases. This approach will significantly reduce morbidity, mortality, and healthcare costs and ensure healthy aging.&lt;/p></description></item><item><title>Radiation therapy, used to treat some cancers, causes less damage if use Vitamin D (or Melatonin)</title><link>/posts/radiation-therapy-used-to-treat-some-cancers-causes-less-damage-if-use-vitamin-d-or-melatonin.html</link><pubDate>Tue, 04 Jul 2023 00:00:00 +0000</pubDate><guid>/posts/radiation-therapy-used-to-treat-some-cancers-causes-less-damage-if-use-vitamin-d-or-melatonin.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#ionizing-radiation-as-a-source-of-oxidative-stressthe-protective-role-of-melatonin-and-vitamin-d">Ionizing Radiation as a Source of Oxidative Stress—The Protective Role of Melatonin and Vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="ionizing-radiation-as-a-source-of-oxidative-stressthe-protective-role-of-melatonin-and-vitamin-d">Ionizing Radiation as a Source of Oxidative Stress—The Protective Role of Melatonin and Vitamin D&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2020, 21(16), 5804; &lt;a href="https://doi.org/10.3390/ijms21165804">https://doi.org/10.3390/ijms21165804&lt;/a>&lt;/p>
&lt;p>Jarosław Nuszkiewicz *ORCID,Alina Woźniak andKarolina Szewczyk-Golec *ORCID&lt;/p>
&lt;p>Department of Medical Biology and Biochemistry, Faculty of Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 24 Karłowicza St, 85-092 Bydgoszcz, Poland&lt;/p></description></item><item><title>Chronic Kidney Disease needs Vitamin D - many studies</title><link>/posts/chronic-kidney-disease-needs-vitamin-d-many-studies.html</link><pubDate>Tue, 18 Apr 2023 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-disease-needs-vitamin-d-many-studies.html</guid><description>&lt;!-- ~tc~ start ~/tc~ -->
&lt;p>&lt;a href="/posts/chronic-kidney-disease-decreases-vitamin-d-in-4-ways">Chronic Kidney Disease decreases Vitamin D level in 4 ways&lt;/a>&lt;/p>
&lt;p>&lt;a href="/tags/kidney-dialysis-often-filters-out-vitamin-d.html">Kidney dialysis often filters out vitamin D&lt;/a>&lt;/p>
&lt;p>Low vitamin D causes many health problems, such as weak bones&lt;/p>
&lt;p>Want to have good Vitamin D levels to prevent CKD from causing other health problems&lt;/p>
&lt;p>Higher vitamin D levels can treat CKD &lt;a href="/posts/more-than-30-ng-of-vitamin-d-is-sometimes-needed-kidney-needs-50-ng">50 ng&lt;/a>   &lt;a href="/posts/need-at-least-80-ng-of-vitamin-d-if-have-chronic-kidney-disease">80 ng&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/vitamin-d-treatment-of-chronic-kidney-disease-monthly-better-than-daily-rct">Monthly dosing appears better than daily for CKD&lt;/a> and many other health problems&lt;/p></description></item><item><title>Hemodialysis and Vitamin D - many studies</title><link>/posts/hemodialysis-and-vitamin-d-many-studies.html</link><pubDate>Fri, 20 Jan 2023 00:00:00 +0000</pubDate><guid>/posts/hemodialysis-and-vitamin-d-many-studies.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#hemodialysis-patients-reduced-dementia-chance-by-60-if-take-40000-iu-of-vitamin-d-weekly--aug-2023">Hemodialysis patients reduced dementia chance by 60% if take 40,000 IU of vitamin D weekly – Aug 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#perplexity-ai-suggests-those-on-dialysis-take-50000-iu-of-vitamin-d-weekly-and-daily-magnesium---feb-2025">Perplexity AI suggests those on dialysis take 50,000 IU of Vitamin D weekly and daily Magnesium - Feb 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hemodialysis-patients-probably-helped-by-monthly-100000-iu-of-vitamin-d---march-2023">Hemodialysis patients probably helped by monthly 100,000 IU of Vitamin D - March 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#long-term-cholecalciferol-supplementation-in-hemodialysis-patients-effects-on-mineral-metabolism-inflammation-and-cardiac-parameters---jan-2023">Long-term cholecalciferol supplementation in hemodialysis patients: Effects on mineral metabolism, inflammation, and cardiac parameters - Jan 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#more-hemodialysis-pain-if-low-vitamin-d---jan-2023">More Hemodialysis pain if low vitamin D - Jan 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="hemodialysis-patients-reduced-dementia-chance-by-60-if-take-40000-iu-of-vitamin-d-weekly--aug-2023">Hemodialysis patients reduced dementia chance by 60% if take 40,000 IU of vitamin D weekly – Aug 2023&lt;/h4>
&lt;p>&lt;strong>The Protective Effect of Vitamin D on Dementia Risk in Hemodialysis Patients&lt;/strong>&lt;/p></description></item><item><title>PTH and Vitamin D - many studies</title><link>/posts/pth-and-vitamin-d-many-studies.html</link><pubDate>Thu, 29 Dec 2022 00:00:00 +0000</pubDate><guid>/posts/pth-and-vitamin-d-many-studies.html</guid><description>&lt;p>&lt;strong>The decrease in PTH (&lt;span style="color:#F00;">P&lt;/span>ara&lt;span style="color:#F00;">t&lt;/span>hyroid &lt;span style="color:#F00;">H&lt;/span>ormone) is a good (only?) indicator that Vitamin D is actually getting into the cells&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#what-is-the-difference-between-the-intact-parathyroid-hormone-and-the-parathyroid-hormone-asked-ai">What is the difference between the Intact Parathyroid Hormone and the Parathyroid Hormone (asked AI)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="what-is-the-difference-between-the-intact-parathyroid-hormone-and-the-parathyroid-hormone-asked-ai">What is the difference between the Intact Parathyroid Hormone and the Parathyroid Hormone (asked AI)&lt;/h4>
&lt;p>The difference between Intact Parathyroid Hormone (iPTH) and Parathyroid Hormone (PTH) primarily lies in the specific forms of the hormone that each assay measures and their clinical utility.&lt;/p></description></item><item><title>Kidney Inflammation not reduced by 30 ng Vitamin D (many health problems need 50 ng)</title><link>/posts/kidney-inflammation-not-reduced-by-30-ng-vitamin-d-many-health-problems-need-50-ng.html</link><pubDate>Wed, 09 Nov 2022 00:00:00 +0000</pubDate><guid>/posts/kidney-inflammation-not-reduced-by-30-ng-vitamin-d-many-health-problems-need-50-ng.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#effects-of-vitamin-d-on-inflammatory-state-in-patients-with-chronic-kidney-disease-a-controversial-issue">Effects of vitamin D on inflammatory state in patients with chronic kidney disease: a controversial issue&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="effects-of-vitamin-d-on-inflammatory-state-in-patients-with-chronic-kidney-disease-a-controversial-issue">Effects of vitamin D on inflammatory state in patients with chronic kidney disease: a controversial issue&lt;/h4>
&lt;p>Ther Apher Dial . 2022 Nov 8. &lt;a href="https://doi.org/10.1111/1744-9987.13949">doi: 10.1111/1744-9987.13949&lt;/a>&lt;/p>
&lt;p>Liangbin Zhao 1 , Guoshuang Zhu 2 , Ling Wu 1 , Dengpiao Xie 1&lt;/p>
&lt;p>Background: The anti-inflammatory effect of vitamin D in patients with chronic kidney disease (CKD) remains controversial. This study aimed to conduct a meta-analysis of randomized controlled trials to assess the anti-inflammatory effects of vitamin D in patients with CKD.&lt;/p></description></item><item><title>Kidney Dialysis, low Vitamin D, low Magnesium - many studies</title><link>/posts/kidney-dialysis-low-vitamin-d-low-magnesium-many-studies.html</link><pubDate>Wed, 02 Nov 2022 00:00:00 +0000</pubDate><guid>/posts/kidney-dialysis-low-vitamin-d-low-magnesium-many-studies.html</guid><description>&lt;h4 id="kidney-dialysis-clinics-are-aware-of-the-problem-but-are-not-paid-to-restore-the-removed-vitamin-d">Kidney dialysis clinics are aware of the problem, but are not paid to restore the removed Vitamin D&lt;/h4>
&lt;ul>
&lt;li>&lt;strong>&lt;a href="/posts/kidney-dialysis-clinics-reluctant-to-add-vitamin-d-treatment-as-they-are-not-reimbursed">Kidney Dialysis clinics reluctant to add vitamin D treatment as they are not reimbursed – Oct 2012&lt;/a>&lt;/strong>&lt;/li>
&lt;/ul>
&lt;hr>
&lt;h4 id="hemodialysis-and-magnesium">Hemodialysis and Magnesium&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>The effect of hemodialysis on serum magnesium concentration in hemodialysis patients May 2020 &lt;a href="https://doi.org/10.21037/apm-20-992">doi: 10.21037/apm-20-992&lt;/a> FREE PDF&lt;/p>
&lt;ul>
&lt;li>&amp;ldquo;Hemodialysis treatment can decrease the total serum magnesium concentration.&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study - Jyly 2018 &lt;a href="https://doi.org/10.1038/s41598-018-28629-x">https://doi.org/10.1038/s41598-018-28629-x&lt;/a> FREE PDF&lt;/p></description></item><item><title>Model of Vitamin D and metabolites reaction to 5,000 IU daily</title><link>/posts/model-of-vitamin-d-and-metabolites-reaction-to-5000-iu-daily.html</link><pubDate>Sun, 04 Sep 2022 00:00:00 +0000</pubDate><guid>/posts/model-of-vitamin-d-and-metabolites-reaction-to-5000-iu-daily.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#physiologically-based-pharmacokinetic-modeling-of-vitamin-d-3-and-metabolites-in-vitamin-d-insufficient-patients">Physiologically Based Pharmacokinetic Modeling of Vitamin D 3 and Metabolites in Vitamin D-Insufficient Patients&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="physiologically-based-pharmacokinetic-modeling-of-vitamin-d-3-and-metabolites-in-vitamin-d-insufficient-patients">Physiologically Based Pharmacokinetic Modeling of Vitamin D 3 and Metabolites in Vitamin D-Insufficient Patients&lt;/h4>
&lt;p>Drug Metab Dispos. 2022 Sep;50(9):1161-1169 &lt;a href="https://doi.org/10.1124/dmd.121.000609">doi: 10.1124/dmd.121.000609&lt;/a>&lt;/p>
&lt;p>Colton W Sawyer 1 , Stacey M Tuey 2 , Raymond E West 3rd 2 , Thomas D Nolin 2 , Melanie S Joy 2&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/model-1.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/model-25.jpg" alt="image" width="600">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/actual-and-prediction.jpg" alt="image" width="600">
&lt;p>A physiologically based pharmacokinetic (PBPK) model of vitamin D3 and metabolites &lt;span>[25(OH)D3, 1,25(OH)2D3, and 24,25(OH)2D3]&lt;/span> is presented. In this study, patients with 25(OH)D3 plasma concentrations below 30 ng/ml were studied after a single dose of 5000 I.U. (125 µg) cholecalciferol, provided with 5000 I.U. daily cholecalciferol supplementation until vitamin D replete &lt;a href="25(OH)D3%20plasma%20concentrations%20above%2030%20ng/ml">25(OH)D3 plasma concentrations above 30 ng/ml&lt;/a>, and had serial plasma samples were collected at each phase for 14 days. Total concentrations of vitamin D3 and metabolites were measured by ultra-high performance liquid chromatography tandem mass spectrometry. A nine-compartment PBPK model was built using MATLAB to represent the triphasic study nature (insufficient, replenishing, and sufficient). The stimulatory and inhibitory effect of 1,25(OH)2D3 were incorporated by fold-changes in the primary metabolic enzymes CYP27B1 and CYP24A1, respectively. Incorporation of dynamic adipose partition coefficients for vitamin D3 and 25(OH)D3 and variable enzymatic reactions aided in model fitting. Measures of model predictions agreed well with data from metabolites, with 97%, 88%, and 98% of the data for 25(OH)D3, 24,25(OH)2D3, and 1,25(OH)2D3, respectively, within twofold of unity (fold error values between 0.5 and 2.0). Bootstrapping was performed and optimized parameters were reported with 95% confidence intervals. This PBPK model could be a useful tool for understanding the connections between vitamin D and its metabolites under a variety of clinical situations.&lt;/p></description></item><item><title>Vitamin D sources, role, deficiency, toxicity, testing, etc. – massive review</title><link>/posts/vitamin-d-sources-role-deficiency-toxicity-testing-etc-massive-review.html</link><pubDate>Mon, 16 May 2022 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-sources-role-deficiency-toxicity-testing-etc-massive-review.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-sources-physiological-role-biokinetics-deficiency-therapeutic-use-toxicity-and-overview-of-analytical-methods-for-detection-of-vitamin-d-and-its-metabolites">Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#a-few-of-the-images">A few of the images&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#introduction">Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#oral-absorption">Oral absorption&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#distribution">Distribution&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mechanism-of-action">Mechanism of action&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-in-specific-health-conditions">Vitamin D in specific health conditions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-toxicity">Vitamin D toxicity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#clinical-manifestations">Clinical manifestations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#analytical-methods-for-the-determination-of-vitamin-d-and-its-metabolites-with-emphasis-to-clinical-practice">Analytical methods for the determination of vitamin D and its metabolites with emphasis to clinical practice&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusions">Conclusions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-note-had-problems-extracting-from-pdf---blocks-of--may-be-incorrect__">References** Note: had problems extracting from PDF - blocks of # may be incorrect__&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="vitamin-d-sources-physiological-role-biokinetics-deficiency-therapeutic-use-toxicity-and-overview-of-analytical-methods-for-detection-of-vitamin-d-and-its-metabolites">Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites&lt;/h3>
&lt;p>Critical Reviews in Clinical Laboratory Sciences &lt;a href="https://doi.org/10.1080/10408363.2022.2070595">https://doi.org/10.1080/10408363.2022.2070595&lt;/a>&lt;/p></description></item><item><title>French pediatric consensus: 30 – 60 ng of Vitamin D</title><link>/posts/french-pediatric-consensus-30-60-ng-of-vitamin-d.html</link><pubDate>Mon, 21 Mar 2022 00:00:00 +0000</pubDate><guid>/posts/french-pediatric-consensus-30-60-ng-of-vitamin-d.html</guid><description>&lt;p>:: &lt;strong>Note by VitaminDWiki: The formatting of the PDF made it difficult to extract the data.&lt;br>
The following is just a small portion of the PDF&lt;/strong> ::&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-calcium-intakes-in-general-pédiatrie-populations-a-french-expert-consensus-paper">Vitamin D and calcium intakes in general pédiatrie populations: A French expert consensus paper&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-calcium-intakes-in-general-pédiatrie-populations-a-french-expert-consensus-paper">Vitamin D and calcium intakes in general pédiatrie populations: A French expert consensus paper&lt;/h4>
&lt;p>Arch Pediatr. 2022 Mar 16;S0929-693X(22)00073-2. &lt;a href="https://doi.org/10.1016/j.arcped.2022.02.008.">doi: 10.1016/j.arcped.2022.02.008.&lt;/a>&lt;/p>
&lt;p>J. Bacchettaa,b&amp;rsquo;c&amp;rsquo;*, T. Edouardd, G. Lavernye, J. Bernardorbf, A. Bertholet-Thomasa,b, M. Castanetg, C. Garniera, I. Gennerod, J. Harambath&amp;rsquo;&amp;rsquo;, A. LapillonneJ&amp;rsquo;,k, A. Molin1, C. Nauda, J.P. Sallesd,&lt;/p></description></item><item><title>Asthma, Fractures, Prostate Cancer, Lupus, etc associated with low Vitamin D – umbrella review</title><link>/posts/asthma-fractures-prostate-cancer-lupus-etc-associated-with-low-vitamin-d-umbrella-review.html</link><pubDate>Tue, 11 Jan 2022 00:00:00 +0000</pubDate><guid>/posts/asthma-fractures-prostate-cancer-lupus-etc-associated-with-low-vitamin-d-umbrella-review.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-and-multiple-health-outcomes-an-umbrella-review-of-observational-studies-randomized-controlled-trials-and-mendelian-randomization-studies">Vitamin D and Multiple Health Outcomes: An Umbrella Review of Observational Studies, Randomized Controlled Trials, and Mendelian Randomization Studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-umbrella-review---2014">vitamin D Umbrella Review - 2014&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-and-multiple-health-outcomes-an-umbrella-review-of-observational-studies-randomized-controlled-trials-and-mendelian-randomization-studies">Vitamin D and Multiple Health Outcomes: An Umbrella Review of Observational Studies, Randomized Controlled Trials, and Mendelian Randomization Studies&lt;/h4>
&lt;p>Adv Nutr. 2021 Nov 23;nmab142. &lt;a href="https://doi.org/10.1093/advances/nmab142">doi: 10.1093/advances/nmab142&lt;/a>&lt;/p>
&lt;p>Di Liu 1 2, Xiaoni Meng 1, Qiuyue Tian 1, Weijie Cao 1, Xin Fan 3, Lijuan Wu 1, Manshu Song 4, Qun Meng 1, Wei Wang 1 4 5, Youxin Wang 1 4&lt;/p></description></item><item><title>Lawsuit against Pfizer (adverse event secrecy)</title><link>/posts/lawsuit-against-pfizer-adverse-event-secrecy.html</link><pubDate>Tue, 14 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/lawsuit-against-pfizer-adverse-event-secrecy.html</guid><description>&lt;h4 id="news-itemhttpsconstitutionwatchcomaupfizer-cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048-dec-13-2021">&lt;a href="https://constitutionwatch.com.au/pfizer-cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048/">News item&lt;/a> Dec 13, 2021&lt;/h4>
&lt;p>Additional Pfizer data being released: &lt;a href="https://phmpt.org/pfizers-documents/">https://phmpt.org/pfizers-documents/&lt;/a> 21 as of Dec 14, 2021&lt;/p>
&lt;p>The group behind the lawsuit: &lt;a href="https://phmpt.org/">https://phmpt.org/&lt;/a>&lt;/p>
&lt;p>The court case: &lt;a href="https://www.sirillp.com/wp-content/uploads/2021/11/020-Second-Joint-Status-Report-8989f1fed17e2d919391d8df1978006e.pdf">PDF&lt;/a>&lt;/p>
&lt;p>thanks to hilja.gebest for pointing this out&lt;/p>
&lt;hr>
&lt;h4 id="pfizer-knew-of-290-kinds-of-covid-vaccine-problemspostspfizer-knew-of-290-kinds-of-covid-vaccine-problems---which-follow">&lt;a href="/posts/pfizer-knew-of-290-kinds-of-covid-vaccine-problems">Pfizer knew of 290 kinds of COVID vaccine problems&lt;/a> - which follow&lt;/h4>
&lt;p>1p36 deletion syndrome:   2-Hydroxyglutaric aciduria:   5&amp;rsquo;nucleotidase increased:   Acoustic neuritis:   Acquired C1 inhibitor deficiency:   Acquired epidermolysis bullosa:   Acquired epileptic aphasia:   Acute cutaneous lupus erythematosus:   Acute disseminated encephalomyelitis:   Acute encephalitis with refractory, repetitive partial seizures:   Acute febrile neutrophilic dermatosis:   Acute flaccid myelitis:   Acute haemorrhagic leukoencephalitis:   Acute haemorrhagic oedema of infancy:   Acute kidney injury:   Acute macular outer retinopathy:   Acute motor axonal neuropathy:   Acute motor-sensory axonal neuropathy:   Acute myocardial infarction:   Acute respiratory distress syndrome:   Acute respiratory failure:   Addison&amp;rsquo;s disease:   Administration site thrombosis:   Administration site vasculitis:   Adrenal thrombosis:   Adverse event following immunisation:   Ageusia:   Agranulocytosis:   Air embolism:   Alanine aminotransferase abnormal:   Alanine aminotransferase increased:   Alcoholic seizure:   Allergic bronchopulmonary mycosis:   Allergic oedema:   Alloimmune hepatitis:   Alopecia areata:   Alpers disease:   Alveolar proteinosis:   Ammonia abnormal:   Ammonia increased:   Amniotic cavity infection:   Amygdalohippocampectomy:   Amyloid arthropathy:   Amyloidosis:   Amyloidosis senile:   Anaphylactic reaction:   Anaphylactic shock:   Anaphylactic transfusion reaction:   Anaphylactoid reaction:   Anaphylactoid shock:   Anaphylactoid syndrome of pregnancy:   Angioedema:   Angiopathic neuropathy:   Ankylosing spondylitis:   Anosmia:   Antiacetylcholine receptor antibody positive:   Anti-actin antibody positive:   Anti-aquaporin-4 antibody positive:   Anti-basal ganglia antibody positive:   Anti-cyclic citrullinated peptide antibody positive:   Anti-epithelial antibody positive:   Anti-erythrocyte antibody positive:   Anti-exosome complex antibody positive:   Anti- GAD antibody negative:   Anti-GAD antibody positive:   Anti-ganglioside antibody positive:   Antigliadin antibody positive:   Anti-glomerular basement membrane antibody positive:   Anti-glomerular basement membrane disease:   Anti-glycyl-tRNA synthetase antibody positive:   Anti-HLA antibody test positive:   Anti-IA2 antibody positive:   Anti-insulin antibody increased:   Anti-insulin antibody positive:   Anti-insulin receptor antibody increased:   Anti- insulin receptor antibody positive:   Anti-interferon antibody negative:   Anti-interferon antibody positive:   Anti-islet cell antibody positive:   Antimitochondrial antibody positive:   Anti-muscle specific kinase antibody positive:   Anti-myelin-associated glycoprotein antibodies positive:   Anti-myelin-associated glycoprotein associated polyneuropathy:   Antimyocardial antibody positive:   Anti-neuronal antibody positive:   Antineutrophil cytoplasmic antibody increased:   Antineutrophil cytoplasmic antibody positive:   Anti-neutrophil cytoplasmic antibody positive vasculitis:   Anti-NMDA antibody positive:   Antinuclear antibody increased:   Antinuclear antibody positive:   Antiphospholipid antibodies positive:   Antiphospholipid syndrome:   Anti-platelet antibody positive:   Anti-prothrombin antibody positive:   Antiribosomal P antibody positive:   Anti-RNA polymerase III antibody positive:   Anti-saccharomyces cerevisiae antibody test positive:   Anti-sperm antibody positive:   Anti-SRP antibody positive:   Antisynthetase syndrome:   Anti-thyroid antibody positive:   Anti-transglutaminase antibody increased:   Anti-VGCC antibody positive:   Anti- VGKC antibody positive:   Anti-vimentin antibody positive:   Antiviral prophylaxis:   Antiviral treatment:   Anti-zinc transporter 8 antibody positive:   Aortic embolus:   Aortic thrombosis:   Aortitis:   Aplasia pure red cell:   Aplastic anaemia:   Application site thrombosis:   Application site vasculitis:   Arrhythmia:   Arterial bypass occlusion:   Arterial bypass thrombosis:   Arterial thrombosis:   Arteriovenous fistula thrombosis:   Arteriovenous graft site stenosis:   Arteriovenous graft thrombosis:   Arteritis:   Arteritis coronary:   Arthralgia:   Arthritis:   Arthritis enteropathic:   Ascites:   Aseptic cavernous sinus thrombosis:   Aspartate aminotransferase abnormal:   Aspartate aminotransferase increased:   Aspartate-glutamate-transporter deficiency:   AST to platelet ratio index increased:   AST/ALT ratio abnormal:   Asthma:   Asymptomatic COVID- 19:   Ataxia:   Atheroembolism:   Atonic seizures:   Atrial thrombosis:   Atrophic thyroiditis:   Atypical benign partial epilepsy:   Atypical pneumonia:   Aura:   Autoantibody positive:   Autoimmune anaemia:   Autoimmune aplastic anaemia:   Autoimmune arthritis:   Autoimmune blistering disease:   Autoimmune cholangitis:   Autoimmune colitis:   Autoimmune demyelinating disease:   Autoimmune dermatitis:   Autoimmune disorder:   Autoimmune encephalopathy:   Autoimmune endocrine disorder:   Autoimmune enteropathy:   Autoimmune eye disorder:   Autoimmune haemolytic anaemia:   Autoimmune heparin-induced thrombocytopenia:   Autoimmune hepatitis:   Autoimmune hyperlipidaemia:   Autoimmune hypothyroidism:   Autoimmune inner ear disease:   Autoimmune lung disease:   Autoimmune lymphoproliferative syndrome:   Autoimmune myocarditis:   Autoimmune myositis:   Autoimmune nephritis:   Autoimmune neuropathy:   Autoimmune neutropenia:   Autoimmune pancreatitis:   Autoimmune pancytopenia:   Autoimmune pericarditis:   Autoimmune retinopathy:   Autoimmune thyroid disorder:   Autoimmune thyroiditis:   Autoimmune uveitis:   Autoinflammation with infantile enterocolitis:   Autoinflammatory disease:   Automatism epileptic:   Autonomic nervous system imbalance:   Autonomic seizure:   Axial spondyloarthritis:   Axillary vein thrombosis:   Axonal and demyelinating polyneuropathy:   Axonal neuropathy:   &lt;span style="color:#F00;">B&lt;/span>acterascites:   Baltic myoclonic epilepsy:   Band sensation:   Basedow&amp;rsquo;s disease:   Basilar artery thrombosis:   Basophilopenia:   B-cell aplasia:   Behcet&amp;rsquo;s syndrome:   Benign ethnic neutropenia:   Benign familial neonatal convulsions:   Benign familial pemphigus:   Benign rolandic epilepsy:   Beta-2 glycoprotein antibody positive:   Bickerstaffs encephalitis:   Bile output abnormal:   Bile output decreased:   Biliary ascites:   Bilirubin conjugated abnormal:   Bilirubin conjugated increased:   Bilirubin urine present:   Biopsy liver abnormal:   Biotinidase deficiency:   Birdshot chorioretinopathy:   Blood alkaline phosphatase abnormal:   Blood alkaline phosphatase increased:   Blood bilirubin abnormal:   Blood bilirubin increased:   Blood bilirubin unconjugated increased:   Blood cholinesterase abnormal:   Blood cholinesterase decreased:   Blood pressure decreased:   Blood pressure diastolic decreased:   Blood pressure systolic decreased:   Blue toe syndrome:   Brachiocephalic vein thrombosis:   Brain stem embolism:   Brain stem thrombosis:   Bromosulphthalein test abnormal:   Bronchial oedema:   Bronchitis:   Bronchitis mycoplasmal:   Bronchitis viral:   Bronchopulmonary aspergillosis allergic:   Bronchospasm:   Budd- Chiari syndrome:   Bulbar palsy:   Butterfly rash:   &lt;span style="color:#F00;">C&lt;/span>1q nephropathy:   Caesarean section:   Calcium embolism:   Capillaritis:   Caplan&amp;rsquo;s syndrome:   Cardiac amyloidosis:   Cardiac arrest:   Cardiac failure:   Cardiac failure acute:   Cardiac sarcoidosis:   Cardiac ventricular thrombosis:   Cardiogenic shock:   Cardiolipin antibody positive:   Cardiopulmonary failure:   Cardio-respiratory arrest:   Cardio-respiratory distress:   Cardiovascular insufficiency:   Carotid arterial embolus:   Carotid artery thrombosis:   Cataplexy:   Catheter site thrombosis:   Catheter site vasculitis:   Cavernous sinus thrombosis:   CDKL5 deficiency disorder:   CEC syndrome:   Cement embolism:   Central nervous system lupus:   Central nervous system vasculitis:   Cerebellar artery thrombosis:   Cerebellar embolism:   Cerebral amyloid angiopathy:   Cerebral arteritis:   Cerebral artery embolism:   Cerebral artery thrombosis:   Cerebral gas embolism:   Cerebral microembolism:   Cerebral septic infarct:   Cerebral thrombosis:   Cerebral venous sinus thrombosis:   Cerebral venous thrombosis:   Cerebrospinal thrombotic tamponade:   Cerebrovascular accident:   Change in seizure presentation:   Chest discomfort:   Child- Pugh-Turcotte score abnormal:   Child-Pugh-Turcotte score increased:   Chillblains:   Choking:   Choking sensation:   Cholangitis sclerosing:   Chronic autoimmune glomerulonephritis:   Chronic cutaneous lupus erythematosus:   Chronic fatigue syndrome:   Chronic gastritis:   Chronic inflammatory demyelinating polyradiculoneuropathy:   Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids:   Chronic recurrent multifocal osteomyelitis:   Chronic respiratory failure:   Chronic spontaneous urticaria:   Circulatory collapse:   Circumoral oedema:   Circumoral swelling:   Clinically isolated syndrome:   Clonic convulsion:   Coeliac disease:   Cogan&amp;rsquo;s syndrome:   Cold agglutinins positive:   Cold type haemolytic anaemia:   Colitis:   Colitis erosive:   Colitis herpes:   Colitis microscopic:   Colitis ulcerative:   Collagen disorder:   Collagen-vascular disease:   Complement factor abnormal:   Complement factor C1 decreased:   Complement factor C2 decreased:   Complement factor C3 decreased:   Complement factor C4 decreased:   Complement factor decreased:   Computerised tomogram liver abnormal:   Concentric sclerosis:   Congenital anomaly:   Congenital bilateral perisylvian syndrome:   Congenital herpes simplex infection:   Congenital myasthenic syndrome:   Congenital varicella infection:   Congestive hepatopathy:   Convulsion in childhood:   Convulsions local:   Convulsive threshold lowered:   Coombs positive haemolytic anaemia:   Coronary artery disease:   Coronary artery embolism:   Coronary artery thrombosis:   Coronary bypass thrombosis:   Coronavirus infection:   Coronavirus test:   Coronavirus test negative:   Coronavirus test positive:   Corpus callosotomy:   Cough:   Cough variant asthma:   COVID-19:   COVID-19 immunisation:   COVID-19 pneumonia:   COVID-19 prophylaxis:   COVID-19 treatment:   Cranial nerve disorder:   Cranial nerve palsies multiple:   Cranial nerve paralysis:   CREST syndrome:   Crohn&amp;rsquo;s disease:   Cryofibrinogenaemia:   Cryoglobulinaemia:   CSF oligoclonal band present:   CSWS syndrome:   Cutaneous amyloidosis:   Cutaneous lupus erythematosus:   Cutaneous sarcoidosis:   Cutaneous vasculitis:   Cyanosis:   Cyclic neutropenia:   Cystitis interstitial:   Cytokine release syndrome:   Cytokine storm:   &lt;span style="color:#F00;">D&lt;/span>e novo purine synthesis inhibitors associated acute inflammatory syndrome:   Death neonatal:   Deep vein thrombosis:   Deep vein thrombosis postoperative:   Deficiency of bile secretion:   Deja vu:   Demyelinating polyneuropathy:   Demyelination:   Dermatitis:   Dermatitis bullous:   Dermatitis herpetiformis:   Dermatomyositis:   Device embolisation:   Device related thrombosis:   Diabetes mellitus:   Diabetic ketoacidosis:   Diabetic mastopathy:   Dialysis amyloidosis:   Dialysis membrane reaction:   Diastolic hypotension:   Diffuse vasculitis:   Digital pitting scar:   Disseminated intravascular coagulation:   Disseminated intravascular coagulation in newborn:   Disseminated neonatal herpes simplex:   Disseminated varicella:   Disseminated varicella zoster vaccine virus infection:   Disseminated varicella zoster virus infection:   DNA antibody positive:   Double cortex syndrome:   Double stranded DNA antibody positive:   Dreamy state:   Dressler&amp;rsquo;s syndrome:   Drop attacks:   Drug withdrawal convulsions:   Dyspnoea:   Early infantile epileptic encephalopathy with burst-suppression:   Eclampsia:   Eczema herpeticum:   Embolia cutis medicamentosa:   Embolic cerebellar infarction:   Embolic cerebral infarction:   Embolic pneumonia:   Embolic stroke:   Embolism:   Embolism arterial:   Embolism venous:   Encephalitis:   Encephalitis allergic:   Encephalitis autoimmune:   Encephalitis brain stem:   Encephalitis haemorrhagic:   Encephalitis periaxialis diffusa:   Encephalitis post immunisation:   Encephalomyelitis:   Encephalopathy:   Endocrine disorder:   Endocrine ophthalmopathy:   Endotracheal intubation:   Enteritis:   Enteritis leukopenic:   Enterobacter pneumonia:   Enterocolitis:   Enteropathic spondylitis:   Eosinopenia:   Eosinophilicfasciitis:   Eosinophilic granulomatosis with polyangiitis:   Eosinophilic oesophagitis:   Epidermolysis:   Epilepsy:   Epilepsy surgery:   Epilepsy with myoclonic-atonic seizures:   Epileptic aura:   Epileptic psychosis:   Erythema:   Erythema induratum:   Erythema multiforme:   Erythema nodosum:   Evans syndrome:   Exanthema subitum:   Expanded disability status scale score decreased:   Expanded disability status scale score increased:   Exposure to communicable disease:   Exposure to SARS-CoV-2:   Eye oedema:   Eye pruritus:   Eye swelling:   Eyelid oedema:   &lt;span style="color:#F00;">F&lt;/span>ace oedema:   Facial paralysis:   Facial paresis:   Faciobrachial dystonic seizure:   Fat embolism:   Febrile convulsion:   Febrile infection-related epilepsy syndrome:   Febrile neutropenia:   Felty&amp;rsquo;s syndrome:   Femoral artery embolism:   Fibrillary glomerulonephritis:   Fibromyalgia:   Flushing:   Foaming at mouth:   Focal cortical resection:   Focal dyscognitive seizures:   Foetal distress syndrome:   Foetal placental thrombosis:   Foetor hepaticus:   Foreign body embolism:   Frontal lobe epilepsy:   Fulminant type 1 diabetes mellitus:   Galactose elimination capacity test abnormal:   Galactose elimination capacity test decreased:   Gamma-glutamyltransferase abnormal:   Gamma-glutamyltransferase increased:   Gastritis herpes:   Gastrointestinal amyloidosis:   Gelastic seizure:   Generalised onset non-motor seizure:   Generalised tonic-clonic seizure:   Genital herpes:   Genital herpes simplex:   Genital herpes zoster:   Giant cell arteritis:   Glomerulonephritis:   Glomerulonephritis membranoproliferative:   Glomerulonephritis membranous:   Glomerulonephritis rapidly progressive:   Glossopharyngeal nerve paralysis:   Glucose transporter type 1 deficiency syndrome:   Glutamate dehydrogenase increased:   Glycocholic acid increased:   GM2 gangliosidosis:   Goodpasture&amp;rsquo;s syndrome:   Graft thrombosis:   Granulocytopenia:   Granulocytopenia neonatal:   Granulomatosis with polyangiitis:   Granulomatous dermatitis:   Grey matter heterotopia:   Guanase increased:   Guillain- Barre syndrome:  &lt;span style="color:#F00;">H&lt;/span>aemolytic anaemia:   Haemophagocytic lymphohistiocytosis:   Haemorrhage:   Haemorrhagic ascites:   Haemorrhagic disorder:   Haemorrhagic pneumonia:   Haemorrhagic varicella syndrome:   Haemorrhagic vasculitis:   Hantavirus pulmonary infection:   Hashimoto&amp;rsquo;s encephalopathy:   Hashitoxicosis:   Hemimegalencephaly:   Henoch-Schonlein purpura:   Henoch- Schonlein purpura nephritis:   Hepaplastin abnormal:   Hepaplastin decreased:   Heparin-induced thrombocytopenia:   Hepatic amyloidosis:   Hepatic artery embolism:   Hepatic artery flow decreased:   Hepatic artery thrombosis:   Hepatic enzyme abnormal:   Hepatic enzyme decreased:   Hepatic enzyme increased:   Hepatic fibrosis marker abnormal:   Hepatic fibrosis marker increased:   Hepatic function abnormal:   Hepatic hydrothorax:   Hepatic hypertrophy:   Hepatic hypoperfusion:   Hepatic lymphocytic infiltration:   Hepatic mass:   Hepatic pain:   Hepatic sequestration:   Hepatic vascular resistance increased:   Hepatic vascular thrombosis:   Hepatic vein embolism:   Hepatic vein thrombosis:   Hepatic venous pressure gradient abnormal:   Hepatic venous pressure gradient increased:   Hepatitis:   Hepatobiliary scan abnormal:   Hepatomegaly:   Hepatosplenomegaly:   Hereditary angioedema with C1 esterase inhibitor deficiency:   Herpes dermatitis:   Herpes gestationis:   Herpes oesophagitis:   Herpes ophthalmic:   Herpes pharyngitis:   Herpes sepsis:   Herpes simplex:   Herpes simplex cervicitis:   Herpes simplex colitis:   Herpes simplex encephalitis:   Herpes simplex gastritis:   Herpes simplex hepatitis:   Herpes simplex meningitis:   Herpes simplex meningoencephalitis:   Herpes simplex meningomyelitis:   Herpes simplex necrotising retinopathy:   Herpes simplex oesophagitis:   Herpes simplex otitis externa:   Herpes simplex pharyngitis:   Herpes simplex pneumonia:   Herpes simplex reactivation:   Herpes simplex sepsis:   Herpes simplex viraemia:   Herpes simplex virus conjunctivitis neonatal:   Herpes simplex visceral:   Herpes virus infection:   Herpes zoster:   Herpes zoster cutaneous disseminated:   Herpes zoster infection neurological:   Herpes zoster meningitis:   Herpes zoster meningoencephalitis:   Herpes zoster meningomyelitis:   Herpes zoster meningoradiculitis:   Herpes zoster necrotising retinopathy:   Herpes zoster oticus:   Herpes zoster pharyngitis:   Herpes zoster reactivation:   Herpetic radiculopathy:   Histone antibody positive:   Hoigne&amp;rsquo;s syndrome:   Human herpesvirus 6 encephalitis:   Human herpesvirus 6 infection:   Human herpesvirus 6 infection reactivation:   Human herpesvirus 7 infection:   Human herpesvirus 8 infection:   Hyperammonaemia:   Hyperbilirubinaemia:   Hypercholia:   Hypergammaglobulinaemia benign monoclonal:   Hyperglycaemic seizure:   Hypersensitivity:   Hypersensitivity vasculitis:   Hyperthyroidism:   Hypertransaminasaemia:   Hyperventilation:   Hypoalbuminaemia:   H ypocalcaemic seizure:   Hypogammaglobulinaemia:   Hypoglossal nerve paralysis:   Hypoglossal nerve paresis:   Hypoglycaemic seizure:   Hyponatraemic seizure:   Hypotension:   Hypotensive crisis:   Hypothenar hammer syndrome:   Hypothyroidism:   Hypoxia:   Idiopathic CD4 lymphocytopenia:   Idiopathic generalised epilepsy:   Idiopathic interstitial pneumonia:   Idiopathic neutropenia:   Idiopathic pulmonary fibrosis:   IgA nephropathy:   IgM nephropathy:   IIIrd nerve paralysis:   IIIrd nerve paresis:   Iliac artery embolism:   Immune thrombocytopenia:   Immune- mediated adverse reaction:   Immune-mediated cholangitis:   Immune-mediated cholestasis:   Immune-mediated cytopenia:   Immune-mediated encephalitis:   Immune-mediated encephalopathy:   Immune-mediated endocrinopathy:   Immune-mediated enterocolitis:   Immune- mediated gastritis:   Immune-mediated hepatic disorder:   Immune-mediated hepatitis:   Immune- mediated hyperthyroidism:   Immune-mediated hypothyroidism:   Immune-mediated myocarditis:   Immune-mediated myositis:   Immune-mediated nephritis:   Immune-mediated neuropathy:   Immune-mediated pancreatitis:   Immune-mediated pneumonitis:   Immune-mediated renal disorder:   Immune-mediated thyroiditis:   Immune-mediated uveitis:   Immunoglobulin G4 related disease:   Immunoglobulins abnormal:   Implant site thrombosis:   Inclusion body myositis:   Infantile genetic agranulocytosis:   Infantile spasms:   Infected vasculitis:   Infective thrombosis:   Inflammation:   Inflammatory bowel disease:   Infusion site thrombosis:   Infusion site vasculitis:   Injection site thrombosis:   Injection site urticaria:   Injection site vasculitis:   Instillation site thrombosis:   Insulin autoimmune syndrome:   Interstitial granulomatous dermatitis:   Interstitial lung disease:   Intracardiac mass:   Intracardiac thrombus:   Intracranial pressure increased:   Intrapericardial thrombosis:   Intrinsic factor antibody abnormal:   Intrinsic factor antibody positive:   IPEX syndrome:   Irregular breathing:   IRVAN syndrome:   IVth nerve paralysis:   IVth nerve paresis:   JC polyomavirus test positive:   JC virus CSF test positive:   Jeavons syndrome:   Jugular vein embolism:   Jugular vein thrombosis:   Juvenile idiopathic arthritis:   Juvenile myoclonic epilepsy:   Juvenile polymyositis:   Juvenile psoriatic arthritis:   Juvenile spondyloarthritis:   Kaposi sarcoma inflammatory cytokine syndrome:   Kawasaki&amp;rsquo;s disease:   Kayser-Fleischer ring:   Keratoderma blenorrhagica:   Ketosis- prone diabetes mellitus:   Kounis syndrome:   Lafora&amp;rsquo;s myoclonic epilepsy:   Lambl&amp;rsquo;s excrescences:   Laryngeal dyspnoea:   Laryngeal oedema:   Laryngeal rheumatoid arthritis:   Laryngospasm:   Laryngotracheal oedema:   Latent autoimmune diabetes in adults:   LE cells present:   Lemierre syndrome:   Lennox-Gastaut syndrome:   Leucine aminopeptidase increased:   Leukoencephalomyelitis:   Leukoencephalopathy:   Leukopenia:   Leukopenia neonatal:   Lewis-Sumner syndrome:   Lhermitte&amp;rsquo;s sign:   Lichen planopilaris:   Lichen planus:   Lichen sclerosus:   Limbic encephalitis:   Linear IgA disease:   Lip oedema:   Lip swelling:   Liver function test abnormal:   Liver function test decreased:   Liver function test increased:   Liver induration:   Liver injury:   Liver iron concentration abnormal:   Liver iron concentration increased:   Liver opacity:   Liver palpable:   Liver sarcoidosis:   Liver scan abnormal:   Liver tenderness:   Low birth weight baby:   Lower respiratory tract herpes infection:   Lower respiratory tract infection:   Lower respiratory tract infection viral:   Lung abscess:   Lupoid hepatic cirrhosis:   Lupus cystitis:   Lupus encephalitis:   Lupus endocarditis:   Lupus enteritis:   Lupus hepatitis:   Lupus myocarditis:   Lupus myositis:   Lupus nephritis:   Lupus pancreatitis:   Lupus pleurisy:   Lupus pneumonitis:   Lupus vasculitis:   Lupus-like syndrome:   Lymphocytic hypophysitis:   Lymphocytopenia neonatal:   Lymphopenia:   MAGIC syndrome:   Magnetic resonance imaging liver abnormal:   Magnetic resonance proton density fat fraction measurement:   Mahler sign:   Manufacturing laboratory analytical testing issue:   Manufacturing materials issue:   Manufacturing production issue:   Marburg&amp;rsquo;s variant multiple sclerosis:   Marchiafava-Bignami disease:   Marine Lenhart syndrome:   Mastocytic enterocolitis:   Maternal exposure during pregnancy:   Medical device site thrombosis:   Medical device site vasculitis:   MELAS syndrome:   Meningitis:   Meningitis aseptic:   Meningitis herpes:   Meningoencephalitis herpes simplex neonatal:   Meningoencephalitis herpetic:   Meningomyelitis herpes:   MERS-CoV test:   MERS-CoV test negative:   MERS-CoV test positive:   Mesangioproliferative glomerulonephritis:   Mesenteric artery embolism:   Mesenteric artery thrombosis:   Mesenteric vein thrombosis:   Metapneumovirus infection:   Metastatic cutaneous Crohn&amp;rsquo;s disease:   Metastatic pulmonary embolism:   Microangiopathy:   Microembolism:   Microscopic polyangiitis:   Middle East respiratory syndrome:   Migraine-triggered seizure:   Miliary pneumonia:   Miller Fisher syndrome:   Mitochondrial aspartate aminotransferase increased:   Mixed connective tissue disease:   Model for end stage liver disease score abnormal:   Model for end stage liver disease score increased:   Molar ratio of total branched-chain amino acid to tyrosine:   Molybdenum cofactor deficiency:   Monocytopenia:   Mononeuritis:   Mononeuropathy multiplex:   Morphoea:   Morvan syndrome:   Mouth swelling:   Moyamoya disease:   Multifocal motor neuropathy:   Multiple organ dysfunction syndrome:   Multiple sclerosis:   Multiple sclerosis relapse:   Multiple sclerosis relapse prophylaxis:   Multiple subpial transection:   Multisystem inflammatory syndrome in children:   Muscular sarcoidosis:   Myasthenia gravis:   Myasthenia gravis crisis:   Myasthenia gravis neonatal:   Myasthenic syndrome:   Myelitis:   Myelitis transverse:   Myocardial infarction:   Myocarditis:   Myocarditis post infection:   Myoclonic epilepsy:   Myoclonic epilepsy and ragged-red fibres:   Myokymia:   Myositis:   Narcolepsy:   Nasal herpes:   Nasal obstruction:   Necrotising herpetic retinopathy:   Neonatal Crohn&amp;rsquo;s disease:   Neonatal epileptic seizure:   Neonatal lupus erythematosus:   Neonatal mucocutaneous herpes simplex:   Neonatal pneumonia:   Neonatal seizure:   Nephritis:   Nephrogenic systemic fibrosis:   Neuralgic amyotrophy:   Neuritis:   Neuritis cranial:   Neuromyelitis optica pseudo relapse:   Neuromyelitis optica spectrum disorder:   Neuromyotonia:   Neuronal neuropathy:   Neuropathy peripheral:   Neuropathy, ataxia, retinitis pigmentosa syndrome:   Neuropsychiatric lupus:   Neurosarcoidosis:   Neutropenia:   Neutropenia neonatal:   Neutropenic colitis:   Neutropenic infection:   Neutropenic sepsis:   Nodular rash:   Nodular vasculitis:   Noninfectious myelitis:   Noninfective encephalitis:   Noninfective encephalomyelitis:   Noninfective oophoritis:   Obstetrical pulmonary embolism:   Occupational exposure to communicable disease:   Occupational exposure to SARS-CoV-2:   Ocular hyperaemia:   Ocular myasthenia:   Ocular pemphigoid:   Ocular sarcoidosis:   Ocular vasculitis:   Oculofacial paralysis:   Oedema:   Oedema blister:   Oedema due to hepatic disease:   Oedema mouth:   Oesophageal achalasia:   Ophthalmic artery thrombosis:   Ophthalmic herpes simplex:   Ophthalmic herpes zoster:   Ophthalmic vein thrombosis:   Optic neuritis:   Optic neuropathy:   Optic perineuritis:   Oral herpes:   Oral lichen planus:   Oropharyngeal oedema:   Oropharyngeal spasm:   Oropharyngeal swelling:   Osmotic demyelination syndrome:   Ovarian vein thrombosis:   Overlap syndrome:   Paediatric autoimmune neuropsychiatrie disorders associated with streptococcal infection:   Paget-Schroetter syndrome:   Palindromic rheumatism:   Palisaded neutrophilic granulomatous dermatitis:   Palmoplantar keratoderma:   Palpable Purpura:   Pancreatitis:   Panencephalitis:   Papillophlebitis:   Paracancerous pneumonia:   Paradoxical embolism:   Parainfluenzae viral laryngotracheobronchitis:   Paraneoplastic dermatomyositis:   Paraneoplastic pemphigus:   Paraneoplastic thrombosis:   Paresis cranial nerve:   Parietal cell antibody positive:   Paroxysmal nocturnal haemoglobinuria:   Partial seizures:   Partial seizures with secondary generalisation:   Patient isolation:   Pelvic venous thrombosis:   Pemphigoid:   Pemphigus:   Penile vein thrombosis:   Pericarditis:   Pericarditis lupus:   Perihepatic discomfort:   Periorbital oedema:   Periorbital swelling:   Peripheral artery thrombosis:   Peripheral embolism:   Peripheral ischaemia:   Peripheral vein thrombus extension:   Periportal oedema:   Peritoneal fluid protein abnormal:   Peritoneal fluid protein decreased:   Peritoneal fluid protein increased:   Peritonitis lupus:   Pernicious anaemia:   Petit mal epilepsy:   Pharyngeal oedema:   Pharyngeal swelling:   Pityriasis lichenoides et varioliformis acuta:   Placenta praevia:   Pleuroparenchymal fibroelastosis:   Pneumobilia :   Pneumonia:   Pneumonia adenoviral:   Pneumonia cytomegaloviral:   Pneumonia herpes viral:   Pneumonia influenzal:   Pneumonia measles:   Pneumonia mycoplasmal:   Pneumonia necrotising:   Pneumonia parainfluenzae viral:   Pneumonia respiratory syncytial viral:   Pneumonia viral:   POEMS syndrome:   Polyarteritis nodosa:   Polyarthritis:   Polychondritis:   Polyglandular autoimmune syndrome type I:   Polyglandular autoimmune syndrome type II:   Polyglandular autoimmune syndrome type III:   Polyglandular disorder:   Polymicrogyria:   Polymyalgia rheumatica:   Polymyositis:   Polyneuropathy:   Polyneuropathy idiopathic progressive:   Portal pyaemia:   Portal vein embolism:   Portal vein flow decreased:   Portal vein pressure increased:   Portal vein thrombosis:   Portosplenomesenteric venous thrombosis:   Post procedural hypotension:   Post procedural pneumonia:   Post procedural pulmonary embolism:   Post stroke epilepsy:   Post stroke seizure:   Post thrombotic retinopathy:   Post thrombotic syndrome:   Post viral fatigue syndrome:   Postictal headache:   Postictal paralysis:   Postictal psychosis:   Postictal state:   Postoperative respiratory distress:   Postoperative respiratory failure:   Postoperative thrombosis:   Postpartum thrombosis:   Postpartum venous thrombosis:   Postpericardiotomy syndrome:   Post-traumatic epilepsy:   Postural orthostatic tachycardia syndrome:   Precerebral artery thrombosis:   Pre-eclampsia:   Preictal state:   Premature labour:   Premature menopause:   Primary amyloidosis:   Primary biliary cholangitis:   Primary progressive multiple sclerosis:   Procedural shock:   Proctitis herpes:   Proctitis ulcerative:   Product availability issue:   Product distribution issue:   Product supply issue:   Progressive facial hemiatrophy:   Progressive multifocal leukoencephalopathy:   Progressive multiple sclerosis:   Progressive relapsing multiple sclerosis:   Prosthetic cardiac valve thrombosis:   Pruritus:   Pruritus allergic:   Pseudovasculitis:   Psoriasis:   Psoriatic arthropathy:   Pulmonary amyloidosis:   Pulmonary artery thrombosis:   Pulmonary embolism:   Pulmonary fibrosis:   Pulmonary haemorrhage:   Pulmonary microemboli:   Pulmonary oil microembolism:   Pulmonary renal syndrome:   Pulmonary sarcoidosis:   Pulmonary sepsis:   Pulmonary thrombosis:   Pulmonary tumour thrombotic microangiopathy:   Pulmonary vasculitis:   Pulmonary veno-occlusive disease:   Pulmonary venous thrombosis:   Pyoderma gangrenosum:   Pyostomatitis vegetans:   Pyrexia:   Quarantine:   Radiation leukopenia:   Radiculitis brachial:   Radiologically isolated syndrome:   Rash:   Rash erythematous:   Rash pruritic:   Rasmussen encephalitis:   Raynaud&amp;rsquo;s phenomenon:   Reactive capillary endothelial proliferation:   Relapsing multiple sclerosis:   Relapsing-remitting multiple sclerosis:   Renal amyloidosis:   Renal arteritis:   Renal artery thrombosis:   Renal embolism:   Renal failure:   Renal vascular thrombosis:   Renal vasculitis:   Renal vein embolism:   Renal vein thrombosis:   Respiratory arrest:   Respiratory disorder:   Respiratory distress:   Respiratory failure:   Respiratory paralysis:   Respiratory syncytial virus bronchiolitis:   Respiratory syncytial virus bronchitis:   Retinal artery embolism:   Retinal artery occlusion:   Retinal artery thrombosis:   Retinal vascular thrombosis:   Retinal vasculitis:   Retinal vein occlusion:   Retinal vein thrombosis:   Retinol binding protein decreased:   Retinopathy:   Retrograde portal vein flow:   Retroperitoneal fibrosis:   Reversible airways obstruction:   Reynold&amp;rsquo;s syndrome:   Rheumatic brain disease:   Rheumatic disorder:   Rheumatoid arthritis:   Rheumatoid factor increased:   Rheumatoid factor positive:   Rheumatoid factor quantitative increased:   Rheumatoid lung:   Rheumatoid neutrophilic dermatosis:   Rheumatoid nodule:   Rheumatoid nodule removal:   Rheumatoid scleritis:   Rheumatoid vasculitis:   Saccadic eye movement:   SAPHO syndrome:   Sarcoidosis:   SARS-CoV-1 test:   SARS-CoV-1 test negative:   SARS-CoV-1 test positive:   SARS-CoV-2 antibody test:   SARS-CoV-2 antibody test negative:   SARS-CoV-2 antibody test positive:   SARS-CoV-2 carrier:   SARS-CoV-2 sepsis:   SARS-CoV-2 test:   SARS- CoV-2 test false negative:   SARS-CoV-2 test false positive:   SARS-CoV-2 test negative:   SARS- CoV-2 test positive:   SARS-CoV-2 viraemia:   Satoyoshi syndrome:   Schizencephaly:   Scleritis:   Sclerodactylia:   Sderoderma:   Sderoderma associated digital ulcer:   Scleroderma renal crisis:   Scleroderma-like reaction:   Secondary amyloidosis:   Secondary cerebellar degeneration:   Secondary progressive multiple sclerosis:   Segmented hyalinising vasculitis:   Seizure:   Seizure anoxic:   Seizure cluster:   Seizure like phenomena:   Seizure prophylaxis:   Sensation of foreign body:   Septic embolus:   Septic pulmonary embolism:   Severe acute respiratory syndrome:   Severe myoclonic epilepsy of infancy:   Shock:   Shock symptom:   Shrinking lung syndrome:   Shunt thrombosis:   Silent thyroiditis:   Simple partial seizures:   Sjogren&amp;rsquo;s syndrome:   Skin swelling:   SLE arthritis:   Smooth muscle antibody positive:   Sneezing:   Spinal artery embolism:   Spinal artery thrombosis:   Splenic artery thrombosis:   Splenic embolism:   Splenic thrombosis:   Splenic vein thrombosis:   Spondylitis:   Spondyloarthropathy:   Spontaneous heparin-induced thrombocytopenia syndrome:   Status epilepticus:   Stevens-Johnson syndrome:   Stiff leg syndrome:   Stiff person syndrome:   Stillbirth:   Still&amp;rsquo;s disease:   Stoma site thrombosis:   Stoma site vasculitis:   Stress cardiomyopathy:   Stridor:   Subacute cutaneous lupus erythematosus:   Subacute endocarditis:   Subacute inflammatory demyelinating polyneuropathy:   Subclavian artery embolism:   Subclavian artery thrombosis:   Subclavian vein thrombosis:   Sudden unexplained death in epilepsy:   Superior sagittal sinus thrombosis:   Susac&amp;rsquo;s syndrome:   Suspected COVID- 19:   Swelling:   Swelling face:   Swelling of eyelid:   Swollen tongue:   Sympathetic ophthalmia:   Systemic lupus erythematosus:   Systemic lupus erythematosus disease activity index abnormal:   Systemic lupus erythematosus disease activity index decreased:   Systemic lupus erythematosus disease activity index increased:   Systemic lupus erythematosus rash:   Systemic scleroderma:   Systemic sclerosis pulmonary:   Tachycardia:   Tachypnoea:   Takayasu&amp;rsquo;s arteritis:   Temporal lobe epilepsy:   Terminal ileitis:   Testicular autoimmunity:   Throat tightness:   Thromboangiitis obliterans:   Thrombocytopenia:   Thrombocytopenic purpura:   Thrombophlebitis:   Thrombophlebitis migrans:   Thrombophlebitis neonatal:   Thrombophlebitis septic:   Thrombophlebitis superficial:   Thromboplastin antibody positive:   Thrombosis:   Thrombosis corpora cavernosa:   Thrombosis in device:   Thrombosis mesenteric vessel:   Thrombotic cerebral infarction:   Thrombotic microangiopathy:   Thrombotic stroke:   Thrombotic thrombocytopenic purpura:   Thyroid disorder:   Thyroid stimulating immunoglobulin increased:   Thyroiditis:   Tongue amyloidosis:   Tongue biting:   Tongue oedema:   Tonic clonic movements:   Tonic convulsion:   Tonic posturing:   Topectomy:   Total bile acids increased:   Toxic epidermal necrolysis:   Toxic leukoencephalopathy:   Toxic oil syndrome:   Tracheal obstruction:   Tracheal oedema:   Tracheobronchitis:   Tracheobronchitis mycoplasmal:   Tracheobronchitis viral:   Transaminases abnormal:   Transaminases increased:   Transfusion-related alloimmune neutropenia:   Transient epileptic amnesia:   Transverse sinus thrombosis:   Trigeminal nerve paresis:   Trigeminal neuralgia:   Trigeminal palsy:   Truncus coeliacus thrombosis:   Tuberous sclerosis complex:   Tubulointerstitial nephritis and uveitis syndrome:   Tumefactive multiple sclerosis:   Tumour embolism:   Tumour thrombosis:   Type 1 diabetes mellitus:   Type I hypersensitivity:   Type III immune complex mediated reaction:   Uhthoffs phenomenon:   Ulcerative keratitis:   Ultrasound liver abnormal:   Umbilical cord thrombosis:   Uncinate fits:   Undifferentiated connective tissue disease:   Upper airway obstruction:   Urine bilirubin increased:   Urobilinogen urine decreased:   Urobilinogen urine increased:   Urticaria:   Urticaria papular:   Urticarial vasculitis:   Uterine rupture:   Uveitis:   Vaccination site thrombosis:   Vaccination site vasculitis:   Vagus nerve paralysis:   Varicella:   Varicella keratitis:   Varicella post vaccine:   Varicella zoster gastritis:   Varicella zoster oesophagitis:   Varicella zoster pneumonia:   Varicella zoster sepsis:   Varicella zoster virus infection:   Vasa praevia:   Vascular graft thrombosis:   Vascular pseudoaneurysm thrombosis:   Vascular purpura:   Vascular stent thrombosis:   Vasculitic rash:   Vasculitic ulcer:   Vasculitis:   Vasculitis gastrointestinal:   Vasculitis necrotising:   Vena cava embolism:   Vena cava thrombosis:   Venous intravasation:   Venous recanalisation:   Venous thrombosis:   Venous thrombosis in pregnancy:   Venous thrombosis limb:   Venous thrombosis neonatal:   Vertebral artery thrombosis:   Vessel puncture site thrombosis:   Visceral venous thrombosis:   VIth nerve paralysis:   VIth nerve paresis:   Vitiligo:   Vocal cord paralysis:   Vocal cord paresis:   Vogt-Koyanagi-Harada disease:   Warm type haemolytic anaemia:   Wheezing:   White nipple sign:   XIth nerve paralysis:   X-ray hepatobiliary abnormal:   Young&amp;rsquo;s syndrome:   Zika virus associated Guillain Barre syndrome.&lt;/p></description></item><item><title>Pfizer knew of 290 kinds of COVID vaccine problems</title><link>/posts/pfizer-knew-of-290-kinds-of-covid-vaccine-problems.html</link><pubDate>Fri, 10 Dec 2021 00:00:00 +0000</pubDate><guid>/posts/pfizer-knew-of-290-kinds-of-covid-vaccine-problems.html</guid><description>&lt;p>&lt;strong>Update March 11, 2022 - this list may be a list of &amp;ldquo;POSSIBLE&amp;rdquo; vaccine problems&lt;br>
Strange that a list of possible problems should be kept hidden from the medical community&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Freedom of Information Act got the release confidential information about COVID-19 Vaccine&lt;br>
There was so much information that the &lt;a href="https://childrenshealthdefense.org/defender/fda-75-years-release-pfizer-vaccine-documents/?utm_source=salsa&amp;amp;eType=EmailBlastContent&amp;amp;eId=1db64140-a89e-465b-bfe5-4b7943e6538f">FDA says it wlil deliver some each year over the next 75 years&lt;/a>&lt;br>
Here is one item released in 2021&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#536-cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048-bnt162b2-received-through-28-feb-2021">5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#appendix-1-list-of-adverse-events-of-special-interest">APPENDIX 1 LIST OF ADVERSE EVENTS OF SPECIAL INTEREST&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#some-vaccine-publications-in-vitamindwiki">Some Vaccine publications in VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#125-vaccination-publications-in-vitamindwikipostsvaccination-publications-in-vitamindwiki-as-of-dec-2021">125 &lt;a href="/posts/vaccination-publications-in-vitamindwiki">Vaccination publications in VitaminDWiki&lt;/a> as of Dec 2021&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="536-cumulative-analysis-of-post-authorization-adverse-event-reports-of-pf-07302048-bnt162b2-received-through-28-feb-2021">5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021&lt;/h3>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/pfizer-foia.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Vitamin K2 MK- 7 not as available if have Chronic Kidney Disease</title><link>/posts/vitamin-k2-mk-7-not-as-available-if-have-chronic-kidney-disease.html</link><pubDate>Thu, 11 Nov 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-k2-mk-7-not-as-available-if-have-chronic-kidney-disease.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#altered-vitamin-k-biodistribution-and-metabolism-in-experimental-and-human-chronic-kidney-disease">Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease.&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#vitamindwiki">VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="altered-vitamin-k-biodistribution-and-metabolism-in-experimental-and-human-chronic-kidney-disease">Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease.&lt;/h4>
&lt;p>Kidney International online 11 November 2021, &lt;a href="https://doi.org/10.1016/j.kint.2021.10.029">https://doi.org/10.1016/j.kint.2021.10.029&lt;/a>&lt;/p>
&lt;p>NadineKaeslerPhD12FelixSchreibingMD12ThimoteusSpeerMD, PhD34Sofia de laPuente-SecadesM.Sc5NikolasRappM.Sc6ChristianeDrechslerMD7NazaninKabganiPhD2ChristophKuppeMD12PeterBoorMD, PhD81VeraJankowskiPhD5LeonSchurgersPhD126RafaelKramannMD, PhD129∗JürgenFloegeMD1∗&lt;/p>
&lt;p>Chronic kidney disease (CKD) is accompanied with extensive cardiovascular calcification, in part correlating with functional vitamin K deficiency. Here, we sought to determine causes for vitamin K deficiency beyond reduced dietary intake. Initially, vitamin K uptake and distribution into circulating lipoproteins after a single administration of vitamin K1 plus K2 (menaquinone 4 and menaquinone 7, respectively) was determined in patients on dialysis therapy and healthy individuals.&lt;/p></description></item><item><title>French recommended 200,000 IU of Vitamin D to stop COVID-19</title><link>/posts/french-recommended-200000-iu-of-vitamin-d-to-stop-covid-19.html</link><pubDate>Sun, 24 Oct 2021 00:00:00 +0000</pubDate><guid>/posts/french-recommended-200000-iu-of-vitamin-d-to-stop-covid-19.html</guid><description>&lt;p>&lt;strong>Two articles in French after Google Translation to English&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#beneficial-effect-of-vitamin-d-in-covid-what-are-thedata">Beneficial effect of vitamin D in Covid: what are the data?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-in-covid-the-answers-to-your-questions--interview-of-cédric-annweiler">Vitamin D in Covid: the answers to your questions  - Interview of Cédric Annweiler&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#french-consensus--200000-iu-of-vitamin-d-if-get-covid-19--dec-22-2020postsfrench-consensus-200000-iu-of-vitamin-d-if-get-covid-19-in-vitamindwiki">&lt;a href="/posts/french-consensus-200000-iu-of-vitamin-d-if-get-covid-19">French Consensus – 200,000 IU of Vitamin D if get COVID-19 – Dec 22, 2020&lt;/a> in VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="beneficial-effect-of-vitamin-d-in-covid-what-are-thedata">Beneficial effect of vitamin D in Covid: what are the data?&lt;/h4>
&lt;p>&lt;strong>&lt;a href="https://www.larevuedupraticien.fr/article/effet-benefique-de-la-vitamine-d-dans-la-covid-quelles-sont-les-donnees">Original in French&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;span style="color:#4e4e4e;">&lt;/span>#4e4e4e:The beneficial role of vitamin D in preventing SARS-CoV-2 infection and severe forms has been suggested by numerous publications. &lt;sup> &lt;/sup>What data are currently available in the literature? What practical messages can we draw from this? What supplementation to offer for prevention and in the event of Covid?  **** Position and recommendations of experts and French national learned societies *. Exclusive!After 12 months of viral circulation, Covid-19, linked to SARS-CoV-2, has infected millions of people around the world, killing hundreds of thousands, especially in the elderly, frail and those with chronic diseases. &lt;sup>1&lt;/sup> In the absence of an effective and accessible curative treatment to date against Covid-19, resorting to already existing molecules could help control the pandemic. The potential beneficial role of vitamin D is discussed in numerous publications. &lt;sup>2-5 &lt;/sup> The objective of this position paper was to  &lt;strong>specify the data currently available in the biomedical literature on this subject, and to draw clear and pragmatic messages from them.&lt;/strong>  with regard to the interest of ensuring a satisfactory vitamin D status in the general population in the context of Covid-19. &lt;strong>Vitamin D as an aid in the prevention of SARS-CoV-2 infection?&lt;/strong>&lt;/p></description></item><item><title>More people with Chronic Kidney Disease are now getting Vitamin D prescriptions (India)</title><link>/posts/more-people-with-chronic-kidney-disease-are-now-getting-vitamin-d-prescriptions-india.html</link><pubDate>Sun, 05 Sep 2021 00:00:00 +0000</pubDate><guid>/posts/more-people-with-chronic-kidney-disease-are-now-getting-vitamin-d-prescriptions-india.html</guid><description>&lt;p>&lt;strong>&lt;a href="/posts/kidney-patients-who-happened-to-be-getting-high-dose-calcitriol-were-9x-less-lik-die-of-covid-19">Kidney patients who happened to be getting high-dose Calcitriol were 9X less likely to die of COVID-19 - April 6, 2021&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/mortality-calcitriol.jpg" alt="image" width="500">
&lt;/div>
&lt;p>Background and objective: Chronic kidney disease (CKD) is a public health problem, which has a prevalence of 17.2% in India. As kidney function decreases, there is a gradual deterioration in the regulation of bone mineral homeostasis. Vitamin D is recognized as the central player in the maintenance of bonehealth in CKD. Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines suggest that vitamin D supplementation should be given to all CKD patients with serum 25-hydroxyvitaminD (25(OH)D) level &amp;lt; 30 ng/mL. Hence we undertook this study to evaluate the vitamin D status in South Indian patients with CKD.&lt;/p></description></item><item><title>Boosting Immunity with Vitamin D to reduce COVID-19 risks</title><link>/posts/boosting-immunity-with-vitamin-d-to-reduce-covid-19-risks.html</link><pubDate>Fri, 06 Aug 2021 00:00:00 +0000</pubDate><guid>/posts/boosting-immunity-with-vitamin-d-to-reduce-covid-19-risks.html</guid><description>&lt;h3 id="abstract">ABSTRACT&lt;/h3>
&lt;p>The severity and deaths from COVID-19 differed between countries. Northern and southern countries were most affected by the first and the second wave of COVID-19. In contrast, the third wave affects geographically restricted regions: certain south-east Asian countries, Brazil, etc. China, Singapore, South Korea, Vietnam, and Hong Kong, countries that previously experienced SARS, met the challenges effectively with better public cooperation and coordinated public health actions. There was a lack of firm policies in the west, ambiguous and politically motivated guidance from health organisations such as WHO and CDC and some governments that eroded trust. Due to the year-long sunlight, countries proximate to the equator reported low prevalence and death rates from COVID-19. Low reported deaths were unrelated to curfew but due to a combination of reasonable vitamin D levels secondary to passive exposure to sunlight, greater use of ivermectin and hydroxychloroquine, and conducting very low (5% of the needed) number of PCT testing. These led to detecting a few PCR positive cases and related deaths. We examined the published data on the impact of vitamin D on immune functions, differences in reported deaths, and cost-effective ways to prevent complications and deaths from COVID-19. Data suggests that sufficient vitamin D is the most crucial factor protecting against infection, reducing complications and deaths from COVID-19. Despite the rhetoric, considering current inequitable immunisations, relatively shortlived immunity, and high mutation rates, global herd immunity is unlikely to be achieved. Based on recent clinical studies, including RCTs, the combination of population-wide supplementation of vitamin D and safe sun exposure, wearing facemasks, and vaccination is the most effective way to keep COVID under control. Boosting and maintaining innate immunity with nutrients (e.g., vitamin D sufficiency) and acquire immunity through vaccination will facilitate having overall, strong immunity. This combined approach would be the most effective and economical way to control the pandemic. Data are pointing that just antibody-based adaptive immune responses primed by prior infection or vaccination are insufficient to prevent SARS.CoV-2 outbreaks. In the absence of such priming, the robust innate and adaptive immune systems ensure rapid recovery and a low risk of complications. This is most effective when the serum 25-hydroxyvitamin D &lt;span>[25(OH) D]&lt;/span> concentration maintained over 50 ng/mL optimal immune systems function.&lt;/p></description></item><item><title>1,000 IU of vitamin D provides little benefit (Kidney transplant in this case)</title><link>/posts/1000-iu-of-vitamin-d-provides-little-benefit-kidney-transplant-in-this-case.html</link><pubDate>Thu, 22 Apr 2021 00:00:00 +0000</pubDate><guid>/posts/1000-iu-of-vitamin-d-provides-little-benefit-kidney-transplant-in-this-case.html</guid><description>&lt;h4 id="correcting-anemia-and-native-vitamin-d-supplementation-in-kidney-transplant-recipients-candle-kit-a-multicenter-22-factorial-open-label-randomized-clinical-trial">Correcting Anemia and Native Vitamin D Supplementation in Kidney Transplant Recipients (CANDLE-KIT): a Multicenter, 2×2 Factorial, Open-label, Randomized Clinical Trial&lt;/h4>
&lt;p>Transpl Int . 2021 Apr 22. &lt;a href="https://doi.org/10.1111/tri.13885">doi: 10.1111/tri.13885&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>&lt;span style="color:#00F;">Increased chance of benefit if they had done one or more of the following:&lt;/span>&lt;br>
Used more vitamin D(say 4,000 IU)&lt;br>
Started dosing weeks before transplant (dialysis often filters out the vitamin D)&lt;br>
Started with a loading dose&lt;br>
Used a different form of Vitamin D (such as Calcitriol)&lt;br>
Used a source of vitamin D that does not require a healthy gut (topical, UVB, injection)&lt;br>
Also added supplements which reduce inflammation (such as Omega-3)&lt;/strong>&lt;/p></description></item><item><title>Hemodialysis associated with very poor mRNA response (wonder if low vitamin D)</title><link>/posts/hemodialysis-associated-with-very-poor-mrna-response-wonder-if-low-vitamin-d.html</link><pubDate>Wed, 31 Mar 2021 00:00:00 +0000</pubDate><guid>/posts/hemodialysis-associated-with-very-poor-mrna-response-wonder-if-low-vitamin-d.html</guid><description>&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/chronic-kidney-disease-decreases-vitamin-d-in-4-ways">Chronic Kidney Disease decreases Vitamin D in 4 ways – Nov 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/hemodialysis-patients-ckd-helped-by-weekly-50000-iu-of-vitamin-d">Hemodialysis patients (CKD) helped by weekly 50,000 IU of vitamin D – Jan 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/patients-on-hemodialysis-3x-more-likely-if-die-of-heart-failure-if-low-magnesium-meta-analysis">Patients on Hemodialysis 3X more likely if die of heart failure if low Magnesium – meta-analysis Jan 2021&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/kidney-dialysis-clinics-reluctant-to-add-vitamin-d-treatment-as-they-are-not-reimbursed">Kidney Dialysis clinics reluctant to add vitamin D treatment as they are not reimbursed – Oct 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/4x-more-chronic-kidney-disease-patients-are-now-using-vitamin-d">4X more Chronic Kidney disease patients are now using vitamin D – March 2014&lt;/a>&lt;/p></description></item><item><title>Vitamin B12 – great improvements with nano forms</title><link>/posts/vitamin-b12-great-improvements-with-nano-forms.html</link><pubDate>Tue, 16 Mar 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-b12-great-improvements-with-nano-forms.html</guid><description>&lt;h3 id="introduction">Introduction&lt;/h3>
&lt;p>Vitamin B12 (VitB12) (also known as cobalamins) is a group of four molecules characterized by a single cobalt atom bound to a corrin-like core, to 5,6-dimethylbenzimidazole (which is bound in turn to a ribose 5-phosphate), and to one variable residue. The latter includes cyanide, hydroxyl group, methyl group, and 5/-deoxyadenosyl group, which determine cyanocobalamin, hydroxocobalamin, methylcobalamin, and 57-deoxyadenosylcobalamin (also named adenosylcobalamin), respectively. The hydroxocobalamin is the VitB12 found in nature and generally used for administration while cyanocobalamin is an artifact of the extractive process which can be converted after ingestion to the active forms methylcobalamin and adenosylcobalamin &lt;span>[1-3]&lt;/span>.&lt;/p></description></item><item><title>Vitamin D is needed during Dialysis – initially only 29 pcnt tested, extensive education raised it to 32 pcnt</title><link>/posts/vitamin-d-is-needed-during-dialysis-initially-only-29-pcnt-tested-extensive-educ-d-it-to-32-pcnt.html</link><pubDate>Sun, 28 Feb 2021 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-needed-during-dialysis-initially-only-29-pcnt-tested-extensive-educ-d-it-to-32-pcnt.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#implementing-evidence-based-vitamin-d-protocol-in-the-dialysis-clinic-an-educational-approach">Implementing Evidence-Based Vitamin D Protocol in the Dialysis Clinic: An Educational Approach&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki">VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="implementing-evidence-based-vitamin-d-protocol-in-the-dialysis-clinic-an-educational-approach">Implementing Evidence-Based Vitamin D Protocol in the Dialysis Clinic: An Educational Approach&lt;/h4>
&lt;p>Nephrol Nurs J . May-Jun 2020;47(3):239-265.&lt;/p>
&lt;p>Chigozie Uko 1 2 3, Rose Utley 4 5&lt;/p>
&lt;p>Vitamin D deficiency is prevalent among patients with chronic kidney disease (CKD) and even more pronounced in patients with kidney failure who are undergoing peritoneal dialysis and hemodialysis. This project was a nurse practitioner-led quality improvement project conducted in an outpatient hemodialysis unit that focused on determining if educating providers and hemodialysis unit clinical staff on vitamin D guidelines increased the awareness and monitoring of patients on hemodialysis. The number of patients screened for vitamin D levels increased from 29% to 100%,&lt;/p></description></item><item><title>Kidney Dialysis often filters out Vitamin D, a problem for vegetarians and others</title><link>/posts/kidney-dialysis-often-filters-out-vitamin-d-a-problem-for-vegetarians-and-others.html</link><pubDate>Sun, 14 Feb 2021 00:00:00 +0000</pubDate><guid>/posts/kidney-dialysis-often-filters-out-vitamin-d-a-problem-for-vegetarians-and-others.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vegetarian-diet-in-dialysis-patients-a-significant-gap-between-actual-intake-and-current-nutritional-recommendations">Vegetarian diet in dialysis patients: A significant gap between actual intake and current nutritional recommendations&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vegetarian-diet-in-dialysis-patients-a-significant-gap-between-actual-intake-and-current-nutritional-recommendations">Vegetarian diet in dialysis patients: A significant gap between actual intake and current nutritional recommendations&lt;/h4>
&lt;p>Medicine (Baltimore). 2021 Feb 12;100(6):e24617. &lt;a href="https://doi.org/10.1097/MD.0000000000024617.">doi: 10.1097/MD.0000000000024617.&lt;/a>&lt;/p>
&lt;p>Mei-Yin Chen 1 2, Shih-Hsiang Ou 3 4, Ming-Chen Yen 1, Meei-Shyuan Lee 5, Nai-Ching Chen 6, Chun-Hao Yin 4, Chien-Liang Chen 3 4 7&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vegetarian-diet-in-dialysis.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Nutritional status is a predictor of mortality and morbidity in dialysis patients. This study aimed to assess dietary behaviors in dialysis patients compared to the recommendations of the Kidney Disease Outcomes Quality Initiative. Ninety five dialysis patients recruited from a hospital completed a 24-hour dietary recall questionnaire. Body weight, energy requirements, protein requirements, albumin, normalized protein catabolic rate, and 25(OH) vitamin D levels were measured.&lt;/p></description></item><item><title>Hemodialysis with low vitamin D increases risk of 2 health problems by 10 percent</title><link>/posts/hemodialysis-with-low-vitamin-d-increases-risk-of-2-health-problems-by-10-percent.html</link><pubDate>Thu, 06 Aug 2020 00:00:00 +0000</pubDate><guid>/posts/hemodialysis-with-low-vitamin-d-increases-risk-of-2-health-problems-by-10-percent.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#the-use-of-activated-vitamin-d-and-risks-of-hospitalization-for-infection-and-amputation-in-incident-hemodialysis-patients-in-taiwan-a-nationwide-population-based-cohort-study">The use of activated vitamin D and risks of hospitalization for infection and amputation in incident hemodialysis patients in Taiwan: a nationwide population-based cohort study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki-kidney-dialysis-and-vitamin-d">VitaminDWiki: Kidney, Dialysis, and Vitamin D&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="the-use-of-activated-vitamin-d-and-risks-of-hospitalization-for-infection-and-amputation-in-incident-hemodialysis-patients-in-taiwan-a-nationwide-population-based-cohort-study">The use of activated vitamin D and risks of hospitalization for infection and amputation in incident hemodialysis patients in Taiwan: a nationwide population-based cohort study&lt;/h4>
&lt;p>BMC Nephrology volume 21, Article number: 331 (2020)&lt;/p>
&lt;p>Jo-Yen Chao, Chung-Yi Li, Ming-Cheng Wang &amp;amp; Yea-Huei Kao Yang&lt;/p></description></item><item><title>Massive Review of papers on Vitamin D and COVID-19</title><link>/posts/massive-review-of-papers-on-vitamin-d-and-covid-19.html</link><pubDate>Fri, 17 Jul 2020 00:00:00 +0000</pubDate><guid>/posts/massive-review-of-papers-on-vitamin-d-and-covid-19.html</guid><description>&lt;p>&lt;strong>A Basic Review of the Preliminary Evidence that Covid-19 Risk and Severity is Increased in Vitamin D Deficiency&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Updated &lt;a href="/posts/influence-of-vitamin-d-on-covid-19-guidebook-benskin">Influence of Vitamin D on COVID-19 (Guidebook) - Benskin Sept 2021&lt;/a>&lt;/strong>&lt;/p>
&lt;p>ResearchGate preprint (undergoing peer review for publication in Frontiers in Public Health)&lt;/p>
&lt;p>Linda L Benskin1,2 &lt;a href="mailto:LindaBenskin@utexas.edu">LindaBenskin@utexas.edu&lt;/a>&lt;/p>
&lt;p>Independent researcher for improving health in rural areas of tropical developing countries, Austin, TX, USA&lt;/p>
&lt;p>Ferris Mfg. Corp., makers of PolyMem® multifunctional dressings, Ft. Worth, TX, USA&lt;/p></description></item><item><title>Vitamin D nanoemulsion, with comments on COVID-19</title><link>/posts/vitamin-d-nanoemulsion-with-comments-on-covid-19.html</link><pubDate>Wed, 03 Jun 2020 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-nanoemulsion-with-comments-on-covid-19.html</guid><description>&lt;p>&lt;strong>COVID-19 PATHOLOGY AND VITAMIN D NANOEMULSION AS PREVENTIVE AND ALTERNATIVE REMEDIATION FOR SEVERITY: A REVIEW&lt;/strong>&lt;/p>
&lt;p>EUROPEAN JOURIALOF BIOMEDICAL AND PHARMACEUTICAL SCIENCES Volume: 7, Issue: 6, 488-499, Year: 2020&lt;/p>
&lt;p>Zoraida P. Aguilar 1,2*, Enaya Alshahim 3 and Hope Vayle Benedict 2&lt;/p>
&lt;p>1 Zystein, Fayetteville, AR, USA 72703. *Corresponding Author:&lt;/p>
&lt;p>2 Biotech Pharmacal, Fayetteville, AR, USA 72704.&lt;/p>
&lt;p>3 University of Arkansas, Fayetteville, AR, USA 72701.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/nanoemulsion-vitamin-d-may-be-a-substantially-better-form">Nanoemulsion Vitamin D may be a substantially better form&lt;/a>&lt;/p></description></item><item><title>Vitamin D testers have different test results if there is chronic kidney disease</title><link>/posts/vitamin-d-testers-have-different-test-results-if-there-is-chronic-kidney-disease.html</link><pubDate>Mon, 02 Dec 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-testers-have-different-test-results-if-there-is-chronic-kidney-disease.html</guid><description>&lt;h4 id="chronic-kidney-disease-is-a-main-confounding-factor-for-25-vitamin-d-measurement">Chronic kidney disease is a main confounding factor for 25-vitamin D measurement&lt;/h4>
&lt;p>J Bras Nefrol. 2019 Sep 26. &lt;a href="https://doi.org/10.1590/2175-8239-JBN-2019-0053.">doi: 10.1590/2175-8239-JBN-2019-0053.&lt;/a>&lt;/p>
&lt;p>Hanna Karla Andrade Guapyassú Machado, Carolina Steller Wagner Martins, Vanda Jorgetti, Rosilene Motta Elias, Rosa Maria Affonso Moysés&lt;/p>
&lt;p>Jornal Brasileiro de Nefrologia: ʹorgão Oficial de Sociedades Brasileira e Latino-Americana de Nefrologia&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:800px">
&lt;p>&lt;strong>The founder of VitaminDWiki does not recall seeing this before&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/more-than-30-ng-of-vitamin-d-is-sometimes-needed-kidney-needs-50-ng">More than 30 ng of vitamin D is sometimes needed (Kidney needs 50 ng) – March 2019&lt;/a>&lt;/p></description></item><item><title>Intensive Care (ICU) helped by Vitamin D – review of past and on-going studies</title><link>/posts/intensive-care-icu-helped-by-vitamin-d-review-of-past-and-on-going-studies.html</link><pubDate>Fri, 14 Jun 2019 00:00:00 +0000</pubDate><guid>/posts/intensive-care-icu-helped-by-vitamin-d-review-of-past-and-on-going-studies.html</guid><description>&lt;h4 id="vitamin-d-and-critical-illness-what-endocrinology-can-learn-from-intensive-care-and-vice-versa">Vitamin D and critical illness: what endocrinology can learn from intensive care and vice versa.&lt;/h4>
&lt;p>Endocr Connect. 2018 Dec 1;7(12):R304-R315. &lt;a href="https://doi.org/10.1530/EC-18-0184.">doi: 10.1530/EC-18-0184.&lt;/a>&lt;/p>
&lt;p>Amrein K1,2, Papinutti A3, Mathew E3,4, Vila G5, Parekh D6.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/icu-adults-getting-540000-iu-of-vitamin-d-were-2x-more-likely-to-be-alive-30-days-later-rct">ICU adults getting 540,000 IU of Vitamin D were 2X more likely to be alive 30 days later – RCT June 2019&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/improve-your-health-before-surgery-prehabilitation-helps-your-recovery-2018">Improve your health BEFORE surgery (prehabilitation) helps your recovery - 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/10-fewer-days-of-icu-mechanical-ventilation-300000-iu-injection-of-vitamin-d-rct">10 fewer days of ICU Mechanical Ventilation 300,000 IU injection of vitamin D – RCT March 2019&lt;/a>&lt;/p></description></item><item><title>Poor kidneys rarely get enough or the right form of vitamin D</title><link>/posts/poor-kidneys-rarely-get-enough-or-the-right-form-of-vitamin-d.html</link><pubDate>Mon, 25 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/poor-kidneys-rarely-get-enough-or-the-right-form-of-vitamin-d.html</guid><description>&lt;h4 id="cross-sectional-evaluation-of-the-relationship-between-vitamin-d-status-and-supplement-use-across-levels-of-kidney-function-in-adults">Cross-sectional evaluation of the relationship between vitamin D status and supplement use across levels of kidney function in adults.&lt;/h4>
&lt;p>BMJ Open. 2019 Feb 22;9(2):e022471. &lt;a href="https://doi.org/10.1136/bmjopen-2018-022471.">doi: 10.1136/bmjopen-2018-022471.&lt;/a>&lt;/p>
&lt;p>Moore LW1,2, Suki WN3, Lunsford KE1,4, Sabek OM1,4, Knight RJ1,4, Gaber AO1,4.&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:750px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/chronic-kidney-disease-patients-need-more-than-20-ng-of-vitamin-d-workshop-conclusion">Chronic Kidney Disease patients need more than 20 ng of Vitamin D – workshop conclusion Oct 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/chronic-kidney-treatment-by-vitamin-d-lacks-consensus-type-how-much">Chronic kidney treatment by Vitamin D lacks consensus: type, how much – Sept 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/diabetic-nephropathy-kidney-treated-by-50000-iu-of-vitamin-d-weekly-rct">Diabetic nephropathy (Kidney) treated by 50,000 IU of vitamin D weekly – RCT Jan 2019&lt;/a>&lt;/p></description></item><item><title>Vitamin K1 and Vitamin K2 importance to health</title><link>/posts/vitamin-k1-and-vitamin-k2-importance-to-health.html</link><pubDate>Sat, 23 Feb 2019 00:00:00 +0000</pubDate><guid>/posts/vitamin-k1-and-vitamin-k2-importance-to-health.html</guid><description>&lt;ul>
&lt;li>&lt;a href="/posts/vitamin-k-is-important-to-health-review">Vitamin K is important to health - review Jan 2020&lt;/a>&lt;/li>
&lt;/ul>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/k1-k2.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/k1-k2-body.jpg" alt="image" width="300">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/k2-functions.jpg" alt="image" width="1000">
&lt;p>Vitamin K is an essential bioactive compound required for optimal body function. Vitamin K can be present in various isoforms, distinguishable by two main structures, namely, phylloquinone (K1) and menaquinones (K2). The difference in structure between K1 and K2 is seen in different absorption rates, tissue distribution, and bioavailability. Although differing in structure, both act as cofactor for the enzyme gamma-glutamylcarboxylase, encompassing both hepatic and extrahepatic activity. Only carboxylated proteins are active and promote a health profile like hemostasis. Furthermore, vitamin K2 in the form of MK-7 has been shown to be a bioactive compound in regulating osteoporosis, atherosclerosis, cancer and inflammatory diseases without risk of negative side effects or overdosing. This review is the first to highlight differences between isoforms vitamin K1 and K2 by means of source, function, and extrahepatic activity.&lt;/p></description></item><item><title>Vitamin D accumulation in 1 in 300 people due to gene (CYP24A1) can cause Calcium problems</title><link>/posts/vitamin-d-accumulation-in-1-in-300-people-due-to-gene-cyp24a1-can-cause-calcium-problems.html</link><pubDate>Sun, 30 Dec 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-accumulation-in-1-in-300-people-due-to-gene-cyp24a1-can-cause-calcium-problems.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#cyp24a1-mutations-and-human-disease-1-are-carriers---2016">CYP24A1 mutations and human disease (1% are carriers) - 2016&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-hypercalcaemia-of-cyp24a1-inactivation-1---aug-2015">The hypercalcaemia of CYP24A1 inactivation (1%?) - Aug 2015&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#see-also-vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b--oct-2022postsvitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b">See also &lt;a href="/posts/vitamin-d-non-responders-may-have-one-or-more-poor-genes-gc-lipc-cyp24a1-and-pde3b">Vitamin D non-responders may have one or more poor genes: GC, LIPC, CYP24A1, and PDE3B – Oct 2022&lt;/a>&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h3 id="cyp24a1-mutations-and-human-disease-1-are-carriers---2016">CYP24A1 mutations and human disease (1% are carriers) - 2016&lt;/h3>
&lt;p>Endocrine Abstracts (2016) 41 S14.3 | DOI: 10.1530/endoabs.41.S14.3&lt;/p>
&lt;p>Glenville Jones&lt;/p>
&lt;p>Idiopathic infantile hypercalcemia (IIH) constitutes a broad group of diseases with a common outcome namely, hypercalcemia. It is now recognized that mutations of the vitamin D catabolic cytochrome P450, CYP24A1 represent one of the major causes of IIH. Patients often present in neonatal life with transient hypercalcemia, but adults with hypercalciuria, renal stones &amp;amp; nephrocalcinosis also appear with CYP24A1 defects. Recently, there have been reports that pregnant females with IIH can suffer hypercalcemic episodes during pregnancy, presumably due to increased synthesis of 1,25-(OH)2D3 by the placenta, that abate after pregnancy.&lt;/p></description></item><item><title>Hemodialysis deaths less likely if take vitamin D, especially if highest dose vitamin D</title><link>/posts/hemodialysis-deaths-less-likely-if-take-vitamin-d-especially-if-highest-dose-vitamin-d.html</link><pubDate>Sat, 10 Nov 2018 00:00:00 +0000</pubDate><guid>/posts/hemodialysis-deaths-less-likely-if-take-vitamin-d-especially-if-highest-dose-vitamin-d.html</guid><description>&lt;h4 id="assessing-the-effect-of-oral-activated-vitamin-d-on-overall-survival-in-hemodialysis-patients-a-landmark-analysis">Assessing the effect of oral activated vitamin D on overall survival in hemodialysis patients: a landmark analysis&lt;/h4>
&lt;p>BMC Nephrology201819:309, &lt;a href="https://doi.org/10.1186/s12882-018-1111-2">https://doi.org/10.1186/s12882-018-1111-2&lt;/a>&lt;/p>
&lt;p>Jo-Yen Chao, Hsu-Chih Chien, Te-Hui Kuo, Yu-Tzu Chang, Chung-Yi Li, Ming-Cheng Wang and Yea-Huei Kao YangE&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>Poor kidney ==&amp;gt; poor conversion of Vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Very poor kidney ==&amp;gt; Hemodialysis (filtering of blood)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Some Hemodialysis devices filter out Vitamin D&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Some Hemodialysis centers used to restore Vitamin D&lt;/p>
&lt;ul>
&lt;li>&lt;a href="/posts/kidney-dialysis-clinics-reluctant-to-add-vitamin-d-treatment-as-they-are-not-reimbursed">The US govt no longer compensates for vitamin D restoration, so centers are reluctqant to do it.&lt;/a>&lt;/li>
&lt;/ul>
&lt;/li>
&lt;/ul>
&lt;hr>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/hemodialysis-and-vitamin-d-many-studies">Hemodialysis and Vitamin D - many studies&lt;/a> 38 studies as of Jan 2023&lt;/p></description></item><item><title>Vitamin D for adults and elderly – review</title><link>/posts/vitamin-d-for-adults-and-elderly-review.html</link><pubDate>Tue, 16 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-for-adults-and-elderly-review.html</guid><description>&lt;h3 id="introduction">Introduction&lt;/h3>
&lt;p>Vitamin D deficiency is common world-wide and is a public health problem that needs to be addressed since deficiency is reported in between 30 and 80% of populations at all ages, and in tropical as well as temperate and colder countries. This review, therefore, outlines, in brief, our current understanding of the benefits to human health of adequate long-term vitamin D provision through reports of its effects on health outcomes (clinical and epidemiological data), of its &amp;lsquo;modus operandi&amp;rsquo; (mechanistic effects), of the changes in vitamin D patho-physiology with age, and of the scale of vitamin D deficiency internationally.&lt;/p></description></item><item><title>Chronic kidney treatment by Vitamin D lacks consensus: type, how much</title><link>/posts/chronic-kidney-treatment-by-vitamin-d-lacks-consensus-type-how-much.html</link><pubDate>Wed, 03 Oct 2018 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-treatment-by-vitamin-d-lacks-consensus-type-how-much.html</guid><description>&lt;h4 id="native-vitamin-d-in-pre-dialysis-chronic-kidney-disease">Native vitamin D in pre-dialysis chronic kidney disease.&lt;/h4>
&lt;p>Nefrologia. 2018 Sep 28. pii: S0211-6995(18)30123-1. &lt;a href="https://doi.org/10.1016/j.nefro.2018.07.004">doi: 10.1016/j.nefro.2018.07.004&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/hypothesis-magnesium-might-prevent-and-treat-chronic-kidney-disease">Hypothesis: Magnesium might prevent and treat Chronic Kidney Disease – April 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/dialysis-patients-23-percent-more-likely-to-live-if-had-just-10-ng-more-vitamin-d-meta-analysis">Dialysis patients 23 percent more likely to live if had just 10 ng more Vitamin D – meta-analysis Feb 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/uv-is-one-of-the-ways-to-increase-vitamin-d-levels-even-with-poor-kidney">UV is one of the ways to increase Vitamin D levels, even with poor kidney – Jan 2018&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/standard-oral-vitamin-d-is-not-a-good-way-to-supplement-if-have-chronic-kidney-disease">Standard oral vitamin D is not a good way to supplement if have Chronic Kidney Disease – March 2016&lt;/a> &lt;strong>Promising other methods include: UV, topical, gut-friendly, injection, inhaled, sublingual, spray&lt;/strong>&lt;/p></description></item><item><title>Vitamin D and Vitamin K together fight CVD Part 1- Pizzorno</title><link>/posts/vitamin-d-and-vitamin-k-together-fight-cvd-part-1-pizzorno.html</link><pubDate>Mon, 27 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-vitamin-k-together-fight-cvd-part-1-pizzorno.html</guid><description>&lt;p>&lt;strong>Vitamin D and Vitamin K Team Up to Lower CVD Risk: Part I&lt;/strong>&lt;/p>
&lt;p>by Lara Pizzorno&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-k-cardiovascular-and-interactions-with-vitamin-d-and-vitamin-a-pizzorno">Vitamin K, Cardiovascular and interactions with Vitamin D and Vitamin A – Pizzorno July 2018&lt;/a>&lt;/p>
&lt;ul>
&lt;li>Vitamin D and Vitamin K Team Up to Lower CVD Risk: Part II&lt;/li>
&lt;/ul>
&lt;/li>
&lt;/ul>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#part-i--vitamin-d-deficiency--a-non-traditional-risk-factor-for-cardiovascular-disease">Part I : Vitamin D Deficiency – a Non-Traditional Risk Factor for Cardiovascular Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cardiovascular-disease">Vitamin D and Cardiovascular Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#myocardial-infarction">Myocardial infarction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#peripheral-arterial-disease">Peripheral arterial disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hypertension-and-cardiac-hypertrophy">Hypertension and cardiac hypertrophy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#obesity">Obesity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cholesterol-vitamin-d-statin-connection---chart">Cholesterol, Vitamin D, Statin Connection - chart&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#conclusion">Conclusion&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#about-lara-pizzorno">About Lara Pizzorno&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>Strong correlations have been noted between cardiovascular diseases and low bone density / osteoporosis—connections so strong that the presence of one type of pathology is considered a likely predictor of the other. This potentially causal relationship has led to the hypothesis that these conditions share core mechanisms. Recent advances in our understanding of the complimentary roles played by vitamin D3 and vitamin K2 in vascular and bone health provide support for this hypothesis, along with insight into key metabolic dysfunctions underlying cardiovascular disease and osteoporosis.&lt;/p></description></item><item><title>International Conferences on Controversies on Vitamin D (2017,18,19)</title><link>/posts/international-conferences-on-controversies-on-vitamin-d-20171819.html</link><pubDate>Wed, 22 Aug 2018 00:00:00 +0000</pubDate><guid>/posts/international-conferences-on-controversies-on-vitamin-d-20171819.html</guid><description>&lt;p>&lt;strong>Conferences Held in Italy, apparently sponsored by drug companies&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;a href="https://www.aicgroup.it/2nd-international-conference-on-controversies-in-vitamin-d-borgo-san-luigi-11-14-september-2018">2nd Conf Sept 2018&lt;/a>&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/2nd-international-conf..jpg" alt="image" width="300">
&lt;p>&lt;strong>3rd - Sept 2019&lt;/strong>&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/controversey-3rd.jpg" alt="image" width="300">
&lt;p>&lt;strong>Therapeutics of Vitamin D&lt;/strong>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>The conference and many of the authors are funded by drug companies&lt;/p>
&lt;p>Not surpisingly they ignore the Vitamin D studies which show good results&lt;/p>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/therapeutics-of-vitamin-d.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-as-a-therapeutic-agent-and-its-administration">Vitamin D as a therapeutic agent and its administration&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#specific-therapeutic-areas-relating-to-vitamin-d">Specific therapeutic areas relating to vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#recent-major-and-ongoing-vitamin-d-rcts">Recent major and ongoing vitamin D RCTs&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#future-opportunities">Future Opportunities&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#research-agenda">Research Agenda&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references">REFERENCES&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;p>Ebeling PR1, Adler RA2, Jones G3, Liberman UA4, Mazziotti G5,&lt;/p></description></item><item><title>Pancreatic cancer prevention and treatment by alternates – Vitamin D, Vitamin C, Curcumin, etc</title><link>/posts/pancreatic-cancer-prevention-and-treatment-by-alternates-vitamin-d-vitamin-c-curcumin-etc.html</link><pubDate>Tue, 24 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/pancreatic-cancer-prevention-and-treatment-by-alternates-vitamin-d-vitamin-c-curcumin-etc.html</guid><description>&lt;h4 id="vitamin-d-section-of-the-pdf">Vitamin D section of the PDF&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/pamcreatic-cancer.jpg" alt="image" width="600">
&lt;h5 id="vitamin-d-deficiency-and-cancer">Vitamin D deficiency and cancer&lt;/h5>
&lt;p>Vitamin D deficiency appears common in most cancer patients. One study found that 75% of cancer patients had low vitamin D levels. In this study, low serum vitamin D levels predicted advanced-stage disease. In fact, in patients with levels under 24 ng/mL, the risk of stage 3 disease was almost triple that of those with higher vitamin D levels.2&lt;/p></description></item><item><title>Better erection associated with better Vitamin D</title><link>/posts/better-erection-associated-with-better-vitamin-d.html</link><pubDate>Thu, 05 Jul 2018 00:00:00 +0000</pubDate><guid>/posts/better-erection-associated-with-better-vitamin-d.html</guid><description>&lt;h4 id="the-effect-of-low-vitamin-d-status-on-sexual-functioning-and-depressive-symptoms-in-apparently-healthy-men-a-pilot-study">The effect of low vitamin D status on sexual functioning and depressive symptoms in apparently healthy men: a pilot study&lt;/h4>
&lt;p>Robert Krysiak 1, Anna Szwajkosz 2 &amp;amp; Bogusław Okopień 1&lt;/p>
&lt;p>International J. of Impotence Research (2018) DOI: &lt;a href="https://doi.org/10.1038/s41443-018-0041-7">https://doi.org/10.1038/s41443-018-0041-7&lt;/a>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Department of Internal Medicine and Clinical Pharmacology, Medical University of Silesia, Katowice, Poland&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Oncology Ward, Beskid Oncology Centre—John Paul II Municipal Hospital in Bielsko-Biała, Bielsko-Biała, Poland&lt;/p>
&lt;/li>
&lt;/ol>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>| | | | |
| &amp;mdash; | &amp;mdash; | &amp;mdash; | &amp;mdash; |
| | Group A&lt;br>15 men | Group B&lt;br>16 men | Group C&lt;br>16 men |
| Vitamin D | 14 ng | 24 ng | 40 ng |
| Erectile function | 25 | 28 | 29 |
| Orgasmic Function | 7.3 | 9.1 | 9.4 |
| Sexual Desire | 7.0 | 8.5 | 9.3 |
| Depressive symptoms | 27 % | 12 % | 6% |&lt;/strong>&lt;/p></description></item><item><title>Vitamin D toxicity is extremely rare, none if less than 180 ng</title><link>/posts/vitamin-d-toxicity-is-extremely-rare-none-if-less-than-180-ng.html</link><pubDate>Thu, 31 May 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-toxicity-is-extremely-rare-none-if-less-than-180-ng.html</guid><description>&lt;h4 id="vitamin-d-toxicity-a-16-year-retrospective-study-at-an-academic-medical-center">Vitamin D Toxicity: A 16-Year Retrospective Study at an Academic Medical Center.&lt;/h4>
&lt;p>Lab Med. 2018 Mar 21;49(2):123-129. &lt;a href="https://doi.org/10.1093/labmed/lmx077.">doi: 10.1093/labmed/lmx077.&lt;/a>&lt;/p>
&lt;p>Lee JP1, Tansey M2, Jetton JG3, Krasowski MD1.&lt;/p>
&lt;p>1 Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, IA.&lt;/p>
&lt;p>2 Divisions of Pediatric Endocrinology, University of Iowa Stead Family Children&amp;rsquo;s Hospital, Iowa City, IA.&lt;/p>
&lt;p>3 Divisions of Pediatric Nephrology, Dialysis, and Transplantation, University of Iowa Stead Family Children&amp;rsquo;s Hospital, Iowa City, IA.&lt;/p></description></item><item><title>Vitamin D Supplementation May Help Ease Depression</title><link>/posts/vitamin-d-supplementation-may-help-ease-depression.html</link><pubDate>Thu, 10 May 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-supplementation-may-help-ease-depression.html</guid><description>&lt;h4 id="american-psychiatric-association-meeting-poster-p3-096-presented-may-6-2018httpswwwmedscapecomviewarticle896449srcrssvp_2-medscape">&lt;a href="https://www.medscape.com/viewarticle/896449?src=rss#vp_2">American Psychiatric Association Meeting Poster P3-096, presented May 6, 2018.&lt;/a> Medscape&lt;/h4>
&lt;p>&lt;strong>systematic review and meta-analysis of five randomized controlled trials&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>A 6-week study published in 2011 found no effect of daily supplementation with 5000 IU cholecalciferol on ratings of depression in a group of young healthy adults.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>An 8-week study published in 2013 found that daily supplemention with 1500 IU vitamin D3 plus 20 mg fluoxetine was superior to fluoxetine alone in controlling depressive symptoms in patients with major depressive disorder (MDD).&lt;/p></description></item><item><title>Vitamin D recommendations by Italian Endocrinologists – 40 ng if pregnant, 30 ng if high risk</title><link>/posts/vitamin-d-recommendations-by-italian-endocrinologists-40-ng-if-pregnant-30-ng-if-high-risk.html</link><pubDate>Fri, 27 Apr 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-recommendations-by-italian-endocrinologists-40-ng-if-pregnant-30-ng-if-high-risk.html</guid><description>&lt;h4 id="italian-association-of-clinical-endocrinologists-ame-and-italian-chapter-of-the-american-association-of-clinical-endocrinologists-aace-position-statement-clinical-management-of-vitamin-d-deficiency-in-adults">Italian Association of Clinical Endocrinologists (AME) and Italian Chapter of the American Association of Clinical Endocrinologists (AACE) Position Statement: Clinical Management of Vitamin D Deficiency in Adults&lt;/h4>
&lt;p>Nutrients 2018, 10(5), 546; &lt;a href="https://doi.org/10.3390/nu10050546">https://doi.org/10.3390/nu10050546&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FFFAE2;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;p>&lt;strong>High risk adults should have also included&lt;/strong>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Dark skin&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Wear concealing clothing&lt;/p>
&lt;/li>
&lt;li>
&lt;p>People who get very little noon-day sun&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Diabetic&lt;/p>
&lt;/li>
&lt;li>
&lt;p>On dialysis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Multiple Sclerosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Gut problems&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Gallbladder removed&lt;/p>
&lt;/li>
&lt;li>
&lt;p>HIV&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Depression&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Anemia&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Little Magnesium in water&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Take drugs which remove Magnesium from Body&lt;/p></description></item><item><title>Dialysis patients 23 percent more likely to live if had just 10 ng more Vitamin D – meta-analysis</title><link>/posts/dialysis-patients-23-percent-more-likely-to-live-if-had-just-10-ng-more-vitamin-d-meta-analysis.html</link><pubDate>Tue, 27 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/dialysis-patients-23-percent-more-likely-to-live-if-had-just-10-ng-more-vitamin-d-meta-analysis.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-status-and-mortality-risk-among-patients-on-dialysis-a-systematic-review-and-meta-analysis-of-observational-studies">Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-status-and-mortality-risk-among-patients-on-dialysis-a-systematic-review-and-meta-analysis-of-observational-studies">Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies&lt;/h4>
&lt;p>Nephrology Dialysis Transplantation, gfy016, &lt;a href="https://doi.org/10.1093/ndt/gfy016">https://doi.org/10.1093/ndt/gfy016&lt;/a>&lt;/p>
&lt;p>Yuhui Zhang Darsy Darssan Elaine M Pascoe David W Johnson Haichen Pi Jie Dong&lt;/p>
&lt;hr>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/dialysis-meta-analysis.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p>
&lt;p>Background&lt;/p>
&lt;p>Vitamin D deficiency is highly prevalent in patients on dialysis. Although vitamin D deficiency is closely associated with cardiovascular disease (CVD) and high mortality in the general population, the relationship between serum 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> and all-cause and cardiovascular mortality in dialysis patients is uncertain. We aim to explore the relationship between serum 25(OH)D levels and all-cause and cardiovascular mortality in dialysis patients.&lt;/p></description></item><item><title>UV is one of the ways to increase Vitamin D levels, even with poor kidney</title><link>/posts/uv-is-one-of-the-ways-to-increase-vitamin-d-levels-even-with-poor-kidney.html</link><pubDate>Fri, 16 Feb 2018 00:00:00 +0000</pubDate><guid>/posts/uv-is-one-of-the-ways-to-increase-vitamin-d-levels-even-with-poor-kidney.html</guid><description>&lt;h4 id="partial-body-uv-exposure-in-chronic-kidney-disease-and-extrarenal-vitamin-d-metabolism">Partial Body UV Exposure in Chronic Kidney Disease and Extrarenal Vitamin D Metabolism&lt;/h4>
&lt;p>Anticancer Research 38: 1217-1219 (2018) &lt;a href="https://doi.org/10.21873/anticanres.">doi: 10.21873/anticanres.&lt;/a> 12342&lt;/p>
&lt;p>ROLFDIETER KRAUSE1’2’3, RAINER STANGE1’2, HEINZ JURGEN ROTH4, HEINRICH KAASE5, ANDREAS MICHALSEN1’2 and MICHAEL F. HOLICK6&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:680px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/uvb-increases-vitamin-d-even-if-poor-kidney-by-changing-cyp27b1-genes-in-skin">UVB increases vitamin D even if poor kidney by changing CYP27B1 genes in skin – Dec 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/inhaled-vitamin-d-help-lungs-many-studies">Inhaled vitamin D help lungs - many studies&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/topical-vitamin-d-raised-blood-level-to-38-ng-used-aloe-vera-gel-rct">Topical vitamin D raised blood level to 38 ng (used Aloe Vera gel) – RCT March 2014&lt;/a>&lt;/p></description></item><item><title>Vitamin K and bone – review</title><link>/posts/vitamin-k-and-bone-review.html</link><pubDate>Thu, 25 Jan 2018 00:00:00 +0000</pubDate><guid>/posts/vitamin-k-and-bone-review.html</guid><description>&lt;p>Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):200-206. &lt;a href="https://doi.org/10.11138/ccmbm/2017.14.1.200.">doi: 10.11138/ccmbm/2017.14.1.200.&lt;/a> Epub 2017 Oct 25.&lt;/p>
&lt;p>Maria Fusaro1’2 Maria Cristina Mereu3 Andrea Aghi4 Giorgio Iervasi1 Maurizio Gallieni5&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/overview-vitamin-k-and-vitamin-d">Overview Vitamin K and Vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/bone-formation-in-the-lab-is-aided-by-vitamin-d-vitamin-k1-and-vitamin-k2-meta-analysis">Bone formation in the lab is aided by Vitamin D, Vitamin K1, and Vitamin K2 – meta-analysis Nov 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-k-2-180-ug-mk-7-helped-both-bone-density-and-strength-rct">Vitamin K-2 (180 ug MK-7) helped both bone density and strength – RCT March 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/bone-fracture-low-energy-19x-more-likely-in-children-if-low-vitamin-k2">Bone fracture (low energy) 19X more likely in children if low vitamin K2 - June 2017&lt;/a>&lt;/p></description></item><item><title>Cardiovascular Diseases associated with both Vitamin D and innate immune system (TLR)</title><link>/posts/cardiovascular-diseases-associated-with-both-vitamin-d-and-innate-immune-system-tlr.html</link><pubDate>Sat, 28 Oct 2017 00:00:00 +0000</pubDate><guid>/posts/cardiovascular-diseases-associated-with-both-vitamin-d-and-innate-immune-system-tlr.html</guid><description>&lt;h4 id="the-role-of-toll-like-receptors-and-vitamin-d-in-cardiovascular-diseasesa-review">The Role of Toll-Like Receptors and Vitamin D in Cardiovascular Diseases—A Review&lt;/h4>
&lt;p>Int. J. Mol. Sci. 2017,18,2252; doi:10.3390/ijms18112252&lt;/p>
&lt;p>Daria M. Adamczak&lt;/p>
&lt;p>Dept of Cardiology, Poznan University of Medical Sciences, Dluga Street 1/2, 61-848 Poznan, Poland; &lt;a href="mailto:daria.m.adamczak@gmail.com">daria.m.adamczak@gmail.com&lt;/a>;&lt;/p>
&lt;p>Received: 30 September 2017; Accepted: 25 October 2017; Published: 27 October 2017&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/t1dm-toll-like-receptors-and-vitamin-d-in-rats">T1DM, toll-like receptors and vitamin D in rats – May 2014&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-interactions-inside-of-the-cell">Vitamin D interactions inside of the cell - May 2016&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/innate-and-adaptive-immune-systems-probably-helped-by-vitamin-d">Innate and adaptive immune systems probably helped by vitamin D – Oct 2014&lt;/a>&lt;/p></description></item><item><title>Transdermal Magnesium Review - unsure if it is as good</title><link>/posts/transdermal-magnesium-review-unsure-if-it-is-as-good.html</link><pubDate>Mon, 18 Sep 2017 00:00:00 +0000</pubDate><guid>/posts/transdermal-magnesium-review-unsure-if-it-is-as-good.html</guid><description>&lt;h4 id="myth-or-realitytransdermal-magnesium">Myth or Reality—Transdermal Magnesium?&lt;/h4>
&lt;p>Nutrients 2017, 9, 813; doi:10.3390/nu9080813&lt;/p>
&lt;p>Uwe Grober&amp;rsquo;*, Tanja Werner , Jurgen Vormann 2 and Klaus Kisters 1,3 ®&lt;/p>
&lt;p>Akademie fur Mikronahrstoffmedizin, Zweigertstr. 55, 45130 Essen, Germany; &lt;a href="mailto:kisters@annahospital.de">kisters@annahospital.de&lt;/a>&lt;/p>
&lt;p>IPEV Institute for Prevention and Nutrition, Adalperostr. 37, D-85737 Ismaning, Germany; &lt;a href="mailto:werner.tanja@protina.de">werner.tanja@protina.de&lt;/a> (T.W.); &lt;a href="mailto:vormann@ipev.de">vormann@ipev.de&lt;/a> (J.V.)&lt;/p>
&lt;p>Medizinische Klinik I, St. Anna-Hospital, 44649 Herne, Germany * Correspondence: &lt;a href="mailto:uwegroeber@gmx.net">uwegroeber@gmx.net&lt;/a>&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/transdermal-magnesium-no-solid-proof-no-mention-of-dmso">Transdermal Magnesium – no solid proof, no mention of DMSO – July 2017&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/magnesium-in-the-central-nervous-system-2011-ebook">Magnesium in the Central Nervous System 2011 ebook&lt;/a>&lt;/p></description></item><item><title>Randomized Controlled Trials, vs Pragmatic Trials, vs Health Insurance Trials – NEJM</title><link>/posts/randomized-controlled-trials-vs-pragmatic-trials-vs-health-insurance-trials-nejm.html</link><pubDate>Wed, 06 Sep 2017 00:00:00 +0000</pubDate><guid>/posts/randomized-controlled-trials-vs-pragmatic-trials-vs-health-insurance-trials-nejm.html</guid><description>&lt;h4 id="randomized-controlled-trials-in-health-insurance-systems">Randomized, Controlled Trials in Health Insurance Systems&lt;/h4>
&lt;p>N Engl J Med 2017; 377:957-964 September 7, 2017DOI: 10.1056/NEJMra1510058&lt;/p>
&lt;p>Niteesh K. Choudhry, M.D., Ph.D.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:600px">
&lt;p>&lt;strong>| | |
| &amp;mdash; | &amp;mdash; |
| Randomized Contolled Trials | highest cost, &lt;br>Fewest participants &lt;br>Best controlled&lt;br>Cannot adapt treatment to the patient |
| Pragmatic Trials | lower cost, more real-world than RCT |
| Health Insurance | very low cost, the most real-world&lt;br>a lot of data |&lt;/strong>&lt;/p></description></item><item><title>Vitamin D review</title><link>/posts/vitamin-d-review.html</link><pubDate>Wed, 19 Oct 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Beneficial Effects of UV-Radiation: Vitamin D and beyond&lt;/strong>&lt;/p>
&lt;p>International Journal of Environmental Research and Public Health; 2016,13,1028; doi:10.3390/ijerph13101028&lt;/p>
&lt;p>Christian Trammer, Marlene Pandis 1, Nicolas Verheyen , Martin R. Grubler 1,s,&lt;/p>
&lt;p>Martin Gaksch 1, Barbara Obermayer-Pietsch 1, Andreas Tomaschitz , Thomas R. Pieber 1, Stefan Pilz h* and Verena Schwetz 1&lt;/p>
&lt;p>Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Auenbruggerplatz 15, Graz 8036, Austria; &lt;a href="mailto:christian.trummer@medunigraz.at">christian.trummer@medunigraz.at&lt;/a> (C.T.); &lt;a href="mailto:marlene.pandis@medunigraz.at">marlene.pandis@medunigraz.at&lt;/a> (M.P.); &lt;a href="mailto:martin.gruebler@gmx.net">martin.gruebler@gmx.net&lt;/a> (M.R.G.); &lt;a href="mailto:martin.gaksch@gmail.com">martin.gaksch@gmail.com&lt;/a> (M.G.); &lt;a href="mailto:barbara.obermayer@medunigraz.at">barbara.obermayer@medunigraz.at&lt;/a> (B.O.-P.); &lt;a href="mailto:thomas.pieber@medunigraz.at">thomas.pieber@medunigraz.at&lt;/a> (T.R.P.); &lt;a href="mailto:verena.schwetz@medunigraz.at">verena.schwetz@medunigraz.at&lt;/a> (V.S.)&lt;/p></description></item><item><title>Kidney failure – still debating what form of vitamin D to use</title><link>/posts/kidney-failure-still-debating-what-form-of-vitamin-d-to-use.html</link><pubDate>Thu, 28 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/kidney-failure-still-debating-what-form-of-vitamin-d-to-use.html</guid><description>&lt;h4 id="pro-should-we-correct-vitamin-d-deficiencyinsufficiency-in-chronic-kidney-disease-patients-with-inactive-forms-of-vitamin-d-or-just-treat-them-with-active-vitamin-d-forms">Pro: Should we correct vitamin D deficiency/insufficiency in chronic kidney disease patients with inactive forms of vitamin D or just treat them with active vitamin D forms?&lt;/h4>
&lt;p>Nephrology Dialysis Transplantation Volume 31, Issue 5Pp. 698-705.&lt;/p>
&lt;p>David J.A. Goldsmith, &lt;a href="mailto:david.goldsmith@gstt.nhs.uk">david.goldsmith@gstt.nhs.uk&lt;/a>&lt;/p>
&lt;p>Guy&amp;rsquo;s and St Thomas’ Hospitals, London, UK&lt;/p>
&lt;p>Evidence for the usefulness of using vitamin D to treat ‘renal bone disease’ is now nearly six decades old. In regular clinical practice, however, it is more like three decades, at most, that we have routinely been using vitamin D to try to prevent, or reverse, the impact of hyperparathyroidism on the skeleton of patients with chronic kidney disease (CKD). The practice has been in the main to use high doses of synthetic vitamin D compounds, not naturally occurring ones. However, the pharmacological impacts of the different vitamin D species and of their different modes, and styles of administration cannot be assumed to be uniform across the spectrum. It is disappointingly true to say that even in 2016 there is a remarkable paucity of evidence concerning the clinical benefits of vitamin D supplementation to treat vitamin D insufficiency in patients with stage 3b–5 CKD. This is even more so if we consider the non-dialysis population. While there are a number of studies that report the impact of vitamin D supplementation on serum vitamin D concentrations (unsurprisingly, usually reporting an increase), and some variable evidence of parathyroid hormone concentration suppression, there has been much less focus on hard or semi-rigid clinical end point analysis (e.g. fractures, hospitalizations and overall mortality). Now, in 2016, with the practice pattern changes of first widespread clinical use of vitamin D and second widespread supplementation of cholecalciferol or ergocalciferol by patients (alone, or as multivitamins), it is now, in my view, next to impossible to run a placebo-controlled trial over a decent period of time, especially one which involved clinically meaningful (fractures, hospitalisation, parathyroidectomy, death) end-points. In this challenging situation, we need to ask what it is we are trying to achieve here, and how best to balance potential benefits with potential harm.&lt;/p></description></item><item><title>Vitamin D Receptor Activator might help treat or prevent various diseases</title><link>/posts/vitamin-d-receptor-activator-might-help-treat-or-prevent-various-diseases.html</link><pubDate>Wed, 13 Apr 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-receptor-activator-might-help-treat-or-prevent-various-diseases.html</guid><description>&lt;h4 id="pubmed-vitamin-d-receptor-activator-httpwwwncbinlmnihgovpubmedterm22vitamindreceptoractivator22-89-items-as-of-oct-2018">&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=%22Vitamin+D+Receptor+Activator+%22">PubMed: &amp;ldquo;Vitamin D Receptor Activator &amp;ldquo;&lt;/a> 89 items as of Oct 2018&lt;/h4>
&lt;hr>
&lt;h4 id="predialysis-vitamin-d-receptor-activator-treatment-and-cardiovascular-events-after-dialysis-initiation-a-multicenter-observational-study--april-2016">Predialysis Vitamin D Receptor Activator Treatment and Cardiovascular Events after Dialysis Initiation: A Multicenter Observational Study – April 2016&lt;/h4>
&lt;p>Nephron, (DOI:10.1159/000445507)&lt;/p>
&lt;p>Inaguma D. · Tanaka A. · Shinjo H. · Kato A. · Murata M. · Aichi cohort study of prognosis in patients newly initiated into dialysis (AICOPP) group&lt;/p>
&lt;p>Department of Nephrology, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan&lt;/p></description></item><item><title>Pregnancy and placenta: benefits of vitamin D – 2010</title><link>/posts/pregnancy-and-placenta-benefits-of-vitamin-d-2010.html</link><pubDate>Sun, 06 Mar 2016 00:00:00 +0000</pubDate><guid>/posts/pregnancy-and-placenta-benefits-of-vitamin-d-2010.html</guid><description>&lt;h4 id="vitamin-d-effects-on-pregnancy-and-the-placenta">Vitamin D effects on pregnancy and the placenta&lt;/h4>
&lt;p>J.S. Shina,b, M.Y. Choib, M.S. Longtineb, D.M. Nelson b &lt;a href="mailto:nelsondm@wudosis.wustl.edu">nelsondm@wudosis.wustl.edu&lt;/a>&lt;/p>
&lt;p>a Department of Obstetrics and Gynecology, CHA University School of Medicine, Seoul, Republic of Korea b Department of Obstetrics and Gynecology, Washington University School of Medicine, 4566 Scott Ave, St. Louis, MO 63110, USA&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:700px">
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/healthy-pregnancies-need-lots-of-vitamin-d">Healthy pregnancies need lots of vitamin D&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/the-placenta-and-vitamin-d">The placenta and vitamin D – July 2012&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="https://www.VitaminDWiki.com/Search+Results?hl=en&amp;amp;oe=UTF-8&amp;amp;ie=UTF-8&amp;amp;btnG=Google+Search&amp;amp;googles.x=0&amp;amp;googles.y=0&amp;amp;q=placenta&amp;amp;domains=VitaminDWiki.com&amp;amp;sitesearch=VitaminDWiki.com">Search VitaminDWiki for PLACENTA&lt;/a> 339 items as of Aug 2016&lt;/p></description></item><item><title>Vitamin D – millions of years more ancient than Calcium</title><link>/posts/vitamin-d-millions-of-years-more-ancient-than-calcium.html</link><pubDate>Fri, 08 Jan 2016 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-millions-of-years-more-ancient-than-calcium.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-a-dynamic-molecule-how-relevant-might-the-dynamism-for-a-vitamin-be">Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#history-of-vitamin-by-lorenz-borsche---written-to-a-friend---march-2022">History of Vitamin by Lorenz Borsche - written to a friend - March 2022&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-a-dynamic-molecule-how-relevant-might-the-dynamism-for-a-vitamin-be">Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be?&lt;/h4>
&lt;p>Nephrology Dialysis Transplantation Volume 31, Issue 1Pp. 23-30.&lt;/p>
&lt;p>Sandro Mazzaferro1, &lt;a href="mailto:sandro.mazzaferro@uniroma1.it">sandro.mazzaferro@uniroma1.it&lt;/a> and Marzia Pasquali1&lt;/p>
&lt;p>1Department of Cardiovascular Respiratory Nephrologic Anesthetic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy&lt;/p></description></item><item><title>Congenital Heart problems - vitamin D levels drop even lower after surgery, loading dose probably required - thesis 2015</title><link>/posts/congenital-heart-problems-vitamin-d-levels-drop-even-lower-after-surgery-loading-red-thesis-2015.html</link><pubDate>Sun, 06 Dec 2015 00:00:00 +0000</pubDate><guid>/posts/congenital-heart-problems-vitamin-d-levels-drop-even-lower-after-surgery-loading-red-thesis-2015.html</guid><description>&lt;h4 id="table-of-contents-in-thesis">Table of contents in thesis&lt;/h4>
&lt;p>&lt;strong>Chapter 1 - Thesis overview&lt;/strong>&lt;/p>
&lt;p>Summary&lt;/p>
&lt;p>Hypotheses&lt;/p>
&lt;p>Objectives&lt;/p>
&lt;p>Global Objectives&lt;/p>
&lt;p>Specific Objectives for the thesis&lt;/p>
&lt;p>Presentation of thesis work	3&lt;/p>
&lt;p>&lt;strong>Chapter 2 - Background&lt;/strong>&lt;/p>
&lt;p>Population and problem	5&lt;/p>
&lt;p>Overview of Vitamin D	5&lt;/p>
&lt;p>Vitamin D axis&lt;/p>
&lt;p>Evaluation of vitamin D status&lt;/p>
&lt;p>Vitamin D deficiency in CHD	patients	7&lt;/p>
&lt;p>Factors contributing to post-operative VDD	9&lt;/p>
&lt;p>Primary vitamin D deficiency&lt;/p>
&lt;p>Secondary vitamin D deficiency&lt;/p>
&lt;p>Role of vitamin D deficiency in	CHD patients	11&lt;/p></description></item><item><title>Chronic Kidney Disease not treated by 1400 IU of vitamin D</title><link>/posts/chronic-kidney-disease-not-treated-by-1400-iu-of-vitamin-d.html</link><pubDate>Fri, 20 Nov 2015 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-disease-not-treated-by-1400-iu-of-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-status-and-cholecalciferol-supplementation-in-chronic-kidney-disease-patients-an-italian-cohort-report">Vitamin D status and cholecalciferol supplementation in chronic kidney disease patients: an Italian cohort report&lt;/h3>
&lt;p>International Journal of Nephrology and Renovascular Disease November 2015 Volume 2015:8 Pages 151—157&lt;/p>
&lt;p>Cupisti A, Vigo V, Baronti ME, D’Alessandro C, Ghiadoni L, Egidi MF&lt;/p>
&lt;p>Nephrology, Transplant and Dialysis Division, AOUP, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy&lt;/p>
&lt;p>This study investigated the factors associated with hypovitaminosis D, in a cohort of 405 prevalent patients with chronic kidney disease (CKD) stages 2–4, living in Italy and followed-up in tertiary care.&lt;/p></description></item><item><title>Vitamin D papers from European Vitamin D Association Conference</title><link>/posts/vitamin-d-papers-from-european-vitamin-d-association-conference.html</link><pubDate>Mon, 26 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-papers-from-european-vitamin-d-association-conference.html</guid><description>&lt;p>Most of the ENGLISH presentations of the conference follow&lt;/p>
&lt;p>Polish Presentations and Polish abstracts are in the &lt;span>[dl3144]&lt;/span>&lt;/p>
&lt;p>Graphics and table are generally in the &lt;span>[dl3144]&lt;/span>&lt;/p>
&lt;p>References are generally in the &lt;span>[dl3144]&lt;/span> as well&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-update-2015-what-we-need-to-know-about-its-health-benefits-and-potential-for-toxicity">Vitamin D Update 2015: What We Need to Know about Its Health Benefits and Potential for Toxicity?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#spanskin-synthesis-of-vitamin-d---pros-and-consspan-english-abstract">&lt;span>[Skin synthesis of vitamin D - pros and cons]&lt;/span> English Abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#nutritional-rickets---global-guidelines-for-prevention-and-treatment">Nutritional Rickets - global guidelines for prevention and treatment&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vitamin-d-supplementation-in-treating-health-conditions-and-diseases-common-among-those-with-intellectual-andor-developmental-disabilities">The role of vitamin D supplementation in treating health conditions and diseases common among those with intellectual and/or developmental disabilities&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#spanvitamin-d-in-dermatologists-practicespan-english-abstract">&lt;span>[Vitamin D in dermatologists&amp;rsquo; practice]&lt;/span> English abstract&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-role-of-vdr-gene-polymorphisms-in-basal-cell-carcinoma-development">The role of VDR gene polymorphisms in basal cell carcinoma development&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-melanoma">Vitamin D and melanoma&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#potential-use-of-vitamin-d-analogs-in-the-treatment-of-skin-diseases">Potential use of vitamin D analogs in the treatment of skin diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#biomarkers-of-vitamin-d-metabolism-current-state-of-knowledge">Biomarkers of Vitamin D Metabolism: Current State of Knowledge&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#standardization-of-vitamin-d-assays">Standardization of Vitamin D Assays:&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#assays-for-vitamin-d-metabolites-performance-in-the-real-world">Assays for vitamin D metabolites; performance in the real world&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-two-immunoassays-for-vitamin-d-measurement-is-age-a-confounder">Comparison of two immunoassays for vitamin D measurement is age a confounder?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pleiotropic-action-of-vitamin-d-in-light-of-recent-meta-analyzes">Pleiotropic action of vitamin D in light of recent meta-analyzes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-requirements-during-pregnancy-and-lactation">Vitamin D Requirements during Pregnancy and Lactation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#25-hydroxyvitamin-d-insufficiency-in-extraskeletal-diseases">25-hydroxyvitamin D insufficiency in extraskeletal diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cardiovascular-disorders">Vitamin D and Cardiovascular disorders&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#endothelial-function-and-pulse-wave-velocity-in-patients-with-chronic-heart-failure-and-d-deficiency">Endothelial function and pulse wave velocity in patients with chronic heart failure and D-deficiency&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-insufficiency-in-young-children-in-russia-the-results-of-the-multicentre-cohort-study-rodnichok-2013-2014">Vitamin D Insufficiency in Young Children in Russia: the Results of the Multicentre Cohort Study RODNICHOK (2013-2014)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-residents-of-belarus-analysis-of-the-three-year-data">Vitamin D status in residents of Belarus: analysis of the three-year data&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-correction-in-elderly-people">Vitamin D deficiency correction in elderly people&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#span-stylecolorf00postersspan">&lt;span style="color:#F00;">POSTERS&lt;/span>&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-status-in-north-west-russian-region">Vitamin D status in north-west russian region&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-ways-of-vitamin-d-deficiency-correction-in-ukraine">The ways of vitamin d deficiency correction in ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#high-dose-vitamin-d3-supplementation-as-a-novel-strategy-in-clinical-management-of-wintertime-preeclampsia">High-dose vitamin D3 supplementation as a novel strategy in clinical management of wintertime preeclampsia&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-of-bsmi-polymorphism-of-vdr-gene-with-vitamin-d-status-in-children-with-vitamin-d---deficient-rickets">Association of BsmI polymorphism of VDR gene with vitamin D status in children with vitamin D - deficient rickets&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-levels-may-influence-microarchitecture-of-bone-tissue-in-men">Vitamin D levels may influence microarchitecture of bone tissue in men&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#ameliorative-effect-of-vitamin-d3-against-liver-disorders-and-impaired-bone-remodeling-associated-with-experimental-type-1-diabetes">Ameliorative effect of vitamin D3 against liver disorders and impaired bone remodeling associated with experimental type 1 diabetes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-and-inflammation-in-copd-patients-preliminary-findings-from-a-seasonal-observation-study">Vitamin D status and inflammation in COPD patients: preliminary findings from a seasonal observation study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-a-primary-prevention-program-incorporating-vitamin-and-mineral-supplementation-on-glycemic-status-an-observational-study">Effect of a primary prevention program incorporating vitamin and mineral supplementation on glycemic status: an observational study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementation---positive-effects-on-lipid-profile-in-patients-with-hypertension">Vitamin D supplementation - positive effects on lipid profile in patients with hypertension&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-effects-of-a-preventive-health-program-and-vitamin-d-status-on-metabolic-syndrome">The Effects of a Preventive Health Program and Vitamin D Status on Metabolic Syndrome&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#serum-vitamin-d-status-a-threat-neither-for-hypercalcemia-nor-for-inflammation">Serum Vitamin D Status, a Threat neither for Hypercalcemia nor for Inflammation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#synthesis-of-novel-vitamin-d-analogs-and-their-biological-evaluation">Synthesis of novel vitamin D analogs and their biological evaluation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#tissue-in-children-with-ergocalciferol-deficiency-in-anamnesis">Tissue in children with ergocalciferol deficiency in anamnesis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#correlation-between-vitamin-d-level-and-behcets-disease-activity-in-patients-in-west-region-of-ukraine">Correlation between Vitamin D level and Behcet&amp;rsquo;s disease activity in patients in West region of Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#dynamics-of-the-vitamin-d-and-of-the-bones-metabolism-other-indicators-in-the-pregnant-women-with-perinatal-infection">Dynamics of the vitamin D and of the bone&amp;rsquo;s metabolism other indicators in the pregnant women with perinatal infection&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-intakes-among-pregnant-women-in-an-urban-and-rural-population-of-western-ukraine">Vitamin d intakes among pregnant women in an urban and rural population of Western Ukraine&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-curious-situation-of-europeans-and-vitamin-d---an-environmental-mismatch">The Curious Situation of Europeans and Vitamin D - an Environmental Mismatch?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-among-healthy-infants-in-poland---assessment-based-on-randomly-selected-sample-from-the-population">Vitamin D status among healthy infants in Poland - assessment based on randomly selected sample from the population&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-protective-effect-of-vitamin-d3-against-prednisolone-induced-liver-injury-in-rats">The protective effect of vitamin D3 against prednisolone-induced liver injury in rats&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#effect-of-cholecalciferol-on-plasma-rennin-activity-in-women-with-arterial-hypertension-in-premenopausal-and-early-postmenopausal-periods">Effect of cholecalciferol on plasma rennin activity in women with arterial hypertension in premenopausal and early postmenopausal periods&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#multiple-mechanisms-by-which-both-vitamin-d-deficiency-and-toxicity-affect-cardiovascular-health">Multiple mechanisms by which both vitamin D deficiency and toxicity affect cardiovascular health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-undifferentiated-connective-tissue-dysplasia-provide-the-vitamin-d3-for-adolescent-children">The undifferentiated connective tissue dysplasia provide the vitamin D3 for adolescent children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-25-hydroxyvitamin-d-deficiency-in-children-on-dialysis-and-after-kidney-transplantation">Prevalence of 25-Hydroxyvitamin D Deficiency in Children on Dialysis and After Kidney Transplantation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-in-children-with-bronchial-asthma">Vitamin D status in children with bronchial asthma&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#prevalence-of-vitamin-d-deficiency-in-adult-outpatients-with-schizophrenia-or-bipolar-disorder">Prevalence of vitamin D deficiency in adult outpatients with schizophrenia or bipolar disorder&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#rickets-in-premature-infants-with-very-low-birth-weight-clinical-features-and-course-of-the-disease">Rickets in Premature Infants with Very Low Birth Weight: Clinical Features and Course of the Disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-undifferentiated-connective-tissue-dysplasia-provide-the-vitamin-d3-for-adolescent-children-1">The undifferentiated connective tissue dysplasia provide the vitamin D3 for adolescent children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#influence-of-125oh2d3-and-its-derivatives---pri-2191-and-pri-2205">Influence of 1,25(OH)2D3 and its derivatives - PRI-2191 and PRI-2205&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-deficiency-in-patients-with-subclinical-and-overt-hypothyroidism">Vitamin d deficiency in patients with subclinical and overt hypothyroidism&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d3-supplementation-using-an-oral-spray-solution-resolves-deficiency-but-has-no-significant-effect-on-vo2max-in-gaelic-athletes-results-from-a-randomised-doubleblind-placebo-controlled-trial__">Vitamin D3 supplementation using an oral spray solution resolves deficiency but has no significant effect on VO2max in Gaelic athletes:** results from a randomised, doubleblind, placebo-controlled trial__&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#maternal-obesity-and-associated-vitamin-d-status-in-pregnancy-data-from-the-fasstt-study">Maternal obesity and associated vitamin D status in pregnancy: data from the FASSTT study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#immunoglobulin-g-in-children-with-recurrent-respiratory-infections">immunoglobulin G in children with recurrent respiratory infections&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cancer-diseases">Vitamin d and cancer diseases&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#correction-of-hypovitaminosis-d-with-vitamin-d-supplements-in-patients-with-psoriasis">Correction of hypovitaminosis D with vitamin D supplements in patients with psoriasis&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#association-between-vitamin-d-and-lipid-accumulation-product-in-community-dwelling-elderly-persons">Association Between Vitamin D and Lipid Accumulation Product in Community Dwelling Elderly Persons&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-supplementary-intake-throughout-3rd-trimester-of-pregnancy">Vitamin D supplementary intake throughout 3rd trimester of pregnancy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#evaluation-of-the-current-vitamin-d-content-of-ni-milk-and-its-efficacy-to-increase-vitamin-d-intake-of-the-population-through-fortification">Evaluation of the current vitamin D content of NI milk and its efficacy to increase vitamin D intake of the population through fortification&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#can-vitamin-d-influence-bmd-in-hyperthyroid-patients-with-and-without-silent-vertebral-fractures">Can Vitamin D influence BMD in hyperthyroid patients with and without silent vertebral fractures?&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h4 id="vitamin-d-update-2015-what-we-need-to-know-about-its-health-benefits-and-potential-for-toxicity">Vitamin D Update 2015: What We Need to Know about Its Health Benefits and Potential for Toxicity?&lt;/h4>
&lt;p>Michael F. Holick&lt;/p></description></item><item><title>Magnesium in Prevention and Therapy – (28 pages)</title><link>/posts/magnesium-in-prevention-and-therapy-28-pages.html</link><pubDate>Wed, 14 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/magnesium-in-prevention-and-therapy-28-pages.html</guid><description>&lt;p>Nutrients ISSN 2072-6643&lt;/p>
&lt;p>Uwe Grober &lt;a href="mailto:uwegroeber@gmx.net">uwegroeber@gmx.net&lt;/a> , Joachim Schmidt1 and Klaus Kisters 1,2&lt;/p>
&lt;p>Academy of Micronutrient Medicine, Essen 45130, Germany;&lt;/p>
&lt;p>E-Mails: &lt;a href="mailto:Prof.schmidt.dd@t-online.de">Prof.schmidt.dd@t-online.de&lt;/a> (J.S.); &lt;a href="mailto:kisters@annahospital.de">kisters@annahospital.de&lt;/a> (K.K.)&lt;/p>
&lt;p>Department of Internal Medicine I, St. Anna-Hospital, Herne 44649, Germany&lt;/p>
&lt;p>Received: 18 June 2015 /Accepted: 11 September 2015 /Published: 23 September 2015&lt;/p>
&lt;p>Abstract:&lt;/p>
&lt;p>Magnesium is the fourth most abundant mineral in the body. It has been recognized as a cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine triphosphate (ATP) metabolism. Magnesium is required for DNA and RNA synthesis, reproduction, and protein synthesis. Moreover, magnesium is essential for the regulation of muscular contraction, blood pressure, insulin metabolism, cardiac excitability, vasomotor tone, nerve transmission and neuromuscular conduction. Imbalances in magnesium status—primarily hypomagnesemia as it is seen more common than hypermagnesemia—might result in unwanted neuromuscular, cardiac or nervous disorders. Based on magnesium&amp;rsquo;s many functions within the human body, it plays an important role in prevention and treatment of many diseases. Low levels of magnesium have been associated with a number of chronic diseases, such as Alzheimer’s disease, insulin resistance and type-2 diabetes mellitus, hypertension, cardiovascular disease (e.g., stroke), migraine headaches, and attention deficit hyperactivity disorder (ADHD).&lt;/p></description></item><item><title>Vitamin D, Calcium and protein very important to bone health</title><link>/posts/vitamin-d-calcium-and-protein-very-important-to-bone-health.html</link><pubDate>Wed, 07 Oct 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-calcium-and-protein-very-important-to-bone-health.html</guid><description>&lt;p>&lt;strong>Life-course approach to nutrition&lt;/strong>&lt;/p>
&lt;p>Osteoporos Int DOI 10.1007/s00198-015-3288-6&lt;/p>
&lt;p>P. J. Mitchell1,2 • C. Cooper3,4 • B. Dawson-Hughes • C. M. Gordon • R. Rizzoli, &lt;a href="mailto:cc@mrc.soton.ac.uk">cc@mrc.soton.ac.uk&lt;/a>&lt;/p>
&lt;p>Synthesis Medical NZ Ltd, Auckland, New Zealand&lt;/p>
&lt;p>University of Notre Dame Australia, Sydney, Australia&lt;/p>
&lt;p>NIHR Musculoskeletal Biomedical Research Unit, Nuffield Dept of Orthopaedics, Rheumatology and Musculoskeletal Sciences, U. of Oxford, Oxford, UK&lt;/p>
&lt;p>MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK&lt;/p>
&lt;p>Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA&lt;/p></description></item><item><title>Vitamin D Binding Protein</title><link>/posts/vitamin-d-binding-protein.html</link><pubDate>Mon, 07 Sep 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-and-its-gene-polymorphisms-the-risk-of-malignant-tumors-and-other-diseases---oct-2020">Vitamin D Binding Protein and Its Gene Polymorphisms —The Risk of Malignant Tumors and Other Diseases - Oct 2020&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#low-response-to-vitamin-d-can-be-improved-in-many-ways">Low response to Vitamin D can be improved in many ways&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-web">See also web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-binding-protein-mutations-are-not-noticed-by-the-vitamin-d-test--march-2024">Vitamin D Binding Protein mutations are not noticed by the Vitamin D Test – March 2024&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-binding-protein-and-its-gene-polymorphisms-the-risk-of-malignant-tumors-and-other-diseases---oct-2020">Vitamin D Binding Protein and Its Gene Polymorphisms —The Risk of Malignant Tumors and Other Diseases - Oct 2020&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/vdbp1.jpg" alt="image" width="800">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/vdbp2.jpg" alt="image" width="800">
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/vdbp-tumors-etc..pdf">PDF &lt;/a>&lt;/strong>&lt;/p></description></item><item><title>Graph of weekly response to monthly vitamin D supplementation</title><link>/posts/graph-of-weekly-response-to-monthly-vitamin-d-supplementation.html</link><pubDate>Tue, 18 Aug 2015 00:00:00 +0000</pubDate><guid>/posts/graph-of-weekly-response-to-monthly-vitamin-d-supplementation.html</guid><description>&lt;h4 id="kinetics-of-serum-25-hydroxyvitamin-d-in-haemodialysis-patients-treated-with-monthly-oral-cholecalciferol">Kinetics of serum 25-hydroxyvitamin D in haemodialysis patients treated with monthly oral cholecalciferol.&lt;/h4>
&lt;p>Clin Kidney J. 2015 Aug;8(4):388-92. &lt;a href="https://doi.org/10.1093/ckj/sfv052.">doi: 10.1093/ckj/sfv052.&lt;/a> Epub 2015 Jun 30.&lt;/p>
&lt;p>Jean G1, Souberbielle JC2, Lechevallier S3, Chazot C1.&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;p>BACKGROUND:&lt;/p>
&lt;p>We previously reported that oral cholecalciferol (CCF) (100 000 IU) taken monthly by haemodialysis patients is effective in accomplishing serum 25-hydroxyvitamin D (25-D) levels &amp;gt;75 nmol/L in &amp;gt;80% of cases. We aimed to study the weekly kinetecs of serum 25-D in HD patients receiving oral CCF during the first 6 months of HD.&lt;/p></description></item><item><title>Links between Vitamin D Deficiency and Cardiovascular Diseases</title><link>/posts/links-between-vitamin-d-deficiency-and-cardiovascular-diseases.html</link><pubDate>Wed, 10 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/links-between-vitamin-d-deficiency-and-cardiovascular-diseases.html</guid><description>&lt;p>Biomed Res Int. 2015;2015:109275. Epub 2015 Apr 27.&lt;/p>
&lt;p>Mozos I1, Marginean O2&lt;/p>
&lt;p>1 Department of Functional Sciences, &amp;ldquo;Victor Babes&amp;rdquo; University of Medicine and Pharmacy, 300173 Timisoara, Romania.&lt;/p>
&lt;p>2 Department of Pediatrics, &amp;ldquo;Victor Babes&amp;rdquo; University of Medicine and Pharmacy, 300173 Timisoara, Romania.&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:400px">
&lt;p>&lt;a href="/posts/overview-cardiovascular-and-vitamin-d">Overview Cardiovascular and vitamin D&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/overview-stroke-and-vitamin-d">Overview Stroke and vitamin D&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/overview-hypertension-and-vitamin-d">Overview Hypertension and Vitamin D&lt;/a>&lt;/p>
&lt;p>&lt;a href="/posts/overview-metabolic-syndrome-and-vitamin-d">Overview Metabolic Syndrome and vitamin D&lt;/a>&lt;/p>
&lt;/div>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/cvd-april-2015.pdf">Download the PDF from VitaminDWiki&lt;/a>&lt;/strong>&lt;/p></description></item><item><title>ICU death 2X more likely if low vitamin D (sensitivity and selectivity chart)</title><link>/posts/icu-death-2x-more-likely-if-low-vitamin-d-sensitivity-and-selectivity-chart.html</link><pubDate>Wed, 03 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/icu-death-2x-more-likely-if-low-vitamin-d-sensitivity-and-selectivity-chart.html</guid><description>&lt;h3 id="vitamin-d-deficiency-is-independently-associated-with-mortality-among-critically-ill-patients">Vitamin D deficiency is independently associated with mortality among critically ill patients&lt;/h3>
&lt;p>Clinics vol.70 no.5 São Paulo May 2015 Epub May 2015,&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.6061/clinics/2015(05)04">http://dx.doi.org/10.6061/clinics/2015(05)04&lt;/a>&lt;/p>
&lt;p>Rafael Barberena MoraesI*, Gilberto FriedmanI, Iuri Christmann WawrzeniakI, Leonardo S. MarquesI, Fabiano Márcio NagelI, Thiago Costa LisboaI, Mauro Antonio CzepielewskiII&lt;/p>
&lt;p>IUniversidade Federal do Rio Grande do Sul, Department of Internal Medicine, Division of Critical Care Medicine, Porto Alegre/RS, Brazil&lt;/p>
&lt;p>IIUniversidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Department of Internal Medicine, Division of Endocrinology, Porto Alegre/RS, Brazil.&lt;/p></description></item><item><title>Vitamin D video: calcification, narrow-band UV, 4,000 IU, 50 ng – Dr. DeLuca</title><link>/posts/vitamin-d-video-calcification-narrow-band-uv-4000-iu-50-ng-dr-deluca.html</link><pubDate>Wed, 03 Jun 2015 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-video-calcification-narrow-band-uv-4000-iu-50-ng-dr-deluca.html</guid><description>&lt;h4 id="vitamin-d-a-pharmaceutical-fountain---with-hector-delucahttpsvimeocom128651420">&lt;a href="https://vimeo.com/128651420">Vitamin D: A Pharmaceutical Fountain - with Hector DeLuca&lt;/a>&lt;/h4>
&lt;p>Vimeo, 60 minute talk, 29 minute Q&amp;amp;A&lt;/p>
&lt;p>Renowned biochemist and Wisconsin Academy Fellow Hector DeLuca discusses the profound application of vitamin D in medicine, including new treatments in the areas of immunity and autoimmunity, in this special Wisconsin Academy Talk.&lt;/p>
&lt;p>DeLuca shares insight from a career devoted to the research of vitamin D and physiological events linked to the function of this vitamin. Among the most important research activities in his laboratory has been the synthesis of tissue-specific analogs of vitamin D for the treatment of diseases. DeLuca&amp;rsquo;s group has produced eight pharmaceuticals that are used for the treatment of diseases, including osteoporosis, vitamin D-resistant rickets, and bone diseases linked to kidney failure.&lt;/p></description></item><item><title>Cardiovascular Diseases and Vitamin D – Review</title><link>/posts/cardiovascular-diseases-and-vitamin-d-review.html</link><pubDate>Sun, 31 May 2015 00:00:00 +0000</pubDate><guid>/posts/cardiovascular-diseases-and-vitamin-d-review.html</guid><description>&lt;p>&lt;strong>Links between Vitamin D Deficiency and Cardiovascular Diseases - Review Article&lt;/strong>&lt;/p>
&lt;p>BioMed Research International, Volume 2015 (2015), Article ID 109275, 12 pages&lt;/p>
&lt;p>&lt;a href="http://dx.doi.org/10.1155/2015/109275">http://dx.doi.org/10.1155/2015/109275&lt;/a>&lt;/p>
&lt;p>Ioana Mozos 1 and Otilia Marginean 2&lt;/p>
&lt;p>1Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, 300173 Timisoara, Romania&lt;/p>
&lt;p>2Department of Pediatrics, “Victor Babes” University of Medicine and Pharmacy, 300173 Timisoara, Romania&lt;/p>
&lt;p>Received 31 October 2014; Accepted 8 February 2015&lt;/p>
&lt;p>&lt;strong>Abstract&lt;/strong>&lt;/p>
&lt;p>The aim of the present paper was to review the most important mechanisms explaining the possible association of vitamin D deficiency and cardiovascular diseases, focusing on recent experimental and clinical data. Low vitamin D levels favor atherosclerosis enabling vascular inflammation, endothelial dysfunction, formation of foam cells, and proliferation of smooth muscle cells. The antihypertensive properties of vitamin D include suppression of the renin-angiotensin-aldosterone system, renoprotective effects, direct effects on endothelial cells and calcium metabolism, inhibition of growth of vascular smooth muscle cells, prevention of secondary hyperparathyroidism, and beneficial effects on cardiovascular risk factors. Vitamin D is also involved in glycemic control, lipid metabolism, insulin secretion, and sensitivity, explaining the association between vitamin D deficiency and metabolic syndrome. Vitamin D deficit was associated in some studies with the number of affected coronary arteries, postinfarction complications, inflammatory cytokines and cardiac remodeling in patients with myocardial infarction, direct electromechanical effects and inflammation in atrial fibrillation, and neuroprotective effects in stroke. In peripheral arterial disease, vitamin D status was related to the decline of the functional performance, severity, atherosclerosis and inflammatory markers, arterial stiffness, vascular calcifications, and arterial aging. Vitamin D supplementation should further consider additional factors, such as phosphates, parathormone, renin, and fibroblast growth factor 23 levels.&lt;/p></description></item><item><title>Gallbladder performs poorly during pregnancy if low vitamin D</title><link>/posts/gallbladder-performs-poorly-during-pregnancy-if-low-vitamin-d.html</link><pubDate>Tue, 12 May 2015 00:00:00 +0000</pubDate><guid>/posts/gallbladder-performs-poorly-during-pregnancy-if-low-vitamin-d.html</guid><description>&lt;h4 id="vitamin-d-deficiency-is-associated-with-gallbladder-stasis-among-pregnant-women">Vitamin-D Deficiency Is Associated with Gallbladder Stasis Among Pregnant Women&lt;/h4>
&lt;p>Digestive Diseases and Sciences, May 2015&lt;/p>
&lt;p>Rimpi Singla, Usha Dutta, Neelam Aggarwal, Sanjay Kumar Bhadada, Rakesh Kochhar, Lakhbir K. Dhaliwal&lt;/p>
&lt;div class="border" style="background-color:#FF9;padding:15px;margin:10px 0;border-radius:5px;width:550px">
&lt;p>&lt;strong>20%&lt;/strong> of pregnant women with low vitamin D had Gallbladder Statis&lt;/p>
&lt;p>&lt;strong>0%&lt;/strong> of pregnant women with adequate vitamin D had Gallbladder Stasis&lt;/p>
&lt;p>&lt;strong>See also VitaminDWiki&lt;/strong>&lt;/p>
&lt;p>&lt;a href="/posts/gallbladder-removal-and-vitamin-d-deficiency">Gallbladder removal and vitamin D deficiency&lt;/a>&lt;/p>
&lt;/div>
&lt;p>Background&lt;/p>
&lt;p>Pregnant women are at increased risk of gallbladder (GB) stasis, an important risk factor for gallstones (GS). In non-pregnant women, Vitamin-D deficiency (VDD) is associated with GB stasis, which improves on supplementation. Relationship of VDD with GB stasis among pregnant women is not known.&lt;/p></description></item><item><title>Blacks have 4X more Kidney disease than whites – probably due to low vitamin D</title><link>/posts/blacks-have-4x-more-kidney-disease-than-whites-probably-due-to-low-vitamin-d.html</link><pubDate>Thu, 19 Mar 2015 00:00:00 +0000</pubDate><guid>/posts/blacks-have-4x-more-kidney-disease-than-whites-probably-due-to-low-vitamin-d.html</guid><description>&lt;h3 id="kidney-failure-a-leading-cause-of-death-in-african-americanshttpbaystatebannercomnews2015mar18kidney-failure-leading-cause-death-african-america-bay-state-banner">&lt;a href="http://baystatebanner.com/news/2015/mar/18/kidney-failure-leading-cause-death-african-america/">Kidney failure: A leading cause of death in African Americans&lt;/a> Bay State Banner&lt;/h3>
&lt;ul>
&lt;li>“The problem is that kidney disease is initially silent. Damage progresses slowly and quietly through five stages. Stage 5 is considered end-stage kidney failure. At that point, only two procedures — dialysis or transplantation — can keep a person alive.”&lt;/li>
&lt;/ul>
&lt;p>Dark skin ==&amp;gt; Low Vitamin D&lt;/p>
&lt;p>Smoking ==&amp;gt; Low Vitamin D&lt;/p>
&lt;p>Obesity ==&amp;gt; Low Vitamin D&lt;/p>
&lt;p>Low vitamin D ==&amp;gt; Diabetes ==&amp;gt; Kidney failure&lt;/p></description></item><item><title>Kidney disease helped by active or high dose Vitamin D</title><link>/posts/kidney-disease-helped-by-active-or-high-dose-vitamin-d.html</link><pubDate>Wed, 25 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/kidney-disease-helped-by-active-or-high-dose-vitamin-d.html</guid><description>&lt;h4 id="the-beneficial-impact-of-vitamin-d-treatment-in-ckd-patients-whats-next---editorial-comment">The beneficial impact of vitamin D treatment in CKD patients: what&amp;rsquo;s next? - Editorial Comment&lt;/h4>
&lt;p>Clin Kidney J (2015) 8:38-40 &lt;a href="https://doi.org/10.1093/ckj/sfu135">doi: 10.1093/ckj/sfu135&lt;/a>&lt;/p>
&lt;p>Patients with chronic kidney disease (CKD) have markedly higher rates of severe vitamin D deficiency and reduced ability to convert 25-(OH)vitamin D into the active form, 1,25-dihydroxyvitamin D &lt;sup>[1]&lt;/sup>. In the setting of CKD, secondary hyperparathyroidism develops as a consequence of reduced renal production of active vitamin D and phosphate retention resulting in hypocalcaemia and hyperpho- sphataemia. This is a process that is dangerously linked with metabolic bone disease, arterial calcifications and cardiovascular mortality &lt;sup>[2]&lt;/sup>. Therefore, the conventional rationale for vitamin D treatment in CKD is to slow the progression of secondary hyperparathyroidism.&lt;/p></description></item><item><title>Calcitriol (active Vitamin D) recommended after kidney transplant</title><link>/posts/calcitriol-active-vitamin-d-recommended-after-kidney-transplant.html</link><pubDate>Tue, 24 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/calcitriol-active-vitamin-d-recommended-after-kidney-transplant.html</guid><description>&lt;h3 id="therapeutic-use-of-calcitriol">Therapeutic use of calcitriol.&lt;/h3>
&lt;p>Curr Vasc Pharmacol. 2014 Mar;12(2):294-9.&lt;/p>
&lt;p>Rodriguez M, Munoz-Castaneda JR, Almaden Y1.&lt;/p>
&lt;p>The synthesis of 1α,25-dihydroxyvitamin D3 (Calcitriol) takes place mostly in the kidneys through the action of 1α-hydroxylase (CYP27B1) which converts 25(OH)D into 1,25(OH)2D3. Renal production of calcitriol is stimulated by PTH, low calcium and low phosphate and it is reduced by high phosphate and FGF23. Binding of 1α,25-dihydroxyvitamin D3 to its receptor (VDR) causes gut absorption of calcium and phosphate, decrease in PTH synthesis, stimulation of FGF23. At the bone level calcitriol suppresses pre-osteoblasts and activates mature osteoblasts. VDR is present in a large variety of cells that do not have any direct role in the regulation of mineral metabolism. Calcitriol regulates immune and inflammatory response, cell turnover, cell differentiation, Renin production, reduces proteinuria and others. In patients with Chronic Kidney Disease (CKD) there is a decrease in calcitriol that is apparent at early stages of renal disease; this is probably due to the elevation of FGF23 which is present since very early stage of CKD. In CKD stage, 3-4 moderate doses of calcitriol are effective to control secondary hyperparathyroidism and observational studies suggest that calcitriol therapy increases survival and slows the progression of renal disease as long as phosphate and calcium levels are controlled. Calcitriol (0.5 µg calcitriol twice per week) has been effective in decreasing proteinuria in patients with IgA nephropathy. In dialysis patients, the administration of calcitriol reduces serum PTH levels but it is also known that high doses of calcitriol are associated with hypercalcemia and worse control of hyperphosphatemia.&lt;/p></description></item><item><title>Peritoneal Dialysis nicely treated by active vitamin D</title><link>/posts/peritoneal-dialysis-nicely-treated-by-active-vitamin-d.html</link><pubDate>Wed, 04 Feb 2015 00:00:00 +0000</pubDate><guid>/posts/peritoneal-dialysis-nicely-treated-by-active-vitamin-d.html</guid><description>&lt;h4 id="treatment-with-oral-active-vitamin-d-is-associated-with-decreased-risk-of-peritonitis-and-improved-survival-in-patients-on-peritoneal-dialysis">Treatment with Oral Active Vitamin D Is Associated with Decreased Risk of Peritonitis and Improved Survival in Patients on Peritoneal Dialysis&lt;/h4>
&lt;h3 id="chart-was-created-from-study-data">Chart was created from study data&lt;/h3>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/kerschbaum.jpg" alt="image">
&lt;p>PLOS One 2013DOI: 10.1371/journal.pone.0067836&lt;/p>
&lt;p>Julia Kerschbaum, Andreas Vychytil, Karl Lhotta, Friedrich C. Prischl, Martin Wiesholzer, Veronika Machhold-Fabrizii, Gertrude Kopriva-Altfahrt, Christoph Schwarz, Peter Balcke, Rainer Oberbauer, Reinhard Kramar, Paul König, Michael Rudnicki mail&lt;/p>
&lt;p>Peritonitis is a major complication of peritoneal dialysis (PD) being associated with hospitalization, catheter loss, technique failure, and increased mortality. Data on incidence rates and risk factors for peritonitis episodes vary between centers. In seven Austrian PD units clinical and laboratory data on each peritonitis episode were collected from all patients (n = 726) who performed PD between January 2000 and December 2009. The peritonitis incidence rate was 0.32 episodes/patient-year. In a multivariate analysis the risk of peritonitis was decreased by 57% in patients treated with oral active vitamin D (HR 0.43; 95% CI 0.28–0.64). Renal disease classified as “other or unknown” (HR 1.65; 95% CI 1.08–2.53) and serum albumin &amp;lt;3500 mg/dl (HR 1.49; 95% CI 1.04–2.15) were also associated with an increased risk of peritonitis. Albumin levels &amp;lt;3500 mg/dl (HR 1.89; 95% CI 1.13–3.17), age (HR 1.06 per year; 95% CI 1.03–1.09), and cardiomyopathy (HR 3.01; 95% CI 1.62–5.59) were associated with increased mortality, whereas treatment with oral active vitamin D was associated with a significantly lower risk of death (HR 0.46; 95% CI 0.27–0.81). In this retrospective multi-center study we identified several factors being related to increased risk of peritonitis in PD patients. Treatment with oral active vitamin D was identified as being independently associated with decreased risk of peritonitis, and decreased all-cause mortality in PD patients.&lt;/p></description></item><item><title>Uptodate – Medical professional information – on Vitamin D, etc.</title><link>/posts/uptodate-medical-professional-information-on-vitamin-d-etc.html</link><pubDate>Fri, 02 Jan 2015 00:00:00 +0000</pubDate><guid>/posts/uptodate-medical-professional-information-on-vitamin-d-etc.html</guid><description>&lt;ul>
&lt;li>
&lt;p>UpToDate® is an evidence-based, physician-authored clinical decision support resource which clinicians trust to make the right point-of-care decisions.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>More than 5,700 world-renowned physician authors, editors and peer reviewers use a rigorous editorial process to synthesize the most recent medical information into trusted, evidence-based recommendations that are proven to improve patient care and quality.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>More than 850,000 clinicians in 164 countries and almost 90% of academic medical centers in the United States rely on UpToDate to provide the best care.&lt;/p></description></item><item><title>Quantifying the vitamin D economy in the body - Heaney</title><link>/posts/quantifying-the-vitamin-d-economy-in-the-body-heaney.html</link><pubDate>Tue, 30 Dec 2014 00:00:00 +0000</pubDate><guid>/posts/quantifying-the-vitamin-d-economy-in-the-body-heaney.html</guid><description>&lt;p>&lt;strong>Figure 1&lt;/strong>&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image" width="600">
&lt;p>Quantifying the vitamin D economy&lt;/p>
&lt;p>Nutrition Reviews VR Vol. 73(1):51–67, &lt;a href="https://doi.org/10.1093/nutrit/nuu004">doi: 10.1093/nutrit/nuu004&lt;/a> Special Article&lt;/p>
&lt;p>Robert P. Heaney and Laura A.G. Armas&lt;/p>
&lt;p>R.P. Heaney is with Creighton University, Omaha, Nebraska, USA. &lt;a href="mailto:rpheaney@creighton.edu">rpheaney@creighton.edu&lt;/a>&lt;/p>
&lt;p>L.A.G. Armas is with the Department of Medicine, Creighton University, Omaha, Nebraska, USA&lt;/p>
&lt;p>&lt;strong>&lt;i class="fas fa-file-pdf" style="margin-right: 0.3em;">&lt;/i>&lt;a href="https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/quantifying-the-vitamin-d-economy.pdf">Download the PDF with all figures from VitaminDWiki.&lt;/a>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>The following is virtually all of the text, most of the equations, and a few of the figures&lt;/strong>&lt;/p></description></item><item><title>Antimicrobial peptides (which attack pathogens) are increased by Vitamin D</title><link>/posts/antimicrobial-peptides-which-attack-pathogens-are-increased-by-vitamin-d.html</link><pubDate>Tue, 30 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/antimicrobial-peptides-which-attack-pathogens-are-increased-by-vitamin-d.html</guid><description>&lt;ul>
&lt;li>
&lt;p>&lt;strong>Cathelicidins&lt;/strong> are antimicrobial peptides found in vertebrates that kill pathogens directly and regulate immune responses. They contain a conserved cathelin domain and variable antimicrobial region, functioning in both pathogen defense and immune modulation.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;strong>Antimicrobial particles, proteins, and peptides&lt;/strong> are natural defense molecules that fight pathogens. Particles are the largest, proteins are medium-sized complex molecules, and peptides are the smallest (12-100 amino acids). All three types kill microbes, but peptides are particularly effective due to their size and multiple mechanisms of action.&lt;/p></description></item><item><title>Vitamin D levels in Europe</title><link>/posts/vitamin-d-levels-in-europe.html</link><pubDate>Tue, 30 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-levels-in-europe.html</guid><description>&lt;p>&lt;strong>Vitamin D: An overview of vitamin D status and intake in Europe&lt;/strong>&lt;/p>
&lt;p>Nutrition Bulletin. Article first published online: 30 SEP 2014, DOI: 10.1111/nbu.12108&lt;/p>
&lt;p>A. Spiro* and J. L. Buttriss&lt;/p>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t4.jpg" alt="image" width="1000">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t5.jpg" alt="image" width="1000">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t7.jpg" alt="image" width="1000">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/e-t6.jpg" alt="image" width="500">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/policies.jpg" alt="image" width="1000">
&lt;p>In recent years, there have been reports suggesting a high prevalence of low vitamin D intakes and vitamin D deficiency or inadequate vitamin D status in Europe. Coupled with growing concern about the health risks associated with low vitamin D status, this has resulted in increased interest in the topic of vitamin D from healthcare professionals, the media and the public. Adequate vitamin D status has a key role in skeletal health. Prevention of the well-described vitamin D deficiency disorders of rickets and osteomalacia are clearly important, but there may also be an implication of low vitamin D status in bone loss, muscle weakness and falls and fragility fractures in older people, and these are highly significant public health issues in terms of morbidity, quality of life and costs to health services in Europe.&lt;/p></description></item><item><title>VPS Healthcare in Abu Dhabi invested million dollars in Vitamin D research</title><link>/posts/vps-healthcare-in-abu-dhabi-invested-million-dollars-in-vitamin-d-research.html</link><pubDate>Thu, 11 Sep 2014 00:00:00 +0000</pubDate><guid>/posts/vps-healthcare-in-abu-dhabi-invested-million-dollars-in-vitamin-d-research.html</guid><description>&lt;h4 id="this-1000000-will-fund-vitamin-d-rd">This $1,000,000 will fund Vitamin D R&amp;amp;D:&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>causes and consequences of deficiencies,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>the effect deficiency has on pregnancy within the UAE.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>impact of Vitamin D deficiency on chronic kidney disease patients requiring dialysis.”&lt;/p>
&lt;/li>
&lt;li>
&lt;p>creation of new protocols in the supplementation and fortification, guidelines&lt;/p>
&lt;/li>
&lt;li>
&lt;p>provide insights into the retrospective and interventional aspects of Vitamin D.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Research will be extended to cancer, diabetes and neurological disorders.&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>&lt;strong>Principle Scientist for the research will be Dr. Haq&lt;/strong>&lt;/p></description></item><item><title>UVB increases vitamin D even if poor kidney by changing CYP27B1 genes in skin</title><link>/posts/uvb-increases-vitamin-d-even-if-poor-kidney-by-changing-cyp27b1-genes-in-skin.html</link><pubDate>Wed, 13 Aug 2014 00:00:00 +0000</pubDate><guid>/posts/uvb-increases-vitamin-d-even-if-poor-kidney-by-changing-cyp27b1-genes-in-skin.html</guid><description>&lt;h4 id="a-narrow-band-ultraviolet-b-course-improves-vitamin-d-balance-and-alters-cutaneous-cyp27a1-and-cyp27b1-mrna-expression-levels-in-haemodialysis-patients-supplemented-with-oral-vitamin-d">A narrow-band ultraviolet B course improves vitamin D balance and alters cutaneous CYP27A1 and CYP27B1 mRNA expression levels in haemodialysis patients supplemented with oral vitamin D.&lt;/h4>
&lt;p>Nephron Clin Pract. 2013;124(1-2):17-22. &lt;a href="https://doi.org/10.1159/000355010.">doi: 10.1159/000355010.&lt;/a> Epub 2013 Sep 12.&lt;/p>
&lt;p>Ala-Houhala MJ1, Vähävihu K, Snellman E, Hasan T, Kautiainen H, Karisola P, Dombrowski Y, Schauber J, Saha H, Reunala T.&lt;/p>
&lt;p>Department of Dermatology, Tampere University Hospital, Tampere, Finland&lt;/p>
&lt;p>BACKGROUND/AIMS:&lt;/p>
&lt;p>Chronic kidney disease (CKD) patients on dialysis are prone to vitamin D insufficiency despite oral vitamin D supplementation. Here, we studied whether narrow-band ultraviolet B (NB-UVB) exposures improve vitamin D balance.&lt;/p></description></item><item><title>Blood tests can be a poor measure of actual vitamin D due to D Binding Protein (DBP)</title><link>/posts/blood-tests-can-be-a-poor-measure-of-actual-vitamin-d-due-to-d-binding-protein-dbp.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/blood-tests-can-be-a-poor-measure-of-actual-vitamin-d-due-to-d-binding-protein-dbp.html</guid><description>&lt;p>&lt;strong>Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions&lt;/strong>&lt;/p>
&lt;p>Hindawi Publishing Corporation International Journal of Endocrinology Volume 2014, Article ID 981581, 6 pages &lt;a href="http://dx.doi.org/10.1155/2014/981581">http://dx.doi.org/10.1155/2014/981581&lt;/a>&lt;/p>
&lt;p>Pegah Yousefzadeh,1 Sue A. Shapses,2 and Xiangbing Wang1&lt;/p>
&lt;p>1 Division of Endocrinology, Metabolism &amp;amp; Nutrition, Department of Medicine, Rutgers University-Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA&lt;/p>
&lt;p>2 Department of Nutritional Sciences, Rutgers University, New Brunswick, NJ 08901, USA&lt;/p></description></item><item><title>Vitamin D-binding protein and vitamin D status of black Americans and white Americans</title><link>/posts/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white-americans.html</link><pubDate>Thu, 29 May 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-binding-protein-and-vitamin-d-status-of-black-americans-and-white-americans.html</guid><description>&lt;p>N Engl J Med. 2013 Nov 21;369(21):1991-2000. &lt;a href="https://doi.org/10.1056/NEJMoa1306357.">doi: 10.1056/NEJMoa1306357.&lt;/a>&lt;/p>
&lt;p>Powe CE1, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R.&lt;/p>
&lt;p>1From the Department of Medicine, Brigham and Women&amp;rsquo;s Hospital (C.E.P.), Division of Nephrology, Massachusetts General Hospital (J.W., H.T., I.B., R.T.), Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School (A.H.B.), Division of Nephrology, Beth Israel Deaconess Medical Center (D.Z., S.A.K.), and Howard Hughes Medical Institute (D.Z., S.A.K.) - all in Boston; the Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore (M.K.E., A.B.Z.); the Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD (M.N.); and the Department of Medicine, San Francisco General Hospital and University of California, San Francisco, San Francisco (N.R.P.).&lt;/p></description></item><item><title>Vitamin D Conference papers and poster abstracts – London</title><link>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</link><pubDate>Thu, 24 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-conference-papers-and-poster-abstracts-london.html</guid><description>&lt;p>&lt;strong>&lt;span style="color:#F00;">188 abstracts&lt;/span>&lt;/strong>&lt;/p>
&lt;p>Browser (cntrl F usually) can FIND words, phrases, authors, etc.&lt;/p>
&lt;p>Note: due to extraction and formatting problems all &lt;span>[ became ( &lt;del>hs&lt;/del> &lt;del>hs&lt;/del> and all ]&lt;/span> became )&lt;/p>
&lt;p>Conference is described at: &lt;a href="/posts/vitamin-d-conference-in-england-april-23-25-2014">Vitamin D conference in England - April 23-25 2014&lt;/a>&lt;/p>
&lt;p>These absracts of presentations and posters were published in the &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/25054551?dopt=Abstract">Journal Nutrients&lt;/a> July 2014&lt;/p>
&lt;p>    Note: Clicking on Hide Health Problems above will make it easier to read the Table of Contents&lt;/p></description></item><item><title>137 health problems associated with low vitamin D – meta-meta-analysis</title><link>/posts/137-health-problems-associated-with-low-vitamin-d-meta-meta-analysis.html</link><pubDate>Tue, 01 Apr 2014 00:00:00 +0000</pubDate><guid>/posts/137-health-problems-associated-with-low-vitamin-d-meta-meta-analysis.html</guid><description>&lt;p>Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials&lt;/p>
&lt;img src="/attachments/d3.mock.jpg" alt="image">
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#evidence-category-from-the-study">Evidence category (from the study)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#forest-plots-from-the-study">Forest plots (from the study)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#methods">Methods&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#structure-of-umbrella-review">Structure of umbrella review&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#search-strategy">Search strategy&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#eligibility-criteria-and-appraisal-of-included-studies">Eligibility criteria and appraisal of included studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#data-extraction">Data extraction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#data-analysis">Data analysis&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#results">Results&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-concentrations-and-health-outcomes-systematic-reviews-of-observational-studies">Vitamin D concentrations and health outcomes: systematic reviews of observational studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-concentrations-and-health-outcomes-meta-analyses-of-observational-studies">Vitamin D concentrations and health outcomes: meta-analyses of observational studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#summary-effects-heterogeneity-and-bias-tests-for-meta-analyses-of-observational-associations">Summary effects, heterogeneity, and bias tests for meta-analyses of observational associations&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#significant-observational-associations-without-hints-of-bias">Significant observational associations without hints of bias&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#meta-analyses-of-randomised-controlled-trials-of-vitamin-d-supplementation">Meta-analyses of randomised controlled trials of vitamin D supplementation&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#comparison-of-findings-from-observational-studies-and-clinical-trials">Comparison of findings from observational studies and clinical trials&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#discussion">Discussion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#strengths-and-weaknesses-of-study-and-in-relation-to-other-studies">Strengths and weaknesses of study and in relation to other studies&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#possible-explanations-and-implications-for-clinicians-and-policy-makers">Possible explanations and implications for clinicians and policy makers&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#conclusions-unanswered-questions-and-future-research">Conclusions, unanswered questions, and future research&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#what-is-already-known-on-this-topic">What is already known on this topic&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#what-this-study-adds">What this study adds&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#editorial-on-the-study-vitamin-d-and-chronic-disease-prevention">Editorial on the study: Vitamin D and chronic disease prevention&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#references-1">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>BMJ2014;348:g2035 &lt;a href="https://doi.org/10.1136/bmj.g2035">doi: 10.1136/bmj.g2035&lt;/a> (Published 1 April 2014)&lt;/p></description></item><item><title>Atherogenesis, atherosclerosis and vitamin D – review</title><link>/posts/atherogenesis-atherosclerosis-and-vitamin-d-review.html</link><pubDate>Thu, 20 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/atherogenesis-atherosclerosis-and-vitamin-d-review.html</guid><description>&lt;h2 id="the-role-of-the-intraplaque-vitamin-d-system-in-atherogenesis">The Role of the Intraplaque Vitamin D System in Atherogenesis&lt;/h2>
&lt;p>Scientifica, Volume 2013 (2013), Article ID 620504, 14 pages, &lt;a href="http://dx.doi.org/10.1155/2013/620504">http://dx.doi.org/10.1155/2013/620504&lt;/a>&lt;/p>
&lt;p>Federico Carbone 1,2 and Fabrizio Montecucco 1,3&lt;/p>
&lt;p>1Department of Internal Medicine, University of Genoa School of Medicine, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, 6 Viale Benedetto XV, 16132 Genoa, Italy&lt;/p>
&lt;p>2Cardiology Division, Foundation for Medical Researches, Department of Internal Medicine, University of Geneva, 64, Avenue de la Roseraie, 1211 Geneva, Switzerland&lt;/p></description></item><item><title>Chronic Kidney Disease patients need more vitamin D and phosphate</title><link>/posts/chronic-kidney-disease-patients-need-more-vitamin-d-and-phosphate.html</link><pubDate>Sat, 08 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-disease-patients-need-more-vitamin-d-and-phosphate.html</guid><description>&lt;h3 id="nutrition-prescription-to-achieve-positive-outcomes-in-chronic-kidney-disease-a-systematic-review">Nutrition prescription to achieve positive outcomes in chronic kidney disease: a systematic review.&lt;/h3>
&lt;p>Nutrients. 2014 Jan 22;6(1):416-51. &lt;a href="https://doi.org/10.3390/nu6010416.">doi: 10.3390/nu6010416.&lt;/a>&lt;/p>
&lt;p>Ash S1, Campbell KL2, Bogard J3, Millichamp A4.&lt;/p>
&lt;p>In Chronic Kidney Disease (CKD), management of diet is important in prevention of disease progression and symptom management, however evidence on nutrition prescription is limited. Recent international CKD guidelines and literature was reviewed to address the following question &amp;ldquo;What is the appropriate nutrition prescription to achieve positive outcomes in adult patients with chronic kidney disease?&amp;rdquo; Databases included in the search were Medline and CINAHL using EBSCOhost search engine, Embase and the Cochrane Database of Systematic Reviews published from 2000 to 2009. International guidelines pertaining to nutrition prescription in CKD were also reviewed from 2000 to 2013. Three hundred and eleven papers and eight guidelines were reviewed by three reviewers. Evidence was graded as per the National Health and Medical Research Council of Australia criteria. The evidence from thirty six papers was tabulated under the following headings: protein, weight loss, enteral support, vitamin D, sodium, fat, fibre, oral nutrition supplements, nutrition counselling, including protein and phosphate, nutrients in peritoneal dialysis solution and intradialytic parenteral nutrition, and was compared to international guidelines. While more evidence based studies are warranted, the customary nutrition prescription remains satisfactory with the exception of Vitamin D and phosphate. In these two areas, additional research is urgently needed given the potential of adverse outcomes for the CKD patient.&lt;/p></description></item><item><title>Roles of Vitamin D in 11 diseases</title><link>/posts/roles-of-vitamin-d-in-11-diseases.html</link><pubDate>Mon, 03 Feb 2014 00:00:00 +0000</pubDate><guid>/posts/roles-of-vitamin-d-in-11-diseases.html</guid><description>&lt;h3 id="summary-of-studies-of-vitamin-d-and-the-following-concerns">Summary of studies of Vitamin D and the following concerns&lt;/h3>
&lt;p>Sorry that we do not have hyperlinks (yet). You will have to scroll down or FIND table #&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Table 1 Diabetes Mellitus&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 2 Tuberculosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 3 Hypertension&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 4 Cardiovascular Diseases&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 5 Osteoporosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 6 Multiple Sclerosis&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 7 Cognition&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 8 Chronic Pain&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 9 Colon Cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 10 Breast cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 11 Prostate cancer&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Table 12 Vitamin D levels recommended&lt;/p></description></item><item><title>Vitamin D and its active metabolites – DeLuca</title><link>/posts/vitamin-d-and-its-active-metabolites-deluca.html</link><pubDate>Fri, 10 Jan 2014 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-its-active-metabolites-deluca.html</guid><description>&lt;h3 id="history-of-the-discovery-of-vitamin-d-and-its-active-metabolites">History of the discovery of vitamin D and its active metabolites&lt;/h3>
&lt;p>BoneKEy Reports 3, Article number: 479 (2014) | doi:10.1038/bonekey.2013.213 © 2014 International Bone &amp;amp; Mineral Society All rights reserved 2047-6396/14 Hector F DeLuca&lt;/p>
&lt;p>Department of Biochemistry, University of Wisconsin-Madison, Madison, WI, USA. &lt;a href="mailto:deluca@biochem.wisc.edu">deluca@biochem.wisc.edu&lt;/a>&lt;/p>
&lt;p>Before the twentieth century, it was not possible to describe the essentials of a diet that could support life, growth and reproduction of higher animals. The discovery of vitamin A by McCollum and Davis in 1913 ushered in the era of accessory food substances culminating in the achievement of that goal. It included the discovery of vitamin D and its production in skin caused by ultraviolet light. This was followed by a description of its actions at the physiological level that resulted in a healthy skeleton and beyond. To carry out these functions, vitamin D is converted to a hormone that acts through a nuclear receptor. The findings leading to this concept and their importance to biology and medicine are presented.&lt;/p></description></item><item><title>Vascular calcification greatly reduced by 3 per week 1000 ug of Vitamin K2 MK-7</title><link>/posts/vascular-calcification-greatly-reduced-by-3-per-week-1000-ug-of-vitamin-k2-mk-7.html</link><pubDate>Sat, 21 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/vascular-calcification-greatly-reduced-by-3-per-week-1000-ug-of-vitamin-k2-mk-7.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#press-release-12192013-menaq7-vitamin-k2-supplementation-may-benefit-dialysis-patients-by-inhibiting-vascular-calcification">Press Release 12/19/2013: MenaQ7® Vitamin K2 Supplementation May Benefit Dialysis Patients by Inhibiting Vascular Calcification&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-k2-supplementation-in-haemodialysis-patients-a-randomized-dose-finding-study">Vitamin K2 supplementation in haemodialysis patients: a randomized dose-finding study*&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="press-release-12192013-menaq7-vitamin-k2-supplementation-may-benefit-dialysis-patients-by-inhibiting-vascular-calcification">Press Release 12/19/2013: MenaQ7® Vitamin K2 Supplementation May Benefit Dialysis Patients by Inhibiting Vascular Calcification&lt;/h4>
&lt;p>NattoPharma has announced the publication of a new study performed in collaboration with OLV Hospital, Belgium, St. Jan Hospital, Belgium and VitaK, University of Maastricht, the Netherlands, published by Nephrology Dialysis Transplantation. &lt;a href="https://doi.org/10.1093/ndt/gft464">doi: 10.1093/ndt/gft464&lt;/a> .&lt;/p></description></item><item><title>Handbook of Vitamin D – 700 pages – 2013</title><link>/posts/handbook-of-vitamin-d-700-pages-2013.html</link><pubDate>Fri, 20 Dec 2013 00:00:00 +0000</pubDate><guid>/posts/handbook-of-vitamin-d-700-pages-2013.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#handbook-of-vitamin-d-in-human-health-vitamin-d-in-human-health-prevention-treatment-and-toxicity">Handbook of vitamin D in human health: vitamin D in human health, Prevention, treatment and toxicity&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-also-vitamindwiki">See also VitaminDWiki&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#overview-of-key-vitamin-d-modified-conditions">Overview of key vitamin D modified conditions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-musculoskeletal-health">Vitamin D and musculoskeletal health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-chronic-disease">Vitamin D and chronic disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-infectious-disease">Vitamin D and infectious disease&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-cancer">Vitamin D and cancer&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#women-and-children">Women and children&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#index">Index&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;h3 id="handbook-of-vitamin-d-in-human-health-vitamin-d-in-human-health-prevention-treatment-and-toxicity">Handbook of vitamin D in human health: vitamin D in human health, Prevention, treatment and toxicity&lt;/h3>
&lt;p>Edited by: Ronald Ross Watson&lt;/p></description></item><item><title>UVB improved vitamin D levels in 3 diseases, controls improved more – PHD</title><link>/posts/uvb-improved-vitamin-d-levels-in-3-diseases-controls-improved-more-phd.html</link><pubDate>Tue, 12 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/uvb-improved-vitamin-d-levels-in-3-diseases-controls-improved-more-phd.html</guid><description>&lt;p>&lt;strong>Narrow-band Ultraviolet B Exposures Improve Vitamin D Balance Trials Involving Dermatological and Haemodialysis Patients and Healthy Subjects&lt;/strong>&lt;/p>
&lt;p>&lt;strong>MERI ALA-HOUHALA&lt;/strong>&lt;/p>
&lt;p>ACADEMIC DISSERTATION To be presented, with the permission of the Board of the School of Medicine of the University of Tampere, for public discussion in the Small Auditorium of Building M, Pirkanmaa Hospital District, Teiskontie 35, Tampere, on November 22nd, 2013, at 12 o&amp;rsquo;clock.&lt;/p>
&lt;p>UNIVERSITY OF TAMPERE&lt;/p>
&lt;p>&lt;strong>ACADEMIC DISSERTATION University of Tampere, School of Medicine&lt;/strong>&lt;/p></description></item><item><title>Chronic Kidney Disease clinical trials of UV in Germany</title><link>/posts/chronic-kidney-disease-clinical-trials-of-uv-in-germany.html</link><pubDate>Sun, 10 Nov 2013 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-disease-clinical-trials-of-uv-in-germany.html</guid><description>&lt;h2 id="vitamin-d-and-uv-exposure-in-chronic-kidney-disease">Vitamin D and UV exposure in chronic kidney disease&lt;/h2>
&lt;p>Rolfdieter Krause&lt;/p>
&lt;p>Dermato-Endocrinology Vol 5 #1&lt;/p>
&lt;p>With loss of renal function and decreasing glomerula filtration rate the serum levels of 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> as well as 1,25-dihydroxyvitamin D &lt;span>[1,25 (OH)2 D]&lt;/span> often decrease simultaneously. In representative groups of German patients on renal replacement therapy (hemodialysis, peritoneal dialysis, kidney transplantation) our group retrospectively analyzed the vitamin D status over a period of 12 y (1995‒2006).&lt;/p></description></item><item><title>20 ng is enough vitamin D for healthy Nordic Caucasians: 5th Nordic meta-analysis</title><link>/posts/20-ng-is-enough-vitamin-d-for-healthy-nordic-caucasians-5th-nordic-meta-analysis.html</link><pubDate>Thu, 03 Oct 2013 00:00:00 +0000</pubDate><guid>/posts/20-ng-is-enough-vitamin-d-for-healthy-nordic-caucasians-5th-nordic-meta-analysis.html</guid><description>&lt;h2 id="nordic-nutrition-recommendations---the-nnr5-project">Nordic Nutrition Recommendations - the NNR5 project&lt;/h2>
&lt;p>Department of Food and Environmental Sciences, University of Helsinki, Helsinki, Finland;&lt;/p>
&lt;p>2UIT-The Arctic University of Norway, Troms0, Norway; 3Department of Community Medicine, Institute of Health and Society, University of Oslo, Oslo, Norway; 4Norwegian Institute of Public Health, Oslo, Norway; 5Unit for Nutrition Research, LandspitaliUniversity Hospital&amp;amp; University of Iceland, Reykjavik, Iceland&lt;/p>
&lt;hr>
&lt;p>&lt;strong>&lt;span style="color:#00F;">PDF is attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;p>&lt;strong>&lt;span style="color:#00F;">Appendicies are attached at the bottom of this page&lt;/span>&lt;/strong>&lt;/p></description></item><item><title>Off topic: Low-income black churches interest in early disease detection</title><link>/posts/off-topic-low-income-black-churches-interest-in-early-disease-detection.html</link><pubDate>Wed, 04 Sep 2013 00:00:00 +0000</pubDate><guid>/posts/off-topic-low-income-black-churches-interest-in-early-disease-detection.html</guid><description>&lt;p>Article below is from &lt;a href="http://www.salon.com/2013/09/03/it_really_does_take_a_village_how_memphis_is_fixing_healthcare/">Salon – Sept 2013&lt;/a>&lt;/p>
&lt;p>Wonder if churches might increase vitamin D usage in those with dark skin.&lt;/p>
&lt;p>FACT: Most people with dark skins and modern life style have low vitamin D.&lt;/p>
&lt;p>FACT: Vitamin D levels in the Southern US have dropped a lot in past 40 years with the use of air conditioning, increasing the problem&lt;/p>
&lt;p>FACT: Increasing vitamin D improves health&lt;/p>
&lt;p>Note: Poor health of dark skinned immigrants is a big problem around the world - churches might be able to help&lt;/p></description></item><item><title>HIV increases Calcium in soft tissues and reduces Calcium in bones</title><link>/posts/hiv-increases-calcium-in-soft-tissues-and-reduces-calcium-in-bones.html</link><pubDate>Wed, 28 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/hiv-increases-calcium-in-soft-tissues-and-reduces-calcium-in-bones.html</guid><description>&lt;h3 id="inverse-correlation-between-vascular-calcification-and-bone-mineral-density-in-human-immunodeficiency-virus-infected-patients">Inverse Correlation Between Vascular Calcification and Bone Mineral Density in Human Immunodeficiency Virus-Infected Patients&lt;/h3>
&lt;p>Calcified Tissue International, August 2013&lt;/p>
&lt;p>Antonio Bellasi,&lt;/p>
&lt;p>Stefano Zona,&lt;/p>
&lt;p>Gabriella Orlando,&lt;/p>
&lt;p>Federica Carli,&lt;/p>
&lt;p>Guido Ligabue,&lt;/p>
&lt;p>Vincenzo Rochira,&lt;/p>
&lt;p>Antonella Santoro,&lt;/p>
&lt;p>Cristina Mussini,&lt;/p>
&lt;p>Giovanni Guaraldi, &lt;a href="mailto:giovanni.guaraldi@unimore.it">giovanni.guaraldi@unimore.it&lt;/a>&lt;/p>
&lt;p>Paolo Raggi&lt;/p>
&lt;p>HIV-infected individuals suffer from accelerated aging, which manifests as premature cardiovascular and bone disease. However, little is known of the association of these two disorders in the HIV population. Our objective was to investigate the association between a marker of atherosclerosis (coronary artery calcium &lt;span>[CAC]&lt;/span>) and low bone mineral density (BMD) in a cross-sectional cohort of HIV-infected patients. The study was conducted at the University of Modena and Reggio Emilia, Italy. A total of 636 consecutive middle-aged, HIV-infected subjects were recruited between January 2006 and December 2010. All patients underwent CAC and BMD assessment. Patients were categorized according to a CAC score &amp;lt;100 or &amp;gt;100 units based on previous literature that identified this cut-point as a marker of increased risk.&lt;/p></description></item><item><title>Kidney patients need some form vitamin D – the question is, which form</title><link>/posts/kidney-patients-need-some-form-vitamin-d-the-question-is-which-form.html</link><pubDate>Wed, 07 Aug 2013 00:00:00 +0000</pubDate><guid>/posts/kidney-patients-need-some-form-vitamin-d-the-question-is-which-form.html</guid><description>&lt;h2 id="which-vitamin-d-in-ckd-mbd-the-time-of-burning-questions">Which Vitamin D in CKD-MBD? The Time of Burning Questions&lt;/h2>
&lt;p>BioMed Research International, Volume 2013 (2013), Article ID 864012, 10 pages&lt;/p>
&lt;p>1 Antonio Bellasi,2,3 Sara Auricchio,1 Sergio Papagni,4 and Mario Cozzolino31Medical Department, Nephrology Unit, AO Desio Vimercate, Desio Hospital, 20832 Desio, Italy&lt;/p>
&lt;p>2 Department of Nephrology, Sant’Anna Hospital, 22020 Como, Italy&lt;/p>
&lt;p>3 Department of Health Sciences, University of Milan, 20142 Milan, Italy&lt;/p>
&lt;p>4 Division of Nephrology, Dialysis Center CBH-Città di Bisceglie, 70052 Bisceglie, Italy&lt;/p></description></item><item><title>Dialysis patients need real vitamin D – Editorial</title><link>/posts/dialysis-patients-need-real-vitamin-d-editorial.html</link><pubDate>Wed, 24 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/dialysis-patients-need-real-vitamin-d-editorial.html</guid><description>&lt;h3 id="the-many-forms-and-functions-of-essential-vitamin-d-for-dialysis-patients">The Many Forms and Functions of Essential Vitamin D for Dialysis Patients&lt;/h3>
&lt;p>Journal of Renal Nutrition, Volume 23, Issue 4 , Pages e87-e88, July 2013&lt;/p>
&lt;p>Caroline Hamatake, MPH, RD &lt;a href="mailto:caroline.hamatake@fmc-na.com">caroline.hamatake@fmc-na.com&lt;/a>&lt;/p>
&lt;p>Liberty Dialysis–Hawaii, Honolulu, Hawaii&lt;/p>
&lt;p>Feature Editor: Catherine M. Goeddeke-Merickel, MS, RD, LD&lt;/p>
&lt;p>Introduction/Overview&lt;/p>
&lt;p>The screening and treatment of vitamin D deficiency is now routinely done in most dialysis clinics. Many dialysis patients have suboptimal levels of serum 25-hydroxyvitamin D and require vitamin D supplementation even in clinics located in the tropics.&lt;/p></description></item><item><title>Those Dialysis patients with low vitamin D were 75% more likely to die</title><link>/posts/those-dialysis-patients-with-low-vitamin-d-were-75-percent-more-likely-to-die.html</link><pubDate>Mon, 22 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/those-dialysis-patients-with-low-vitamin-d-were-75-percent-more-likely-to-die.html</guid><description>&lt;h4 id="vitamin-d-deficiency-and-mortality-in-patients-receiving-dialysis-the-comprehensive-dialysis-study">Vitamin D Deficiency and Mortality in Patients Receiving Dialysis: The Comprehensive Dialysis Study&lt;/h4>
&lt;p>Journal of Renal Nutrition, Available online 19 July 2013, &lt;a href="http://dx.doi.org/10.1053/j.jrn.2013.05.003">http://dx.doi.org/10.1053/j.jrn.2013.05.003&lt;/a>&lt;/p>
&lt;p>Shuchi Anand, MD∗, Corresponding author&lt;/p>
&lt;p>Glenn M. Chertow, MD, MPH∗,&lt;/p>
&lt;p>Kirsten L. Johansen, MD†, ‡,&lt;/p>
&lt;p>Barbara Grimes, PhD§,&lt;/p>
&lt;p>Lorien S. Dalrymple, MD, MPH¶,&lt;/p>
&lt;p>George A. Kaysen, MD, PhD¶, ∗∗,&lt;/p>
&lt;p>Manjula Kurella Tamura, MD, MPH∗, ††&lt;/p>
&lt;p>∗ Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California&lt;/p></description></item><item><title>Tuberculosis, UV and perhaps vitamin D</title><link>/posts/tuberculosis-uv-and-perhaps-vitamin-d.html</link><pubDate>Mon, 22 Jul 2013 00:00:00 +0000</pubDate><guid>/posts/tuberculosis-uv-and-perhaps-vitamin-d.html</guid><description>&lt;h1 class="svTitle">
&lt;p>&lt;span style="font-size:22px;">Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis&lt;/span>&lt;/h1>&lt;/p>
&lt;div class="publicationHead titleBanner">
&lt;div class="cover">
&lt;div class="title">
&lt;p>&lt;a class="cLink" href="http://www.sciencedirect.com/science/journal/14733099" title="Go to The Lancet Infectious Diseases on SciVerse ScienceDirect">&lt;img alt="The Lancet Infectious Diseases" class="imgLazyJSB" height="25" src="http://ars.els-cdn.com/content/image/B14733099.gif" width="310" />&lt;/a>&lt;a href="http://www.sciencedirect.com/science/journal/14733099/13/1" title="Go to table of contents for this volume/issue">Volume 13, Issue 1&lt;/a>, January 2013, Pages 77–88&lt;/div>&lt;/p>
&lt;/div>
&lt;/div>
&lt;ul class="authorGroup noCollab">&lt;li>
&lt;p>&lt;span class="authorDegrees">Dr &lt;/span>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#" id="authname_N5d0e3940N5d020df8">Anna P Ralph&lt;/a>, &lt;span class="authorDegrees">PhD&lt;/span>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff1" id="baff1" title="Affiliation: a">&lt;sup>a&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff2" id="baff2" title="Affiliation: b">&lt;sup>b&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff3" id="baff3" title="Affiliation: c">&lt;sup>c&lt;/sup>&lt;/a>&lt;sup>, &lt;/sup>&lt;a class="intra_ref auth_corr" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#cor1" id="bcor1" title="Corresponding author contact information">&lt;img alt="Corresponding author contact information" class="imgLazyJSB" src="http://cdn.els-cdn.com/sd/entities/REcor.gif" />&lt;/a>&lt;sup>, &lt;/sup>&lt;a href="mailto:anna.ralph@menzies.edu.au">anna.ralph@menzies.edu.au&lt;/a>&lt;/li>&lt;/p>
&lt;li>
&lt;p>&lt;a class="authorName" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#" id="authname_N5d0e3940N5d020ee8">Robyn M Lucas&lt;/a>, &lt;span class="authorDegrees">PhD&lt;/span>&lt;a class="intra_ref auth_aff" href="http://www.sciencedirect.com/science/article/pii/S147330991270275X#aff4" id="baff4" title="Affiliation: d">&lt;sup>d&lt;/sup>&lt;/a>,&lt;/li>&lt;/p></description></item><item><title>Chronic kidney with low vitamin D: 90 percent of pediatric nephrologists now recommend more D</title><link>/posts/chronic-kidney-with-low-vitamin-d-90-percent-of-pediatric-nephrologists-now-recommend-more-d.html</link><pubDate>Wed, 26 Jun 2013 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-with-low-vitamin-d-90-percent-of-pediatric-nephrologists-now-recommend-more-d.html</guid><description>&lt;h2 id="nutritional-vitamin-d-use-in-chronic-kidney-disease-a-survey-of-pediatric-nephrologists">Nutritional vitamin D use in chronic kidney disease: a survey of pediatric nephrologists.&lt;/h2>
&lt;p>Pediatr Nephrol. 2013 Feb;28(2):265-75. &lt;a href="https://doi.org/10.1007/s00467-012-2307-5.">doi: 10.1007/s00467-012-2307-5.&lt;/a> Epub 2012 Oct 20.&lt;/p>
&lt;p>Griffin LM, Denburg MR, Shults J, Furth SL, Salusky IB, Hwang W, Leonard MB.&lt;/p>
&lt;p>Department of Pediatrics, Children&amp;rsquo;s Hospital of Philadelphia, 3535 Market Street, Room 868, Philadelphia, PA, USA.&lt;/p>
&lt;p>BACKGROUND: Vitamin D deficiency may contribute to risk of cardiovascular disease, diabetes, and infections, in addition to known effects on mineral metabolism. Controversy remains regarding the use of nutritional vitamin D supplementation in chronic kidney disease (CKD), and the supplementation practices of pediatric nephrologists are unknown.&lt;/p></description></item><item><title>Standard and artificial vitamin D both help Chronic Kidney Disease – meta-analysis</title><link>/posts/standard-and-artificial-vitamin-d-both-help-chronic-kidney-disease-meta-analysis.html</link><pubDate>Wed, 24 Apr 2013 00:00:00 +0000</pubDate><guid>/posts/standard-and-artificial-vitamin-d-both-help-chronic-kidney-disease-meta-analysis.html</guid><description>&lt;h2 id="impact-of-vitamin-d-on-chronic-kidney-diseases-in-non-dialysis-patients">Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients:&lt;/h2>
&lt;p>A Meta-Analysis of Randomized Controlled Trials&lt;/p>
&lt;p>PLoS ONE 8(4): e61387. doi:10.1371/journal.pone.0061387&lt;/p>
&lt;p>Lijuan Xu, Xuesi Wan, Zhimin Huang, Fangfang Zeng, Guohong Wei, Donghong Fang, Wanping Deng, Yanbing Li mail&lt;/p>
&lt;p>Background and Objectives: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials.&lt;/p></description></item><item><title>Annual cost of 1000 IU of Vitamin D daily - Consumer Reports</title><link>/posts/annual-cost-of-1000-iu-of-vitamin-d-daily-consumer-reports.html</link><pubDate>Thu, 28 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/annual-cost-of-1000-iu-of-vitamin-d-daily-consumer-reports.html</guid><description>&lt;h4 id="click-herehttpwwwconsumerreportsorgcromagazine201305most-vitamin-d-pills-measure-up-our-tests-findindexhtm-to-see-full-article">&lt;a href="http://www.consumerreports.org/cro/magazine/2013/05/most-vitamin-d-pills-measure-up-our-tests-find/index.htm">CLICK HERE&lt;/a> to see full article&lt;/h4>
&lt;ul>
&lt;li>
&lt;p>at least three samples of each product were analyzed for their level of vitamin D3&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Average vitamin D3 levels ranged from 105 % to 141 % of the labeled amount&lt;/p>
&lt;/li>
&lt;/ul>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cr1.jpg" alt="image">
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/cr2.jpg" alt="image">
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/most-vitamin-d-bought-over-the-counter-meet-requirements">Most vitamin D bought over-the-counter meet requirements – Feb 2013&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/how-vitamin-d3-is-made-from-wool">How vitamin D3 is made from wool&lt;/a>   &lt;a href="/posts/vitamin-d3-for-vegans-many-studies">Vitamin D3 for Vegans - many studies&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/alternatives-if-not-swallow-pills-or-not-absorb-vitamin-d">Alternatives if not swallow pills or not absorb vitamin D&lt;/a>&lt;/p></description></item><item><title>1700 IU of vitamin D not enough to help hemodialysis patients</title><link>/posts/1700-iu-of-vitamin-d-not-enough-to-help-hemodialysis-patients.html</link><pubDate>Sat, 16 Mar 2013 00:00:00 +0000</pubDate><guid>/posts/1700-iu-of-vitamin-d-not-enough-to-help-hemodialysis-patients.html</guid><description>&lt;h3 id="effects-of-cholecalciferol-on-functional-biochemical-vascular-and-quality-of-life-outcomes-in-hemodialysis-patients">Effects of Cholecalciferol on Functional, Biochemical, Vascular, and Quality of Life Outcomes in Hemodialysis Patients.&lt;/h3>
&lt;p>Clin J Am Soc Nephrol. 2013 Mar 14.&lt;/p>
&lt;p>Hewitt NA, O&amp;rsquo;Connor AA, O&amp;rsquo;Shaughnessy DV, Elder GJ.&lt;/p>
&lt;p>Postgraduate Medical School, University of Notre Dame, Sydney, Australia;, †Renal Resource Centre, Sydney Dialysis Centre, Royal North Shore Hospital, Sydney, Australia;, ‡Department of Renal Medicine, Westmead Hospital, Sydney, Australia, §Osteoporosis and Bone Biology Division, Garvan Institute of Medical Research, Sydney, Australia.&lt;/p></description></item><item><title>Vitamin D: Is It the Best Thing Under the Sun - Medscape</title><link>/posts/vitamin-d-is-it-the-best-thing-under-the-sun-medscape.html</link><pubDate>Fri, 08 Feb 2013 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-is-it-the-best-thing-under-the-sun-medscape.html</guid><description>&lt;p>Robert Finn; Deborah Flapan; Darbe Rotach&lt;/p>
&lt;h3 id="the-following-is-the-first-of-25-images">The following is the first of 25 images&lt;/h3>
&lt;img src="/attachments/d3.mock.jpg" alt="image"> 
&lt;p>The number of research studies on vitamin D has soared in recent years.&lt;/p>
&lt;p>Citations of studies involving vitamin D increased from 1142 in the year 2000 to 3877 in 2012.&lt;/p>
&lt;p>In comparison, citations for research on vitamin A and vitamin C have remained more or less level.&lt;/p>
&lt;p>You have to register with &lt;a href="http://www.medscape.com/features/slideshow/vitamin-d#20">Medscape&lt;/a> to see the other images, with text&lt;/p></description></item><item><title>50 percent of Chronic Kidney Disease treatments in Germany include vitamin D</title><link>/posts/50-percent-of-chronic-kidney-disease-treatments-in-germany-include-vitamin-d.html</link><pubDate>Thu, 06 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/50-percent-of-chronic-kidney-disease-treatments-in-germany-include-vitamin-d.html</guid><description>&lt;h4 id="implementation-and-first-results-of-a-german-chronic-kidney-disease-registry">Implementation and first results of a German Chronic Kidney Disease Registry.&lt;/h4>
&lt;p>Clin Nephrol. 2012 Dec 4.&lt;/p>
&lt;p>Kleophas W, Bieber B, Robinson BM, Duttlinger J, Fliser D, Lonnemann G, Rump LC, Pisoni RL, Port FK, Reichel H.&lt;/p>
&lt;p>Advanced chronic kidney disease (CKD) is gaining increasing medical and economical importance, but little information exists about treatment variation and the impact of routine clinical treatments on survival, quality of life, and cost. We demonstrate the first results of a national electronic registry of nephrology clinic data that will serve as a resource for the prospective observation of CKD patients in Germany. A large network of German nephrologist practices is currently joining the project. Routinely obtained clinical data for non-dialysis dependent CKD patients are documented in health records electronically, and elements from these data are extracted using QuaNT (Qualitätssicherung Nephrologie und Transplantation) to create a centralized database. Here, we report cross-sectional data from 59 participating nephrology clinics and 6,187 patients with CKD Stage 3 - 5 in 2011. Mean age ± standard deviation (SD) was 72 ± 12 years. The distribution of CKD 3, 4, and 5 (non-dialysis) was 60%, 33%, and 8%, respectively. The major renal diseases were hypertension/vascular nephropathy (47%) and diabetic nephropathy (26%).&lt;/p></description></item><item><title>The problems of vitamin d insufficiency in older people</title><link>/posts/the-problems-of-vitamin-d-insufficiency-in-older-people.html</link><pubDate>Tue, 04 Dec 2012 00:00:00 +0000</pubDate><guid>/posts/the-problems-of-vitamin-d-insufficiency-in-older-people.html</guid><description>&lt;h3 id="the-problems-of-vitamin-d-insufficiency-in-older-people">The problems of vitamin d insufficiency in older people.&lt;/h3>
&lt;p>Aging Dis. 2012 Aug;3(4):313-29. Epub 2012 Jun 6.&lt;/p>
&lt;p>Boucher BJ. Queen Mary University of London, Centre for Diabetes, Blizard Institute, London, E12AT, UK.&lt;/p>
&lt;p>&lt;strong>(PDF is attached at the bottom of this page)&lt;/strong>&lt;/p>
&lt;p>This report reviews evidence on disorders related to inadequate vitamin D repletion in older people. Vitamin D is as essential for bone health in adults as in children, preventing osteomalacia and muscle weakness and protecting against falls and low-impact fractures. Vitamin D is provided by skin synthesis by UVB-irradiation from summer sunshine and to a small extent by absorption from food. However, these processes become less efficient with age. Loss of mobility or residential care restricts solar exposure. Reduced appetite and financial problems often add to these problems. Thus, hypovitaminosis D is common world-wide, but is more common and more severe in older people.&lt;/p></description></item><item><title>Vitamin D Posters at Beyond the Bone</title><link>/posts/vitamin-d-posters-at-beyond-the-bone.html</link><pubDate>Fri, 23 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-posters-at-beyond-the-bone.html</guid><description>&lt;h2 id="click-heretagsclick-herehtml-for-entire-beyond-the-bone-conference">&lt;a href="/tags/click-here.html">CLICK HERE&lt;/a> for entire Beyond the Bone conference&lt;/h2>
&lt;p>&lt;strong>&lt;span style="color:#F00;">The following is extracted from PDF at the bottom of this page&lt;/span>&lt;/strong>&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Ameri, Pietro&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Coleman, Laura A.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Gilmour, Joyanna&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Giudici, Kelly&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Kelly, Owen&lt;/p>
&lt;/li>
&lt;li>
&lt;p>LeFever, F. Frank&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Li, Lily&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Plotnikoff, Gregory A.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rutten, Erica PA&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Sergeev, Igor&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Trinko, J. Richard&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Weishaar, Tom&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Whisner, Corrie&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Yen, Tim&lt;/p>
&lt;/li>
&lt;/ol>
&lt;h2 id="1--------serum-igf-i-concentration-increases-following-treatment-with-vitamin-d-a-proof-of-principle-study">1. SERUM IGF-I CONCENTRATION INCREASES FOLLOWING TREATMENT WITH VITAMIN D: A PROOF OF PRINCIPLE STUDY&lt;/h2>
&lt;p>Ameri, P1,2, Bovio M1, Giusti A3, Canepa M1,4, Ferone D1, Murialdo G&lt;/p></description></item><item><title>Vitamin D, Beyond the Bone – Presentation New York</title><link>/posts/vitamin-d-beyond-the-bone-presentation-new-york.html</link><pubDate>Fri, 23 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-beyond-the-bone-presentation-new-york.html</guid><description>&lt;p>Presented by the Abbott Nutrition Health Institute, the New York Academy of Sciences, and the Sackler Institute for Nutrition Science&lt;/p>
&lt;p>Reported by Nicholette Zeliadt | Posted November 21, 2012&lt;/p>
&lt;p>Keynote speaker: Daniel D. Bikle (University of California, San Francisco and VA Medical Center)&lt;/p>
&lt;h3 id="beyond-the-bone-conference-summary--june-2013postsbeyond-the-bone-conference-summary--update">&lt;a href="/posts/beyond-the-bone-conference-summary">Beyond the bone: conference summary – June 2013&lt;/a> update&lt;/h3>
&lt;p>First identified nearly a century ago for its essential role in maintaining bone health, vitamin D has recently undergone a renaissance of interest due to the resurgence of vitamin D deficiency and the identification of vitamin D receptors in tissues and cells outside the skeletal system. Indeed, a growing body of evidence indicates that vitamin D has several extraskeletal functions and plays a key role in the immune, cardiovascular, and nervous systems. Furthermore, a growing body of research links vitamin D status to health and vitamin D deficiency to the risk of developing certain diseases, including cancers, multiple sclerosis, type 1 diabetes, rheumatoid arthritis, hypertension, and cardiovascular disease. On September 21, 2012, basic science and clinical researchers gathered to discuss non-classical effects at the Vitamin D: Beyond Bone conference presented by the Abbott Nutrition Health Institute, the Sackler Institute for Nutrition Science, and the New York Academy of Sciences.&lt;/p></description></item><item><title>Thyroid and parathyroid</title><link>/posts/thyroid-and-parathyroid.html</link><pubDate>Fri, 16 Nov 2012 00:00:00 +0000</pubDate><guid>/posts/thyroid-and-parathyroid.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#what-is-the-difference-between-the-intact-parathyroid-hormone-and-the-parathyroid-hormone-asked-ai">What is the difference between the Intact Parathyroid Hormone and the Parathyroid Hormone (asked AI)&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="what-is-the-difference-between-the-intact-parathyroid-hormone-and-the-parathyroid-hormone-asked-ai">What is the difference between the Intact Parathyroid Hormone and the Parathyroid Hormone (asked AI)&lt;/h4>
&lt;p>The difference between Intact Parathyroid Hormone (iPTH) and Parathyroid Hormone (PTH) primarily lies in the specific forms of the hormone that each assay measures and their clinical utility.&lt;/p>
&lt;p>&lt;strong>Intact Parathyroid Hormone (iPTH)&lt;/strong>&lt;/p>
&lt;p>The iPTH assay measures the level of 1-84 PTH, which is the full, active form of the hormone, along with large truncated fragments of non-1-84 PTH, including 7-84 PTH. This assay is widely used, especially in the context of managing patients with chronic kidney disease, including those on dialysis, to assess parathyroid function and secondary hyperparathyroidism. The iPTH assay is considered the standard measurement for PTH in clinical practice and is used for approximately 90% of Japanese dialysis patients 1.&lt;/p></description></item><item><title>Vitamin D3 far better than D2 for hemodialysis</title><link>/posts/vitamin-d3-far-better-than-d2-for-hemodialysis.html</link><pubDate>Wed, 31 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d3-far-better-than-d2-for-hemodialysis.html</guid><description>&lt;h2 id="vitamin-d2-versus-vitamin-d3-supplementation-in-hemodialysis-patients">Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients:&lt;/h2>
&lt;p>a comparative pilot study.&lt;/p>
&lt;p>Daroux M, Shenouda M, Bacri JL, Lemaitre V, Vanhille P, Bataille P&lt;/p>
&lt;p>Department of Nephrology, Doctor Duchenne Hospital, Boulogne-sur-Mer - France; and Department of Nephrology, Regional University Hospital of Lille, Lille - France.&lt;/p>
&lt;p>Journal of Nephrology &lt;span>[2012:0]&lt;/span>&lt;/p>
&lt;p>Background: In patients with chronic kidney disease, vitamin D insufficiency is highly prevalent. It can be corrected by supplementation with either vitamin D2 or vitamin D3. Recent studies in patients without impaired kidney function suggest that vitamin D3 is more efficient than vitamin D2 in correcting vitamin D insufficiency. However, no direct comparison has been made in hemodialysis (HD) patients.&lt;/p></description></item><item><title>Kidney Dialysis clinics reluctant to add vitamin D treatment as they are not reimbursed</title><link>/posts/kidney-dialysis-clinics-reluctant-to-add-vitamin-d-treatment-as-they-are-not-reimbursed.html</link><pubDate>Tue, 16 Oct 2012 00:00:00 +0000</pubDate><guid>/posts/kidney-dialysis-clinics-reluctant-to-add-vitamin-d-treatment-as-they-are-not-reimbursed.html</guid><description>&lt;p>&lt;strong>And, treating with vitamin D would decrease their number of patients thus and their income&lt;/strong>&lt;/p>
&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#a-cost-effective-complement-to-managing-the-vitamin-d-deficient-and-anemic-dialysis-patient-in-the-bundledworld">A cost effective complement to managing the vitamin D deficient and anemic dialysis patient in the bundled world.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-alsoweb">See also web&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="a-cost-effective-complement-to-managing-the-vitamin-d-deficient-and-anemic-dialysis-patient-in-the-bundledworld">A cost effective complement to managing the vitamin D deficient and anemic dialysis patient in the bundled world.&lt;/h4>
&lt;p>Nephrol News Issues. 2012 Jul;26(8):22-4, 26.&lt;/p>
&lt;p>Larkin J, Bea L, Sharma A.&lt;/p>
&lt;p>Pacific Renal Research Institute, Caldwell, Idaho, USA.&lt;/p></description></item><item><title>Omega 3 increases vitamin D in the blood – many studies</title><link>/posts/omega-3-increases-vitamin-d-in-the-blood-many-studies.html</link><pubDate>Sun, 26 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/omega-3-increases-vitamin-d-in-the-blood-many-studies.html</guid><description>&lt;p>&lt;strong>Many articles on this page&lt;/strong>&lt;/p>
&lt;p>Omega-3 increases levels of active vitamin D&lt;/p>
&lt;p>Active vitamin D is the form which the body actually used&lt;/p>
&lt;p>Active vitamin D is not measured by standard vitamin D tests&lt;/p>
&lt;p>Omega-3 is thus especially useful to get vitamin D to the body if the kidney is not functioning properly&lt;/p>
&lt;hr>
&lt;h4 id="the-effects-of-omega-3-fatty-acid-on-vitamin-d-activation-in-hemodialysis-patients-a-pilot-study--2015">The Effects of Omega-3 Fatty Acid on Vitamin D Activation in Hemodialysis Patients: A Pilot Study- 2015&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/active-d-and-omega-3.jpg" alt="image">
&lt;p>Mar. Drugs 2015, 13(2), 741-755; doi:10.3390/md13020741&lt;/p></description></item><item><title>Echocardiograms confirm problems with low vitamin D</title><link>/posts/echocardiograms-confirm-problems-with-low-vitamin-d.html</link><pubDate>Tue, 14 Aug 2012 00:00:00 +0000</pubDate><guid>/posts/echocardiograms-confirm-problems-with-low-vitamin-d.html</guid><description>&lt;h1 id="relationship-of-vitamin-d-deficiency-to-echocardiography-findings-in-veterans">Relationship of Vitamin D Deficiency to Echocardiography Findings in Veterans&lt;/h1>
&lt;p>Joshi et al., J Clin Exp Cardiolog 2012, S:3 &lt;a href="http://dx.doi.org/10.4172/2155-9880.S3-005">http://dx.doi.org/10.4172/2155-9880.S3-005&lt;/a>&lt;/p>
&lt;p>Hetvi Joshi 1, Pablo Lopez 1, Beth Bailey 2, Costy Mattar 3, Todd Manning 4 and Alan Peiris 5 &lt;a href="mailto:peiris@etsu.edu">peiris@etsu.edu&lt;/a>&lt;/p>
&lt;p>&amp;lsquo;East Tennessee State University, Department of Internal Medicine, USA 2East Tennessee State University, Department of Family Medicine, USA &amp;lsquo;Division of Cardiology, Mountain Home Veterans Affairs Medical Center, USA&lt;/p>
&lt;p>Received April &amp;lsquo;2, 2012; Accepted May 2&amp;rsquo;, 2012; Published May 23, 2012&lt;/p></description></item><item><title>Quarterly vitamin D3 is too infrequent – it increases the occurrence of pneumonia</title><link>/posts/quarterly-vitamin-d3-is-too-infrequent-it-increases-the-occurrence-of-pneumonia.html</link><pubDate>Fri, 29 Jun 2012 00:00:00 +0000</pubDate><guid>/posts/quarterly-vitamin-d3-is-too-infrequent-it-increases-the-occurrence-of-pneumonia.html</guid><description>&lt;h3 id="is-quarterly-bolus-vitamin-d3-supplementation-adequate-to-prevent-childhood-pneumonia">Is quarterly bolus vitamin D3 supplementation adequate to prevent childhood pneumonia?&lt;/h3>
&lt;p>?Transl Pediatr 2012 Jun 11. DOI: 10.3978/j.issn.2224-4336.2012.06.01&lt;/p>
&lt;p>Ursula Thiem1, Enikö Kállay2, Kyra Borchhardt1&lt;/p>
&lt;p>1Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Spitalgasse 23, Vienna, Austria;&lt;/p>
&lt;p>2 Department of Pathophysiology and Allergy Research, Medical University of Vienna, Spitalgasse 23, Vienna, Austria&lt;/p>
&lt;p>Corresponding to: Priv.-Doz. Dr. Kyra Borchhardt, Department of Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Spitalgasse 23, 1090 Vienna, Austria. Email: &lt;a href="mailto:kyra.borchhardt@meduniwien.ac.at">kyra.borchhardt@meduniwien.ac.at&lt;/a>.&lt;/p></description></item><item><title>Importance of Vitamins D and K</title><link>/posts/importance-of-vitamins-d-and-k.html</link><pubDate>Thu, 24 May 2012 00:00:00 +0000</pubDate><guid>/posts/importance-of-vitamins-d-and-k.html</guid><description>&lt;h1 id="vitamins-d-and-k-as-pleiotropic-nutrients-clinical-importance-to-the-skeletal-and-cardiovascular-systems-and-preliminary-evidence-for-synergy">Vitamins D and K as pleiotropic nutrients: clinical importance to the skeletal and cardiovascular systems and preliminary evidence for synergy.&lt;/h1>
&lt;p>Altern Med Rev. 2010 Sep;15(3):199-222.&lt;/p>
&lt;p>Kidd PM.&lt;/p>
&lt;p>University of California, Berkeley, USA. &lt;a href="mailto:dockidd@dockidd.com">dockidd@dockidd.com&lt;/a>&lt;/p>
&lt;hr>
&lt;h1 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h1>
&lt;ul>
&lt;li>&lt;a href="/posts/overview-vitamin-k-and-vitamin-d">Overview Vitamin K and Vitamin D&lt;/a>&lt;/li>
&lt;/ul>
&lt;hr>
&lt;p>Vitamins D and K are lipid-phase nutrients that are pleiotropic - endowed with versatile homeostatic capacities at the organ, tissue, and cellular levels. Their metabolic and physiologic roles overlap considerably, as evidenced in the bone and cardiovascular systems. Vitamin D? (cholecalciferol, D?) is the prehormone for the vitamin D endocrine system. Vitamin D? undergoes initial enzymatic conversion to 25-hydroxyvitamin D (25D, calcidiol), then to the seco-steroid hormone 1alpha, 25-dihydroxyvitamin D (1,25D, calcitriol). Beyond its endocrine roles in calcium homeostasis, 1,25D likely has autocrine, paracrine, and intracrine effects. At least 17 tissues likely synthesize 1,25D, and 35 carry the vitamin D receptor (VDR). Vitamin D functional deficiency is widespread in human populations. Vitamin K? (phylloquinone) is more abundant in foods but less bioactive than the vitamin K? menaquinones (especially MK-4, menatetrenone). Menadione (vitamin K?) has minimal K activity. Vitamin K compounds undergo oxidation-reduction cycling within the endoplasmic reticulum membrane, donating electrons to activate specific proteins via enzymatic gamma-carboxylation of glutamate groups before being enzymatically re-reduced. Warfarin inhibits this vitamin K reduction, necessitating K supplementation during anticoagulation therapy. Along with coagulation factors (II, VII, IX, X, and prothrombin), protein C and protein S, osteocalcin (OC), matrix Gla protein (MGP), periostin, Gas6, and other vitamin K-dependent (VKD) proteins support calcium homeostasis, facilitate bone mineralization, inhibit vessel wall calcification, support endothelial integrity, are involved in cell growth control and tissue renewal, and have numerous other effects. This review updates vitamin D and K skeletal and cardiovascular benefits and evidence for their synergy of action.&lt;/p></description></item><item><title>Vitamin D's potential to reduce the risk of hospital-acquired infections</title><link>/posts/vitamin-ds-potential-to-reduce-the-risk-of-hospital-acquired-infections.html</link><pubDate>Mon, 21 May 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-ds-potential-to-reduce-the-risk-of-hospital-acquired-infections.html</guid><description>&lt;h4 id="health-careassociated-and-hospital-acquired-infections-are-two-entities-associated-with-increased-morbidity-and-mortality-dermato-endrocinology-volume-4-issue-2---aprilmayjune-2012">Health care–associated and hospital-acquired infections are two entities associated with increased morbidity and mortality. Dermato Endrocinology Volume 4, Issue 2 April/May/June 2012&lt;/h4>
&lt;p>Dima A. Youssef &lt;a href="mailto:estecina@hotmail.com">estecina@hotmail.com&lt;/a>, Tamra Ranasinghe, William B. Grant and Alan N. Peiris&lt;/p>
&lt;p>They are highly costly and constitute a great burden to the health care system.&lt;/p>
&lt;p>Vitamin D deficiency (&amp;lt; 20 ng/ml) is prevalent and may be a key contributor to both acute and chronic ill health.&lt;/p>
&lt;p>Vitamin D deficiency is associated with decreased innate immunity and increased risk for infections.&lt;/p></description></item><item><title>Calcitrol was as effective as Vitamin D analogues, and 17X less costly</title><link>/posts/calcitrol-was-as-effective-as-vitamin-d-analogues-and-17x-less-costly.html</link><pubDate>Tue, 15 May 2012 00:00:00 +0000</pubDate><guid>/posts/calcitrol-was-as-effective-as-vitamin-d-analogues-and-17x-less-costly.html</guid><description>&lt;h3 id="calcitriol-as-effective-as-vitamin-d-analogues-but-cheaperhttpwwwrenalandurologynewscomcalcitriol-as-effective-as-vitamin-d-analogues-but-cheaperarticle24070420">&lt;a href="http://www.renalandurologynews.com/calcitriol-as-effective-as-vitamin-d-analogues-but-cheaper/article/240704/%20">Calcitriol as Effective as Vitamin D Analogues, but Cheaper&lt;/a>&lt;/h3>
&lt;p>Jody A. CharnowMay 11, 2012&lt;/p>
&lt;p>NATIONAL HARBOR, Md.—Oral calcitriol is as effective as vitamin D analogues for treating secondary hyperparathyroidism (SHPT) in hemodialysis patients but is more cost effective, according to a study presented at the National Kidney Foundation 2012 Spring Clinical Meetings.&lt;/p>
&lt;p>Sandeep Aggarwal, MD, and collaborators at Drexel University College of Medicine in Philadelphia retrospectively studied 52 dialysis patients with SHPT who were converted from intravenous vitamin D analogues (paricalcitol or doxercalciferol) to oral calcitriol. The researchers observed no significant differences in calcium and phosphorus levels at three months after switching to calcitriol and at the end of the study at nine months.&lt;/p></description></item><item><title>Perhaps Vitamin D3 is better than D2 for Chronic Kidney Disease</title><link>/posts/perhaps-vitamin-d3-is-better-than-d2-for-chronic-kidney-disease.html</link><pubDate>Wed, 09 May 2012 00:00:00 +0000</pubDate><guid>/posts/perhaps-vitamin-d3-is-better-than-d2-for-chronic-kidney-disease.html</guid><description>&lt;h1 id="ergocalciferol-and-cholecalciferol-in-ckd">Ergocalciferol and Cholecalciferol in CKD.&lt;/h1>
&lt;p>Am J Kidney Dis. 2012 May 4.&lt;/p>
&lt;p>Nigwekar SU, Bhan I, Thadhani R.&lt;/p>
&lt;p>Division of Nephrology, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Scholars in Clinical Science Program, Harvard Medical School, Boston, MA.&lt;/p>
&lt;p>The development of chronic kidney disease (CKD) is accompanied by a progressive decrease in the ability to produce 1,25-dihydroxyvitamin D. Pharmacological replacement with active vitamin D therefore has been a cornerstone of secondary hyperparathyroidism therapy in the end-stage renal disease population treated by long-term dialysis. Recent evidence suggests that extrarenal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D may have significant biological roles beyond those traditionally ascribed to vitamin D. Furthermore, low 25-hydroxyvitamin D levels are common in patients with all stages of CKD. This article focuses on the role of nutritional vitamin D replacement in CKD and aims to review vitamin D biology and summarize the existing literature regarding nutritional vitamin D replacement in these populations. Based on the current state of the evidence, we provide suggestions for clinical practice and address areas of uncertainty that need further research.&lt;/p></description></item><item><title>Guidelines on prevention and treatment of vitamin D deficiency</title><link>/posts/guidelines-on-prevention-and-treatment-of-vitamin-d-deficiency.html</link><pubDate>Tue, 24 Apr 2012 00:00:00 +0000</pubDate><guid>/posts/guidelines-on-prevention-and-treatment-of-vitamin-d-deficiency.html</guid><description>&lt;p>Reumatismo. 2011 Nov 9;63(3):129-47. &lt;a href="https://doi.org/10.4081/reumatismo.2011.129.">doi: 10.4081/reumatismo.2011.129.&lt;/a>&lt;/p>
&lt;p>Adami S, Romagnoli E, Carnevale V, Scillitani A, Giusti A, Rossini M, Gatti D, Nuti R, Minisola S.&lt;/p>
&lt;p>Unità di Reumatologia, Dipartimento di Medicina, Università di Verona. &lt;a href="mailto:Silvano.adami@univr.it">Silvano.adami@univr.it&lt;/a>.&lt;/p>
&lt;p>The Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) has elaborated the following guidelines about the definition, prevention and treatment of inadequate vitamin D status.&lt;/p>
&lt;p>The highlights are presented here.&lt;/p>
&lt;p>PMID: 22257914&lt;/p>
&lt;hr>
&lt;p>HTML from PDF is in &lt;strong>Italian&lt;/strong> – the Chrome Browser will ask if you want it translated&lt;/p></description></item><item><title>Health problem frequency - 1997</title><link>/posts/health-problem-frequency-1997.html</link><pubDate>Mon, 05 Mar 2012 00:00:00 +0000</pubDate><guid>/posts/health-problem-frequency-1997.html</guid><description>&lt;h1 id="rate-of-human-problemshttphomeznetcomschesterfactsrate_of_human_problemshtml-by-tom-chester">&lt;a href="http://home.znet.com/schester/facts/rate_of_human_problems.html">Rate of Human Problems&lt;/a> by Tom Chester&lt;/h1>
&lt;p>Many of the problems which vitamin D can reduce &lt;strong>have been highlighted&lt;/strong>&lt;/p>
&lt;p>This will allow prioritizing vitamin D benefits by frequency of occurrence&lt;/p>
&lt;p>But not prioritize the problem by impact on the person - say # of disability life years, death, etc&lt;/p>
&lt;!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
&lt;HTML>
&lt;HEAD>
&lt;META HTTP-EQUIV="CONTENT-TYPE" CONTENT="text/html; charset=windows-1252">
&lt;TITLE>&lt;/TITLE>
&lt;META NAME="GENERATOR" CONTENT="OpenOffice.org 3.3 (Win32)">
&lt;META NAME="AUTHOR" CONTENT="Henry Lahore">
&lt;META NAME="CREATED" CONTENT="20120305;6464650">
&lt;META NAME="CHANGEDBY" CONTENT="Henry Lahore">
&lt;META NAME="CHANGED" CONTENT="20120305;7450661">
&lt;META NAME="CHANGEDBY" CONTENT="Henry Lahore">
&lt;STYLE TYPE="text/css">

&lt;!--

@page { size: landscape; margin: 0.79in }

P { margin-bottom: 0.08in }

TD P { margin-bottom: 0in }

H2 { margin-bottom: 0.08in }

H2.cjk { font-family: "SimSun" }

H2.ctl { font-family: "Mangal" }

TH P { margin-bottom: 0in }

A:link { so-language: zxx }

-->

&lt;/STYLE>
&lt;/HEAD>
&lt;BODY LANG="en-US" DIR="LTR">
&lt;P>&lt;A HREF="http://home.znet.com/schester/facts/rate_of_human_problems.html">http://home.znet.com/schester/facts/rate_of_human_problems.html&lt;/A>
&lt;p>1997&lt;/P>&lt;/p></description></item><item><title>Vitamin D: An Evidence-Based Review – 2009</title><link>/posts/vitamin-d-an-evidence-based-review-2009.html</link><pubDate>Sat, 28 Jan 2012 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-an-evidence-based-review-2009.html</guid><description>&lt;p>Teresa Kulie, MD,&lt;/p>
&lt;p>Amy Groff, DO,&lt;/p>
&lt;p>Jackie Redmer, MD, MPH,&lt;/p>
&lt;p>Jennie Hounshell, MD and&lt;/p>
&lt;p>Sarina Schrager, MD, MS&lt;/p>
&lt;p>Department of Family Medicine, University of Wisconsin, Madison&lt;/p>
&lt;p>Corresponding author: Sarina Schrager, MD, MS, Department of Family Medicine, University of Wisconsin, 777 S. Mills St., Madison, WI 53715 (E-mail: &lt;a href="mailto:sbschrag@wisc.edu">sbschrag@wisc.edu&lt;/a>)&lt;/p>
&lt;p>Vitamin D is a fat-soluble vitamin that plays an important role in bone metabolism and seems to have some anti-inflammatory and immune-modulating properties. In addition, recent epidemiologic studies have observed relationships between low vitamin D levels and multiple disease states. Low vitamin D levels are associated with increased overall and cardiovascular mortality, cancer incidence and mortality, and autoimmune diseases such as multiple sclerosis. Although it is well known that the combination of vitamin D and calcium is necessary to maintain bone density as people age, vitamin D may also be an independent risk factor for falls among the elderly. New recommendations from the American Academy of Pediatrics address the need for supplementation in breastfed newborns and many questions are raised regarding the role of maternal supplementation during lactation. Unfortunately, little evidence guides clinicians on when to screen for vitamin D deficiency or effective treatment options.&lt;/p></description></item><item><title>Critical Care patients need vitamin D</title><link>/posts/critical-care-patients-need-vitamin-d.html</link><pubDate>Thu, 19 Jan 2012 00:00:00 +0000</pubDate><guid>/posts/critical-care-patients-need-vitamin-d.html</guid><description>&lt;h1 id="summary-of-studies-of-icu-and-vitamin-d-levels-as-of-jan-2012">Summary of studies of ICU and Vitamin D levels as of Jan 2012&lt;/h1>
&lt;table>
 &lt;thead>
 &lt;tr>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;th>&lt;/th>
 &lt;/tr>
 &lt;/thead>
 &lt;tbody>
 &lt;tr>
 &lt;td>Year&lt;/td>
 &lt;td>ICU problem&lt;/td>
 &lt;td>If vitamin D less than&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>2011 this page&lt;/td>
 &lt;td>85 % increased death&lt;/td>
 &lt;td>20 ng&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;a href="/tags/2011.html">2011&lt;/a>&lt;/td>
 &lt;td>85 % increased death&lt;/td>
 &lt;td>15 ng&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;a href="/tags/2011.html">2011&lt;/a>&lt;/td>
 &lt;td>70 % increased death&lt;/td>
 &lt;td>15ng&lt;/td>
 &lt;/tr>
 &lt;tr>
 &lt;td>&lt;a href="/tags/2011.html">2011&lt;/a>&lt;/td>
 &lt;td>2X more likely to stay 2 days&lt;/td>
 &lt;td>20 ng&lt;/td>
 &lt;/tr>
 &lt;/tbody>
&lt;/table>
&lt;h1 id="future-icu-vitamin-d-options-seem-to-include-opinion-by-vitamindwiki">Future ICU Vitamin D Options seem to include (opinion by VitaminDWiki)&lt;/h1>
&lt;ol>
&lt;li>Give every ICU patient vitamin D3 orally&lt;/li>
&lt;/ol>
&lt;ul>
&lt;li>-Perhaps faster if sub-lingual or IV (is sublingual D3 as available as IV?)&lt;/li>
&lt;/ul>
&lt;ol start="2">
&lt;li>
&lt;p>Give D3 daily vs a single dose as was done for the RCT&lt;/p></description></item><item><title>Review of Vitamin D trials - Grant</title><link>/posts/review-of-vitamin-d-trials-grant.html</link><pubDate>Tue, 10 Jan 2012 00:00:00 +0000</pubDate><guid>/posts/review-of-vitamin-d-trials-grant.html</guid><description>&lt;h1 id="this-web-page-consists-of-3-sections">This web page consists of 3 sections&lt;/h1>
&lt;ol>
&lt;li>
&lt;p>Summary table of Vitamin D Clinical Trials ( in English)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>References for every entry in the summary table (that is, the references are a superset of the table)&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Abstracts include all but two of the entries in the summary table, as well as items not in the summary table&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>There are no hyperlinks between the table entries and the references, abstracts&lt;/p>
&lt;p>If you want to get more information on an item in the table you will need to search for the name of one of the authors and find the correct year.&lt;/p></description></item><item><title>Should seniors get a vitamin D booster shot for Influenza</title><link>/posts/should-seniors-get-a-vitamin-d-booster-shot-for-influenza.html</link><pubDate>Mon, 19 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/should-seniors-get-a-vitamin-d-booster-shot-for-influenza.html</guid><description>&lt;h4 id="aging-adults-and-seasonal-influenza-does-the-vitamin-d-status-harm-the-body">Aging Adults and Seasonal Influenza: Does the Vitamin D Status (H)Arm the Body?&lt;/h4>
&lt;p>Hindawi Publishing Corporation; Journal of Aging Research; Volume 2012, Article ID 806198, 8 pages; doi:10.1155/2012/806198&lt;/p>
&lt;p>Pierre Olivier Lang 1,2 and Dimitrios Samaras 1&lt;/p>
&lt;p>1 Department of Internal Medicine, Rehabilitation and Geriatrics, Medical School and University Hospitals of Geneva, Hospital of Trois-Chene, Chemin du Pont-Bochet 3, CH-1226 Thonex-Geneva, Switzerland&lt;/p>
&lt;p>2 Translational Medicine Research Group, Cranfield Health, Cranfield University, Vincent Building, College Road, Cranfield MK430AL, UK&lt;/p></description></item><item><title>Clinical Trials for Vitamin D - 2012</title><link>/posts/clinical-trials-for-vitamin-d-2012.html</link><pubDate>Thu, 01 Dec 2011 00:00:00 +0000</pubDate><guid>/posts/clinical-trials-for-vitamin-d-2012.html</guid><description>&lt;h1 id="vitamin-d-world-wide-trialshttpappswhointtrialsearchdefaultaspx-who-about-half-are-registered-in-us-clinical-trials">&lt;a href="http://apps.who.int/trialsearch/default.aspx">Vitamin D World-Wide Trials&lt;/a> WHO about half are registered in US Clinical Trials&lt;/h1>
&lt;p>&lt;strong>&lt;span style="color:#F00;">366 Vitamin D Intervention trials &lt;/span>&lt;/strong> as of Jan 2013 - examples of trials listed for Jan 2011 - Dec 1 2011&lt;/p>
&lt;p>&lt;a href="/tags/intervention-add-vitamin-d-and-see-what-happens.html">Intervention = add vitamin D and see what happens&lt;/a>&lt;/p>
&lt;ul>
&lt;li>
&lt;p>Vitamin and &lt;strong>&lt;span style="color:#00F;">Asthma &lt;/span>&lt;/strong> Study 	03/10/2011&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Correction of Vitamin D in Asthma Control 	29/06/2011&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D and airway obstruction 	2011-07-24&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Vitamin D and Chronic Obstructive Lung Disease 	12/08/2011&lt;/p></description></item><item><title>Fraser Health in Canada will be giving 20000 IU vitamin D weekly to reduce falls</title><link>/posts/fraser-health-in-canada-will-be-giving-20000-iu-vitamin-d-weekly-to-reduce-falls.html</link><pubDate>Tue, 08 Nov 2011 00:00:00 +0000</pubDate><guid>/posts/fraser-health-in-canada-will-be-giving-20000-iu-vitamin-d-weekly-to-reduce-falls.html</guid><description>&lt;h2 id="news-releasehttpwwwfraserhealthcaabout_usmedia_centrenews_releases2011_news_releasesnew_vitamin_d_protocol_helps_prevent_falls_and_fractures_in_residential_care">&lt;a href="http://www.fraserhealth.ca/about_us/media_centre/news_releases/2011_news_releases/new_vitamin_d_protocol_helps_prevent_falls_and_fractures_in_residential_care">News Release&lt;/a>&lt;/h2>
&lt;p>Optional for all Fraser Health 7,500 senior residents in Western Canada&lt;/p>
&lt;p>Cost per year to Fraser Health of providing the vitamin D is estimated to about that of the cost of a single hip fracture , $20,000&lt;/p>
&lt;p>Before vitamin D they had 1,000 to 1,500 falls per year&lt;/p>
&lt;p>They hope to prevent 10% to 25% of the falls per year&lt;/p>
&lt;p>Thus they hope to prevent 100 to about 300 falls per year&lt;/p></description></item><item><title>Vitamin D conference in Berlin</title><link>/posts/vitamin-d-conference-in-berlin.html</link><pubDate>Wed, 26 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-conference-in-berlin.html</guid><description>&lt;h2 id="conference-abstracts-are-in-a-combination-of-german-and-english-in-pdf-file-attached-at-bottom-of-this-page">Conference Abstracts are in a combination of German and English in PDF file attached at bottom of this page&lt;/h2>
&lt;h2 id="the-following-are-the-results-of-google-translate">The following are the results of Google Translate&lt;/h2>
&lt;p>The German Foundation for Health Information and Prevention (dsgip) was founded in 2009 as a charitable institution. Their name is their program. In the first step, it collects and sifts the latest research in medicine, natural sciences and the adjacent area in the sociological.&lt;/p></description></item><item><title>Some form of vitamin D may be the lowest cost treatment for CKD – Spanish</title><link>/posts/some-form-of-vitamin-d-may-be-the-lowest-cost-treatment-for-ckd-spanish.html</link><pubDate>Sun, 02 Oct 2011 00:00:00 +0000</pubDate><guid>/posts/some-form-of-vitamin-d-may-be-the-lowest-cost-treatment-for-ckd-spanish.html</guid><description>&lt;h4 id="economic-impact-of-vitamin-d-treatment-on-chronic-kidney-disease-patients--sept-2011">Economic impact of vitamin D treatment on chronic kidney disease patients – Sept 2011&lt;/h4>
&lt;p>Nefrologia. 2011 Sep 20;31(5):528-536. &lt;a href="https://doi.org/10.3265/Nefrologia.pre2011.Aug.11012.">doi: 10.3265/Nefrologia.pre2011.Aug.11012.&lt;/a>&lt;/p>
&lt;p>&lt;span>[Article in Spanish]&lt;/span>&lt;/p>
&lt;p>Ramos R, Alcázar R, Otero A, de Francisco AL, Del Pino MD.&lt;/p>
&lt;hr>
&lt;h2 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d3-becomes-calcidiol-which-becomes-calcitriol">Vitamin D3 becomes Calcidiol which becomes Calcitriol&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/application-to-fda-for-use-of-active-vitamin-d-for-hemodialysis-patients">Application to FDA for use of active Vitamin D for hemodialysis patients – July 2011&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/active-form-of-vitamin-d-appears-to-help-prevent-and-treat-some-cancers">Active form of vitamin D appears to help prevent and treat some cancers – Feb 2011&lt;/a>&lt;/p></description></item><item><title>Is excess calcium harmful to health - 2010</title><link>/posts/is-excess-calcium-harmful-to-health-2010.html</link><pubDate>Sun, 28 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/is-excess-calcium-harmful-to-health-2010.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>&lt;a href="#1-introduction">1. Introduction&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#2-calcium-supplementation-cardiovascular-disease-and-mortality">2. Calcium Supplementation, Cardiovascular Disease and Mortality&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#3-calcium-supplementation-lipids-and-blood-pressure">3. Calcium Supplementation, Lipids and Blood Pressure&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#4-calcium-supplementation-and-vascular-calcification">4. Calcium Supplementation and Vascular Calcification&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#5-calcium-supplementation-and-cerebrovascular-disease-risk">5. Calcium Supplementation and Cerebrovascular Disease Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#6-calcium-supplementation-and-kidney-stones">6. Calcium Supplementation and Kidney Stones&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#7-serum-calcium-and-cardiovascular-disease-risk">7. Serum Calcium and Cardiovascular Disease Risk&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#8-conclusion">8. Conclusion&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#references">References&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;p>&lt;strong>Text is extracted from PDF for ease of translation to other languages - tables not included&lt;/strong>&lt;/p>
&lt;h1 id="review-is-excess-calcium-harmful-to-health">Review: Is Excess Calcium Harmful to Health?&lt;/h1>
&lt;p>Nutrients 2010, 2, 505-522; doi:10.3390/nu2050505&lt;/p></description></item><item><title>2.8X more likely to die of hemodialysis if low on vitamin D</title><link>/posts/28x-more-likely-to-die-of-hemodialysis-if-low-on-vitamin-d.html</link><pubDate>Sun, 14 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/28x-more-likely-to-die-of-hemodialysis-if-low-on-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#vitamin-d-deficiency-mortality-and-hospitalization-in-hemodialysis-patients-with-or-without-protein-energy-wasting--2011">Vitamin D Deficiency, Mortality, and Hospitalization in Hemodialysis Patients with or without Protein-Energy Wasting.- 2011&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-status-and-mortality-of-german-hemodialysis-patients--2012">Vitamin D status and mortality of German hemodialysis patients.- 2012&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="vitamin-d-deficiency-mortality-and-hospitalization-in-hemodialysis-patients-with-or-without-protein-energy-wasting--2011">Vitamin D Deficiency, Mortality, and Hospitalization in Hemodialysis Patients with or without Protein-Energy Wasting.- 2011&lt;/h4>
&lt;p>Nephron Clin Pract. 2011 Aug 11;119(3):c220-c226.&lt;/p>
&lt;p>Fiedler R, Dorligjav O, Seibert E, Ulrich C, Markau S, Girndt M.&lt;/p>
&lt;p>Department of Internal Medicine II, Martin Luther University Halle-Wittenberg, Halle/Saale, Germany.&lt;/p>
&lt;p>Background:Vitamin D deficiency and protein-energy wasting (PEW) are highly prevalent in hemodialysis (HD) patients. The goal of our study was to investigate if a lack of vitamin D influences mortality and hospitalization of HD patients with or without PEW. Methods: In 81 chronic HD patients with different nutritional status assessed by the Malnutrition Inflammation Score (MIS), vitamin D deficiency (25-OH-vitamin D(3) levels ?30 nmol/l or &lt;strong>?12 ng/ml&lt;/strong> ) was prospectively investigated for its prognostic impact on mortality and hospitalization. Over a 3-year follow-up, all-cause mortality and hospitalization were determined. The predictive value of low vitamin D levels and PEW as well as their combined effect were evaluated using a multivariate Cox regression model.&lt;/p></description></item><item><title>People with kidney disease moved faster after adding vitamin D</title><link>/posts/people-with-kidney-disease-moved-faster-after-adding-vitamin-d.html</link><pubDate>Tue, 02 Aug 2011 00:00:00 +0000</pubDate><guid>/posts/people-with-kidney-disease-moved-faster-after-adding-vitamin-d.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="vitamin-d-and-muscle-strength-functional-ability-and-balance-in-peritoneal-dialysis-patients-with-vitamin-d-deficiency">Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D deficiency.&lt;/h1>
&lt;p>Clin Nephrol. 2011 Aug;76(2):110-6.&lt;/p>
&lt;p>Taskapan H, Baysal O, Karahan D, Durmus B, Altay Z, Ulutas O.&lt;/p>
&lt;p>Nephrology Department, and Physical Medicine and Rehabilitation Department, Turgut Ozal Medical Center of Inonu University, Medical Faculty, Malatya, Turkey.&lt;/p>
&lt;p>25(OH)D deficiency has been associated with significantly worse physical performance in individuals with normal renal function. We examined the physical function, muscle strength and balance in age- and gender-matched 25 Stage 3 - 4 CKD patients and 47 Stage 5 CKD patients on peritoneal dialysis (PD) with vitamin D deficiency by objective methods and evaluated the effect of vitamin D replacement on physical performance tests: the &amp;ldquo;timed up and go&amp;rdquo; (TUG) test, gait velocity test, timed chair stand test, stair climb test, dynamic balance tests (TUG test, dynamic postural stability test), static balance test (functional reach test) and muscle strength in these two groups.&lt;/p></description></item><item><title>Application to FDA for use of active Vitamin D for hemodialysis patients</title><link>/posts/application-to-fda-for-use-of-active-vitamin-d-for-hemodialysis-patients.html</link><pubDate>Tue, 26 Jul 2011 00:00:00 +0000</pubDate><guid>/posts/application-to-fda-for-use-of-active-vitamin-d-for-hemodialysis-patients.html</guid><description>&lt;h1 id="rockwell-medical-announces-acquisition-of-generic-drug-vitamin-d-to-treat-secondary-hyperparathyroidism-in-esrd-patients">Rockwell Medical Announces Acquisition of Generic Drug Vitamin-D to Treat Secondary Hyperparathyroidism in ESRD Patients&lt;/h1>
&lt;h2 id="injectable-calcitriol-will-address-estimated-350m-us-dialysis-market-press-release">Injectable Calcitriol Will Address Estimated $350M U.S. Dialysis Market; press release&lt;/h2>
&lt;p>WIXOM, Mich., Jul 26, 2011 (GlobeNewswire via COMTEX) &amp;ndash; Rockwell Medical , a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD), and iron deficiency anemia, announced today that it has acquired an &lt;strong>Abbreviated New Drug Application&lt;/strong> (ANDA) for injectable, active Vitamin-D (Calcitriol) for End Stage Renal Disease (ESRD) patients undergoing hemodialysis. Terms were not disclosed.&lt;/p></description></item><item><title>Each 10 ng increase in vitamin D decreased kidney disease death by 14 percent</title><link>/posts/each-10-ng-increase-in-vitamin-d-decreased-kidney-disease-death-by-14-percent.html</link><pubDate>Thu, 09 Jun 2011 00:00:00 +0000</pubDate><guid>/posts/each-10-ng-increase-in-vitamin-d-decreased-kidney-disease-death-by-14-percent.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="vitamin-d-status-and-mortality-risk-in-ckd-a-meta-analysis-of-prospective-studies">Vitamin D Status and Mortality Risk in CKD: A Meta-analysis of Prospective Studies.&lt;/h1>
&lt;p>Am J Kidney Dis. 2011 May 31.&lt;/p>
&lt;p>Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S.&lt;/p>
&lt;p>Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria; Department of Epidemiology and Biostatistics and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, the Netherlands.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Vitamin D deficiency, assessed as low 25-hydroxyvitamin D (25&lt;span>[OH]&lt;/span>D) level, is highly prevalent in patients with chronic kidney disease (CKD) and is associated with various adverse health outcomes. Whether low 25(OH)D levels in patients with CKD are an independent risk factor for mortality remains to be studied in detail, and this was the objective of our work.&lt;/p></description></item><item><title>Dialysis patients with higher levels of vitamin D were better</title><link>/posts/dialysis-patients-with-higher-levels-of-vitamin-d-were-better.html</link><pubDate>Tue, 24 May 2011 00:00:00 +0000</pubDate><guid>/posts/dialysis-patients-with-higher-levels-of-vitamin-d-were-better.html</guid><description>&lt;h4 id="25-hydroxyvitamin-d-concentration-is-inversely-associated-with-serum-mmp-9-in-a-cross-sectional-study-of-african-american-esrd-patients">25-Hydroxyvitamin D Concentration is Inversely Associated with Serum MMP-9 in a cross-sectional study of African American ESRD Patients.&lt;/h4>
&lt;p>BMC Nephrol. 2011 May 22;12(1):24.&lt;/p>
&lt;p>Wasse H, Cardarelli F, De Staercke C, Hooper C, Veledar E, Guessous I.&lt;/p>
&lt;p>BACKGROUND:&lt;/p>
&lt;p>Circulating 25-hydroxyvitamin D &lt;span>[25(OH)D]&lt;/span> concentration is inversely associated with peripheral arterial disease and hypertension. Vascular remodeling may play a role in this association, however, data relating vitamin D level to specific remodeling biomarkers among ESRD patients is sparse. We tested whether 25(OH)D concentration is associated with markers of vascular remodeling and inflammation in African American ESRD patients.&lt;/p></description></item><item><title>Wearable dialysis device being tested which also converts vitamin D</title><link>/posts/wearable-dialysis-device-being-tested-which-also-converts-vitamin-d.html</link><pubDate>Thu, 03 Mar 2011 00:00:00 +0000</pubDate><guid>/posts/wearable-dialysis-device-being-tested-which-also-converts-vitamin-d.html</guid><description>&lt;h1 id="being-developed-march-2011">Being Developed March 2011&lt;/h1>
&lt;h2 id="perhaps-1000--large-scale-trials-2011-2014-worn-like-a-belt">Perhaps $1000, large scale trials 2011-2014, worn like a belt&lt;/h2>
&lt;h3 id="click-herehttptimesofindiaindiatimescomcitydelhidialysis-device-that-can-be-carried-aroundarticleshow7622329cms">&lt;a href="http://timesofindia.indiatimes.com/city/delhi/Dialysis-device-that-can-be-carried-around/articleshow/7622329.cms">CLICK HERE&lt;/a>&lt;/h3>
&lt;h1 id="see-also-vitamindwiki">See also VitaminDWiki&lt;/h1>
&lt;ul>
&lt;li>&lt;a href="/tags/overview-of-vitamin-d-and-kidney.html">Overview of Vitamin D and Kidney&lt;/a>&lt;/li>
&lt;/ul></description></item><item><title>Dialysis patients with low vitamin D were 2.7 X more likely to die of heart problems</title><link>/posts/dialysis-patients-with-low-vitamin-d-were-27-x-more-likely-to-die-of-heart-problems.html</link><pubDate>Wed, 23 Feb 2011 00:00:00 +0000</pubDate><guid>/posts/dialysis-patients-with-low-vitamin-d-were-27-x-more-likely-to-die-of-heart-problems.html</guid><description>&lt;h4 id="vitamin-d-status-and-clinical-outcomes-in-incident-dialysis-patients-results-from-the-necosad-study">Vitamin D status and clinical outcomes in incident dialysis patients: results from the NECOSAD study&lt;/h4>
&lt;p>Nephrology Dialysis Transplantation, Volume26, Issue3, Pp. 1024-1032.&lt;/p>
&lt;p>Background. The majority of dialysis patients suffer from vitamin D deficiency, which might contribute to an adverse health outcome. We aimed to elucidate whether European dialysis patients with low 25-hydroxyvitamin D (25(OH)D) levels are at increased risk of mortality and specific fatal events.&lt;/p>
&lt;p>Methods. This was a prospective cohort study of incident dialysis patients in the Netherlands (the NECOSAD). We selected all patients with measured 25(OH)D at 12 months after the start of dialysis, the baseline for our study. By Cox regression analyses, we assessed the impact of 25(OH)D levels on short-term (6 months of follow-up) as well as longer-term mortality (3 years of follow-up). Associations of 25(OH)D levels with cardiovascular and non-cardiovascular mortality were also determined.&lt;/p></description></item><item><title>Type 2 diabetes treated by 30 ng of vitamin D</title><link>/posts/type-2-diabetes-treated-by-30-ng-of-vitamin-d.html</link><pubDate>Wed, 23 Feb 2011 00:00:00 +0000</pubDate><guid>/posts/type-2-diabetes-treated-by-30-ng-of-vitamin-d.html</guid><description>&lt;h3 id="vitamin-d-and-type-2-diabetes-mellitus-where-do-we-stand-review">Vitamin D and type 2 diabetes mellitus: Where do we stand? Review&lt;/h3>
&lt;p>Diabetes &amp;amp; Metabolism; doi:10.1016/j.diabet.2011.01.001 |&lt;/p>
&lt;p>Copyright © 2011 Elsevier Masson SAS All rights reserved.&lt;/p>
&lt;p>E. Cavaliera, &lt;a href="mailto:Etienne.cavalier@chu.ulg.ac.be">Etienne.cavalier@chu.ulg.ac.be&lt;/a>, P. Delanayeb, J.-C. Souberbiellec and R.-P. Radermeckerd&lt;/p>
&lt;p>a Department of Clinical Chemistry, University of Liege, CHU Sart-Tilman, 4000 Liège, Belgium&lt;/p>
&lt;p>b Department of Nephrology, Dialysis and Hypertension, University of Liege, CHU Sart-Tilman, 4000 Liège, Belgium&lt;/p>
&lt;p>c Laboratoire d’explorations fonctionnelles, hôpital Necker–Enfants-Malades, 75743 Paris, France&lt;/p></description></item><item><title>Chronic Kidney Disease meta-analysis of vitamin D</title><link>/posts/chronic-kidney-disease-meta-analysis-of-vitamin-d.html</link><pubDate>Thu, 20 Jan 2011 00:00:00 +0000</pubDate><guid>/posts/chronic-kidney-disease-meta-analysis-of-vitamin-d.html</guid><description>&lt;h1 id="vitamin-d-supplementation-in-chronic-kidney-disease-a-systematic-review-and-meta-analysis-of-observational-studies-and-randomized-controlled-trials">Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials&lt;/h1>
&lt;p>CJASN January 2011 vol. 6 no. 1 50-62 , published by American Society of Nephrology&lt;/p>
&lt;ol>
&lt;li>
&lt;p>Praveen Kandula,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Mirela Dobre,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Jesse D. Schold,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Martin J. Schreiber ,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Rajnish Mehrotra,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Sankar D. Navaneethan&lt;/p>
&lt;/li>
&lt;/ol>
&lt;blockquote>
&lt;p>Author Affiliations&lt;/p>
&lt;/blockquote>
&lt;ol>
&lt;li>
&lt;pre>&lt;code> *Department of Nephrology, Indiana University, Indianapolis, Indiana;
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> Department of Internal Medicine, Huron Hospital, Cleveland, Ohio;
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> Department of Nephrology, Case Western Reserve University, Cleveland, Ohio;
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, and
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio;
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> Los Angeles Biomedical Research Institute at Harbor–University of California–Los Angeles Medical Center, Torrance, California; and
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;pre>&lt;code> David Geffen School of Medicine at University of California–Los Angeles, Los Angeles, California
&lt;/code>&lt;/pre>
&lt;/li>
&lt;li>
&lt;p>Correspondence:&lt;/p></description></item><item><title>25 experts recommend vitamin D level of min 30 ng</title><link>/posts/25-experts-recommend-vitamin-d-level-of-min-30-ng.html</link><pubDate>Sun, 12 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/25-experts-recommend-vitamin-d-level-of-min-30-ng.html</guid><description>&lt;h4 id="publication-of-the-nov-2009-meeting-was-sept-2010">Publication of the Nov 2009 meeting was Sept 2010&lt;/h4>
&lt;h4 id="minimum-recommended-vitamin-d-by-25-experts-was-higher-than-the-20-ngml-proclamation-of-the-institute-of-medicine">MINIMUM recommended vitamin D by 25 experts was higher than the 20 ng/ml proclamation of the Institute of Medicine&lt;/h4>
&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/gif/vitamin-d-summit-bars.gif" alt="image" style="max-width: 500px;">
&lt;h4 id="vitamin-d-and-musculoskeletal-health-cardiovascular-disease-autoimmunity-and-cancer-recommendations-for-clinical-practice">Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice&lt;/h4>
&lt;p>Autoimmunity Reviews&lt;/p>
&lt;p>Volume 9, Issue 11, September 2010, Pages 709-715; doi:10.1016/j.autrev.2010.06.009&lt;/p>
&lt;h4 id="spantiki-download_filephpfileid1615span">&lt;span>[tiki-download_file.php?fileId=1615]&lt;/span>&lt;/h4>
&lt;p>Jean-Claude Souberbielle a, Jean-Jacques Body b, Joan M. Lappe c, Mario Plebani d, Yehuda Shoenfeld e, Thomas J. Wang f, Heike A. Bischoff-Ferrari g, Etienne Cavalier h, Peter R. Ebeling i, Patrice Fardellone j, Sara Gandini k, Damien Gruson l, Alain P. Guérin m, Lene Heickendorff n, Bruce W. Hollis o, Sofia Ish-Shalom p, Guillaume Jean q, Philipp von Landenberg r, Alvaro Largura s, Tomas Olsson t, Charles Pierrot-Deseilligny u, Stefan Pilz v, Angela Tincani w, Andre Valcour x and Armin Zittermann y&lt;/p></description></item><item><title>Report on Vitamin D – 35 pages</title><link>/posts/report-on-vitamin-d-35-pages.html</link><pubDate>Wed, 08 Dec 2010 00:00:00 +0000</pubDate><guid>/posts/report-on-vitamin-d-35-pages.html</guid><description>&lt;p> &lt;/p>
&lt;h1 id="vitamin-d-in-health-and-disease-current-perspectives">Vitamin D in health and disease: Current perspectives&lt;/h1>
&lt;p>Ran Zhang and Declan P Naughton&lt;/p>
&lt;p>Nutrition Journal 2010, 9:65doi:10.1186/1475-2891-9-65&lt;/p>
&lt;p>Published: 	8 December 2010&lt;/p>
&lt;p>Despite the numerous reports of the association of vitamin D with a spectrum of development, disease treatment and health maintenance, vitamin D deficiency is common. Originating in part from the diet but with a key source resulting from transformation by exposure to sunshine, a great deal of the population suffers from vitamin D deficiency especially during winter months. It is linked to the treatment and pathogenesis and/or progression of several disorders including cancer, hypertension, multiple sclerosis, rheumatoid arthritis, osteoporosis, muscle weakness and diabetes. This widespread deficiency of Vitamin D merits consideration of widespread policies including increasing awareness among the public and healthcare professionals.&lt;/p></description></item><item><title>International patent for sublingual liquid analogue forms of vitamin D – 2007</title><link>/posts/international-patent-for-sublingual-liquid-analogue-forms-of-vitamin-d-2007.html</link><pubDate>Thu, 07 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/international-patent-for-sublingual-liquid-analogue-forms-of-vitamin-d-2007.html</guid><description>&lt;h2 id="notes-by-vitamindwiki">Notes by VitaminDWiki:&lt;/h2>
&lt;ul>
&lt;li>
&lt;p>Primarily CALCITRIOL, but other forms are covered by this patent&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Sublingual is absorbed quickly,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Less patient to patient variability,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Good for use when kidney is not working well,&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Weekly dosing might be better than daily&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Targets a great number of diseases - especially auto-immune&lt;/p>
&lt;/li>
&lt;/ul>
&lt;p>(WO/2007/036802) SUBLINGUAL DOSAGE FORM COMRISING VITAMIN D ANALOGUE, IN PARTICULAR CALCITRIOL&lt;/p>
&lt;p>Pub. No.:	 	WO/2007/036802 	International Application No.: 	PCT/IB2006/002853&lt;/p>
&lt;p>Publication Date:	05.04.2007 	International Filing Date:	07.07.2006&lt;/p></description></item><item><title>Meta-analysis finds vitamin D helps chronic kidney disease</title><link>/posts/meta-analysis-finds-vitamin-d-helps-chronic-kidney-disease.html</link><pubDate>Wed, 06 Oct 2010 00:00:00 +0000</pubDate><guid>/posts/meta-analysis-finds-vitamin-d-helps-chronic-kidney-disease.html</guid><description>&lt;h1 id="vitamin-d-supplementation-in-chronic-kidney-disease-a-systematic-review-and-meta-analysis-of-observational-studies-and-randomized-controlled-trials">Vitamin D Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Observational Studies and Randomized Controlled Trials.&lt;/h1>
&lt;p>Clin J Am Soc Nephrol. 2010 Sep 28.&lt;/p>
&lt;p>Kandula P, Dobre M, Schold JD, Schreiber MJ Jr, Mehrotra R, Navaneethan SD.&lt;/p>
&lt;p>Indiana University, Indianapolis, Indiana;&lt;/p>
&lt;p>BACKGROUND AND OBJECTIVES: Vitamin D deficiency is highly prevalent among patients with chronic kidney disease (CKD). The benefits and harms of vitamin D supplementation (ergocalciferol or cholecalciferol) were assessed in patients with nondialysis-dependent CKD, dialysis-dependent CKD, and renal transplant recipients.&lt;/p></description></item><item><title>Overview Hyperparathyroidism and vitamin D</title><link>/posts/overview-hyperparathyroidism-and-vitamin-d.html</link><pubDate>Sun, 19 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/overview-hyperparathyroidism-and-vitamin-d.html</guid><description>&lt;h4 id="know-your-dtagsknow-your-dhtml-book-authored-in-june-2010-by-dr-keebler">&lt;a href="/tags/know-your-d.html">Know Your D&lt;/a>: book authored in June 2010 by Dr. Keebler,&lt;/h4>
&lt;p>got me to look up the topic on the web Sept 2010&lt;/p>
&lt;p>pg 150 Be careful adding large amounts of vitamin D to the elderly.&lt;/p>
&lt;ul>
&lt;li>
&lt;p>The incidence of primary hyperparathyroidism increases steadily with age.&lt;/p>
&lt;/li>
&lt;li>
&lt;p>At age 60. 2 in 1000 women and 1 in 1,000 men have it&lt;/p>
&lt;/li>
&lt;li>
&lt;p>By age 90, 60 in 1000 women and 30 in 1,000 men - many undiagnosed&lt;/p></description></item><item><title>Overview Magnesium and vitamin D</title><link>/posts/overview-magnesium-and-vitamin-d.html</link><pubDate>Sat, 18 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/overview-magnesium-and-vitamin-d.html</guid><description>&lt;nav id="TableOfContents">
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>
 &lt;ul>
 &lt;li>&lt;a href="#summary-by-chat-gpt-deep-research-as-of-feb-27-2025">Summary by Chat-GPT Deep Research as of Feb 27, 2025&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#magnesium-by-itself-helps-with-various-healthproblems">Magnesium by itself helps with various health problems&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#magnesium-and-hypertension---fda-allows-claim-as-of-jan2022">Magnesium and Hypertension - FDA allows claim as of Jan 2022&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-deficiency-is-associated-with-poor-mentalhealth">Magnesium deficiency is associated with poor mental health&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#reduce-stress-and-anxiety-with-magnesium---100-page-ebook-june2017">Reduce stress and anxiety with Magnesium - 100-page ebook June 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#national-library-of-medicine-effectiveness-ratings-for-magnesium-with-no-comment-on-vitamind">National Library of Medicine effectiveness ratings for MAGNESIUM (with no comment on vitamin D)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-101-2014">Magnesium 101 (2014)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-is-one-of-the-treatments-for-restlesslegs">Magnesium is one of the treatments for Restless Legs&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#32-signs-you-immediately-need-moremagnesium">32 SIGNS YOU IMMEDIATELY NEED MORE MAGNESIUM&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#hot-flashes-andmagnesium">Hot Flashes and Magnesium&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#are-you-getting-enough-magnesium---aarp-feb2018">Are You Getting Enough Magnesium? - AARP Feb 2018&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#magnesium-supplements">Magnesium supplements&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#many-magnesium-supplements-errored-on-amount-or-type---video-march-2025">Many Magnesium supplements errored on amount or type - video March 2025&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#-magnesium-element-insupplements">% Magnesium element in supplements&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#consumer-lab-review-of-magnesium---as-little-as-2-cents-per-200-mg-ofmg">Consumer Lab Review of Magnesium - as little as 2 cents per 200 mg of Mg&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-chloride">Magnesium Chloride&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-acetyl-taurate-best-in-rat-study--2019">Magnesium acetyl taurate best in rat study - 2019&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#citrate-good-oxide-not-better-than-placebo---rct2003">Citrate good, Oxide not better than placebo - RCT 2003&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#much-more-heart-disease-if-the-calciummagnesium-ratio-is-toohigh">Much more heart disease if the Calcium/Magnesium ratio is too high&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-relateddiseases">Magnesium-related diseases&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#magnesium-bioavailability">Magnesium Bioavailability&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#bioavailability-and-pharmacokinetics-of-magnesium--2001">Bioavailability and Pharmacokinetics of Magnesium - 2001&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-may-not-be-as-available-if-you-have-low-stomach-acidseniors">Magnesium may not be as available if you have low stomach acid (seniors)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#apparently-probiotics-improve-mg-absorption-no-clue-as-to-what-type-how-many-cfus-and-by-how-much">Apparently, probiotics improve Mg absorption; no clue as to what type, how many CFUs, and by how much&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#pros-and-cons-of-various-magnesium-compounds---jan2017">Pros and cons of various Magnesium compounds - Jan 2017&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#bioavailability---from-aforum">Bioavailability - from a forum&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#magnesium-in-thediet">Magnesium in the diet&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#magnesium-in-thediethttpwwwancient-mineralscommagnesium-sourcesdietarydecline">&lt;a href="http://www.ancient-minerals.com/magnesium-sources/dietary/#decline">Magnesium in the diet&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#british-analysis-of-mineral-content-forvegetables-span-stylecolor00ffrom-pdf-which-is-attached-at-the-bottom-of-this-pagespan-img-srchttpsd378j1rmrlek7xcloudfrontnetattachmentsjpeghistorical-mineral-contentjpg-altimage">British Analysis of Mineral Content for Vegetables** &lt;span style="color:#00F;">from PDF, which is attached at the bottom of this page&lt;/span> **&lt;img src="https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/historical-mineral-content.jpg" alt="image">&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#us-govt-study-of-mineral-content-for-a-century-did-not-changemuch">US Govt study of Mineral Content for a century did not change much&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-scientific-evidence-of-mineral-deficiency-infood">The Scientific Evidence of Mineral Deficiency in Food&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#cost-of-food-to-get-400-mgmagnesium">Cost of food to get 400 mg Magnesium&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#excellent-review-of-magnesium-supplementation-and-benefits-at-consumer-labs---updated-feb2023">Excellent review of Magnesium Supplementation and Benefits at Consumer Labs - updated Feb 2023&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#magnesium-deficiency">Magnesium Deficiency&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#36-reasons-for-low-magnesium-1-diseases-associated-with-hypmagnesia-diabetes">36+ reasons for low Magnesium** 1) Diseases associated with Hypmagnesia **Diabetes&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#decrease-in-magnesium-during-the-pastcentury">Decrease in Magnesium during the past century.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-levels-fall-with-chemos-ppi---may2023">Magnesium levels fall with chemos, PPI - May 2023&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#reasons-for-magnesium-deficiencyinclude">Reasons for Magnesium Deficiency include&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#most-people-are-magnesiumdeficient">Most people are Magnesium Deficient&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#reasons-for-magnesium-deficiency---frommetabolicscom">Reasons for Magnesium Deficiency - from Metabolics.com&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#how-muchmagnesium">How much Magnesium&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#whats-the-right-magnesium-dosage-for-optimalhealth">What&amp;rsquo;s The RIGHT Magnesium Dosage For Optimal Health?&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-upper-limit-is-for-supplements-onlyand-is-less-than-therda">The upper limit is for supplements onlyand is less than the RDA&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-requirements">Magnesium Requirements&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#magnesium-tests-magnesium-test-of-your-blood-49-not-cell-test---price-checked-may-2022">Magnesium tests** Magnesium test of your blood $49 (not cell test) - (price checked May 2022)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-and-vitamind">Magnesium and Vitamin D&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#magnesium-and-vitamin-d---similarities-anddifferences">Magnesium and Vitamin D - similarities and differences&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-chart-shows-3-locations-where-low-magnesium-decreases-vitamind">The chart shows 3 locations where low Magnesium decreases Vitamin D&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mg-and-vitamin-d-37-minute-videohttpswwwyoutubecomwatchvyrz-p26yytiab_channeljimlaird---aug-2024">Mg and Vitamin D &lt;a href="https://www.youtube.com/watch?v=yrZ-p26yyTI&amp;amp;ab_channel=JimLaird">37 minute video&lt;/a> - Aug 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamin-d-and-magnesium-are-similar-life-extension-mag---dec2016postsmagnesium-and-vitamin-d">Vitamin D and Magnesium are similar &lt;a href="/posts/magnesium-and-vitamin-d">Life Extension Mag - Dec 2016&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#updates">Updates&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;li>&lt;a href="#other">Other&lt;/a>
 &lt;ul>
 &lt;li>&lt;a href="#great-summary-by-ms-magnesium-dr-c-dean-march2015">Great summary by &amp;ldquo;Ms. Magnesium&amp;rdquo; (Dr. C Dean) March 2015&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mercola-has-many-articles-onmagnesium">Mercola has many articles on Magnesium&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#vitamindwiki-low-cost-to-get-vitamin-d-cofactorstagslow-cost-to-get-vitamin-d-cofactorshtml---includingmagnesium">VitaminDWiki &lt;a href="/tags/low-cost-to-get-vitamin-d-cofactors.html">Low cost to get vitamin D cofactors&lt;/a> - including Magnesium&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#mineralhttpwwwindiumforlifecomour_opinionhtm-decrease-from-vegetables-in-the-pastcentury">&lt;a href="http://www.indiumforlife.com/our_opinion.htm">Mineral&lt;/a> decrease from vegetables in the past century&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#my-notes-of-the-book-magnesium-miracle-by-c-dean-2007--need-to-beconfirmed">My notes of the book Magnesium Miracle by C. Dean 2007 – need to be confirmed.&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-l-threonate--perhaps-more-bioavailable--jan2012postsmagnesium-l-threonate-perhaps-more-bioavailable">&lt;a href="/posts/magnesium-l-threonate-perhaps-more-bioavailable">Magnesium L-Threonate – perhaps more bioavailable – Jan 2012&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-compounds-have-similar-bioavailability--2005">Magnesium compounds have similar bioavailability - 2005&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-in-water-is-associated-with-a-reduction-instroke">Magnesium in water is associated with a reduction in stroke&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-online-resourcecenterhttpwwwmg12info">&lt;a href="http://www.mg12.info/">Magnesium online resource center&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-interactions">Magnesium Interactions&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#the-only-difference-between-chlorophyll-and-hemoglobin-is-that-magnesium-is-in-the-center-instead-ofiron">The only difference between chlorophyll and hemoglobin is that Magnesium is in the center instead of Iron&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#3751-magnesium-binding-sites-on-human-proteins-httpwwwgreenmedinfocomblogmagnesiums-importance-far-greater-previously-imagined-greenmedinfo-dec2012">&lt;a href="http://www.greenmedinfo.com/blog/magnesiums-importance-far-greater-previously-imagined">3,751 magnesium binding sites on human proteins &lt;/a> GreenMedInfo Dec 2012&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#see-alsoweb">See also web&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#infographic-by-ontariohealthhttpwwwontariohealthorginfographicsmagnificent-magnesium">&lt;a href="http://www.ontariohealth.org/infographics/magnificent-magnesium">Infographic by Ontario Health&lt;/a>&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#magnesium-reduces-diabetes-risk-by-53httpwwwnutritionalmagnesiumorgmagnesium-lowers-type-ii-diabetes-by-53utm_sourcenewsletterutm_mediumemailutm_contentmagnesium20lowers20diabetes20riskutm_campaignnewsletter20103014-report-on-a-2013study">&lt;a href="http://www.nutritionalmagnesium.org/magnesium-lowers-type-ii-diabetes-by-53/?utm_source=newsletter&amp;amp;utm_medium=email&amp;amp;utm_content=Magnesium%20Lowers%20Diabetes%20Risk&amp;amp;utm_campaign=Newsletter%2010.30.14">Magnesium Reduces Diabetes Risk by 53%&lt;/a> Report on a 2013 study&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#notes-on-what-needs-to-be-made-into-a-summaryintroduction-may2022">Notes on what needs to be made into a summary/introduction (May 2022)&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extensive-overview-of-all-health-and-magnesium-by-examine---july-2024">Extensive Overview of all Health and Magnesium by Examine - July 2024&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#extensive-overview-of-magnesium-at-pauling-institute---updated-nov2018">Extensive Overview of Magnesium at Pauling Institute - updated Nov 2018&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#it-appears-that-all-forms-of-magnesium-cross-the-blood-brainbarrier">It appears that ALL forms of Magnesium cross the blood-brain barrier&lt;/a>&lt;/li>
 &lt;li>&lt;a href="#overview-of-transdermaltopical-magnesium-chloride--2017">Overview of Transdermal/Topical Magnesium Chloride - 2017&lt;/a>&lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
 &lt;/li>
 &lt;/ul>
&lt;/nav>
&lt;hr>
&lt;h4 id="summary-by-chat-gpt-deep-research-as-of-feb-27-2025">Summary by Chat-GPT Deep Research as of Feb 27, 2025&lt;/h4>
&lt;p>&lt;strong>Magnesium: Overview of Benefits, Deficiency, Dosage, and Interactions&lt;/strong>&lt;/p></description></item><item><title>Vitamin D and calcium raw text of 420 page review</title><link>/posts/vitamin-d-and-calcium-raw-text-of-420-page-review.html</link><pubDate>Sat, 04 Sep 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-calcium-raw-text-of-420-page-review.html</guid><description>&lt;h2 id="vitamin-d-and-calcium-a-systematic-review-of-health-outcomes">Vitamin D and calcium: a systematic review of health outcomes.&lt;/h2>
&lt;p>Evid Rep Technol Assess (Full Rep). 2009 Aug;(183):1-420.&lt;/p>
&lt;p>Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TA.&lt;/p>
&lt;p>BACKGROUND: Since the 1997 Dietary Reference Intake (DRI) values for vitamin D and calcium were established new data have become available on their relationship, both individually and combined, to a wide range of health outcomes. The Institute of Medicine/Food and Nutrition Board has constituted a DRI committee to undertake a review of the evidence and potential revision of the current DRI values for these nutrients. To support this review, several US and Canadian federal government agencies commissioned a systematic review of the scientific literature for use during the deliberations by the committee. The intent of providing a systematic review to the committee is to support transparency of the literature review process and provide a foundation for subsequent reviews of the nutrients.&lt;/p></description></item><item><title>National Standard summary and strength of evidence for vitamin D</title><link>/posts/national-standard-summary-and-strength-of-evidence-for-vitamin-d.html</link><pubDate>Sat, 28 Aug 2010 00:00:00 +0000</pubDate><guid>/posts/national-standard-summary-and-strength-of-evidence-for-vitamin-d.html</guid><description>&lt;p>Natural Standard Bottom Line Monograph, Copyright © 2010 ( &lt;a href="https://www.naturalstandard.com">www.naturalstandard.com&lt;/a> ). Commercial distribution prohibited. This monograph is intended for informational purposes only, and should not be interpreted as specific medical advice. You should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.&lt;/p>
&lt;p>While some complementary and alternative techniques have been studied scientifically, high-quality data regarding safety, effectiveness, and mechanism of action are limited or controversial for most therapies. Whenever possible, it is recommended that practitioners be licensed by a recognized professional organization that adheres to clearly published standards. In addition, before starting a new technique or engaging a practitioner, it is recommended that patients speak with their primary healthcare provider(s). Potential benefits, risks (including financial costs), and alternatives should be carefully considered. The below monograph is designed to provide historical background and an overview of clinically-oriented research, and neither advocates for or against the use of a particular therapy.&lt;/p></description></item><item><title>Clinical measures identify vitamin D deficiency in dialysis</title><link>/posts/clinical-measures-identify-vitamin-d-deficiency-in-dialysis.html</link><pubDate>Sun, 18 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/clinical-measures-identify-vitamin-d-deficiency-in-dialysis.html</guid><description>&lt;p>Clin J Am Soc Nephrol. 2010 Mar;5(3):460-7. Epub 2010 Feb 25.&lt;/p>
&lt;p>Bhan I, Burnett-Bowie SA, Ye J, Tonelli M, Thadhani R.&lt;/p>
&lt;p>Department of Medicine, Massachusetts General Hospital, 50 Staniford Street, Suite 750, Boston, MA 02114, USA. &lt;a href="mailto:ibhan@partners.org">ibhan@partners.org&lt;/a>&lt;/p>
&lt;p>BACKGROUND AND OBJECTIVES: Vitamin D deficiency (defined by serum levels of 25-hydroxyvitamin D) is common in patients with ESRD on hemodialysis, but risk factors are unknown. This study was conducted to determine whether routinely measured clinical and demographic parameters could identify dialysis patients who are vitamin D deficient.&lt;/p></description></item><item><title>Cardiovascular Systematic Review of Vitamin D</title><link>/posts/cardiovascular-systematic-review-of-vitamin-d.html</link><pubDate>Tue, 06 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/cardiovascular-systematic-review-of-vitamin-d.html</guid><description>&lt;h2>&lt;strong>Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events&lt;/strong>&lt;/h2>
&lt;p class="ShowRecord">Wang L, Manson JE, Song Y, Sesso HD from http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12010001316&lt;/p>
&lt;table width="100%" cellspacing="0" cellpadding="5" bordercolor="#ccccc0" border="1" class="DARERecord">
&lt;tbody>
&lt;tr>
&lt;th>CRD summary&lt;/th>
&lt;td>
&lt;p>This review concluded that limited data suggested moderate-to-high doses of vitamin D supplements may reduce cardiovascular disease risk, but calcium supplements may not. Given the potential for missed studies, clinical differences between studies and paucity of good quality data, the reliability of the pooled results is uncertain. However, the authors' conclusions seemed suitably cautious.&lt;/p></description></item><item><title>Use of vitamin D in chronic kidney disease patients.</title><link>/posts/use-of-vitamin-d-in-chronic-kidney-disease-patients.html</link><pubDate>Tue, 06 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/use-of-vitamin-d-in-chronic-kidney-disease-patients.html</guid><description>&lt;p>Kidney Int. 2010 Jul;78(2):146-51. Epub 2010 May 26.&lt;/p>
&lt;p>Gal-Moscovici A, Sprague SM.&lt;/p>
&lt;p>Hebrew University of Jerusalem, Hadassah Hospital, Ein Keren, Jerusalem, Israel.&lt;/p>
&lt;p>Chronic kidney disease (CKD) has been recognized as a significant public health problem, with 20 million Americans, or 11% of the adult population, currently living with CKD. Life expectancy in patients with CKD is limited by the development of disturbances of mineral metabolism, which occurs in virtually all patients during the progression of their disease, and is associated with bone loss and fractures, cardiovascular disease, immune suppression, and increased mortality. As kidney disease develops, there is decreased functional renal mass and a reduction in renal 1alpha-hydroxylase activity and thus in renal production of calcitriol at very early CKD stages.&lt;/p></description></item><item><title>Vitamin D and mortality a meta-analysis of RCT - 2008</title><link>/posts/vitamin-d-and-mortality-a-meta-analysis-of-rct-2008.html</link><pubDate>Tue, 06 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-and-mortality-a-meta-analysis-of-rct-2008.html</guid><description>&lt;p>Autier P, Gandini S  from &lt;a href="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;amp;ID=12007008358">http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;amp;ID=12007008358&lt;/a>.&lt;/p>
&lt;table width="100%" cellspacing="0" cellpadding="5" bordercolor="#ccccc0" border="1" class="DARERecord">
&lt;tbody>
&lt;tr>
&lt;th>CRD summary&lt;/th>
&lt;td>
&lt;p>This review evaluated the effect of vitamin D supplementation on reducing mortality from any cause. The authors concluded that ordinary doses of vitamin D supplements have a positive association with reduced total mortality rates. Poor reporting of the review methodology and the lack of a validity assessment mean that the reliability of the authors' conclusions is unclear.&lt;/p>
&lt;/td>
&lt;/tr>
&lt;tr>
&lt;th>Authors' objectives&lt;/th>
&lt;td>
&lt;p>To assess the effect of vitamin D supplementation on reducing mortality from any health condition.&lt;/p></description></item><item><title>Diabetes Statistics including more diabetes with darker skin – 2007</title><link>/posts/diabetes-statistics-including-more-diabetes-with-darker-skin-2007.html</link><pubDate>Sun, 04 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/diabetes-statistics-including-more-diabetes-with-darker-skin-2007.html</guid><description>&lt;p>From &lt;a href="http://www.diabetes.org/diabetes-basics/diabetes-statistics/">==http://www.diabetes.org/diabetes-basics/diabetes-statistics/==&lt;/a>&lt;/p>
&lt;p>Data from the 2007 National Diabetes Fact Sheet (the most recent year for which data is available)&lt;/p>
&lt;p>Total: 23.6 million children and adults in the United States—7.8% of the population—have diabetes.&lt;/p>
&lt;p>Diagnosed: 17.9 million people&lt;/p>
&lt;p>Undiagnosed: 5.7 million people&lt;/p>
&lt;p>Pre-diabetes: 57 million people&lt;/p>
&lt;p>New Cases: 1.6 million new cases of diabetes are diagnosed in people aged 20 years and older each year.&lt;/p>
&lt;h2 id="total-prevalence-of-diabetes">&lt;strong>Total prevalence of diabetes&lt;/strong>&lt;/h2>
&lt;p>Under 20 years of age&lt;/p></description></item><item><title>Virtually all black dialysis patients with low albumin are vitamin D deficient in the winter</title><link>/posts/virtually-all-black-dialysis-patients-with-low-albumin-are-vitamin-d-deficient-in-the-winter.html</link><pubDate>Sun, 04 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/virtually-all-black-dialysis-patients-with-low-albumin-are-vitamin-d-deficient-in-the-winter.html</guid><description>&lt;h1 id="editorial-followed-by-abstract-of-the-article">Editorial followed by abstract of the article&lt;/h1>
&lt;h3 id="virtually-all-kidney-disease-patients-on-dialysis-have-vitamin-d-deficiencyhttpwwwnaturalnewscom028398_kidney_disease_vitamin_dhtml20">&lt;a href="http://www.naturalnews.com/028398_kidney_disease_vitamin_D.html%20">Virtually all kidney disease patients on dialysis have vitamin D deficiency&lt;/a>&lt;/h3>
&lt;p>March 18, 2010 by: S. L. Baker,&lt;/p>
&lt;p>Ishir Bhan, MD, of Massachusetts General Hospital, and his research team studied data from 908 U.S. dialysis patients in the Accelerated Mortality on Renal Replacement (ArMORR) cohort. The scientists&amp;rsquo; goal was to investigate routinely measured clinical and demographic characteristics to see if they could figure out which patients with end-stage renal disease (ESRD) on dialysis are at increased risk for vitamin D deficiency.&lt;/p></description></item><item><title>Majority of blacks on dialysis were vitamin D deficient</title><link>/posts/majority-of-blacks-on-dialysis-were-vitamin-d-deficient.html</link><pubDate>Fri, 02 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/majority-of-blacks-on-dialysis-were-vitamin-d-deficient.html</guid><description>&lt;h4 id="clinical-measures-identify-vitamin-d-deficiency-in-dialysis">Clinical measures identify vitamin d deficiency in dialysis.&lt;/h4>
&lt;p>by: Ishir Bhan, Sherri-Ann A. Burnett-Bowie, Jun Ye, Marcello Tonelli, Ravi Thadhani&lt;/p>
&lt;p>Clinical journal of the American Society of Nephrology : CJASN, Vol. 5, No. 3. (March 2010), pp. 460-467&lt;/p>
&lt;p>BACKGROUND AND OBJECTIVES: Vitamin D deficiency (defined by serum levels of 25-hydroxyvitamin D) is common in patients with ESRD on hemodialysis, but risk factors are unknown. This study was conducted to determine whether routinely measured clinical and demographic parameters could identify dialysis patients who are vitamin D deficient.&lt;/p></description></item><item><title>Disease Database - nice links for vitamin D</title><link>/posts/disease-database-nice-links-for-vitamin-d.html</link><pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/disease-database-nice-links-for-vitamin-d.html</guid><description>&lt;br />
&lt;p>Links for &lt;a href="http://www.diseasesdatabase.com/ddb13939.htm">Vitamin D&lt;/a>.&lt;br />&lt;/p>
&lt;p>July 2010 &lt;br />&lt;/p>
&lt;p>&amp;#160;&lt;/p>
&lt;table border="1">
&lt;tbody>
&lt;tr>
&lt;th>Site&lt;/th>
&lt;th>Link and description&lt;/th>
&lt;th>Content&lt;/th>
&lt;th>About&lt;/th>
&lt;/tr>
&lt;tr>
&lt;td>ADAM&lt;/td>
&lt;td>&lt;a class="external" href="http://www.nlm.nih.gov/medlineplus/ency/article/002405.htm">Vitamin D: MedlinePlus Medical Encyclopedia&lt;/a>&lt;/td>
&lt;td>Patient information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=29322">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>DermNet NZ&lt;/td>
&lt;td>&lt;a class="external" href="http://dermnetnz.org/systemic/vitamin-d.html">Vitamin D. DermNet NZ&lt;/a>&lt;/td>
&lt;td>Patient information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=74515">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Collaborative Hypertext of Radiology&lt;/td>
&lt;td>&lt;a class="external" href="http://chorus.rad.mcw.edu/doc/00659.html">vitamin D&lt;/a>&lt;/td>
&lt;td>Quick subject review&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=10290">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://www2.cochrane.org/reviews/en/ab000227.html">Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=5920">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD008175/frame.html">Vitamin D compounds for people with chronic kidney disease not requiring dialysis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=73198">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>Cochrane Database&lt;/td>
&lt;td>&lt;a class="external" href="http://mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD005633/frame.html">Vitamin D compounds for people with chronic kidney disease requiring dialysis&lt;/a>&lt;/td>
&lt;td>Critically appraised topic&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=73199">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>MDAdvice.com&lt;/td>
&lt;td>&lt;a class="external" href="http://www.mdadvice.com/library/drug/drug437.html">Vitamin D&lt;/a>&lt;/td>
&lt;td>Drug data sheets / Formulary Information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=37432">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>RxList.com&lt;/td>
&lt;td>&lt;a class="external" href="http://www.rxlist.com/rocaltrol-drug.htm">Rocaltrol (Calcitriol) Drug Information: Uses, Side Effects, Drug Interactions and Warnings at RxList&lt;/a>&lt;/td>
&lt;td>Drug data sheets / Formulary Information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=11770">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;tr>
&lt;td>RxMed&lt;/td>
&lt;td>&lt;a class="external" href="http://www.rxmed.com/b.main/b2.pharmaceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20%28General%20Monographs-%20V%29/VITAMIN%20D.html">Vitamin d&lt;/a>&lt;/td>
&lt;td>Drug data sheets / Formulary Information&lt;/td>
&lt;td>&lt;small>&lt;a rel="nofollow" href="http://www.diseasesdatabase.com/link_details.asp?lngURLID=37556">URL metadata&lt;/a>&lt;/small>&lt;/td>
&lt;/tr>
&lt;/tbody>
&lt;/table>
&lt;hr />
&lt;h3>Search elsewhere for Vitamin D&lt;/h3>
&lt;p>&lt;noscript>&lt;b class='look'>JavaScript must be enabled for some links on this page.&lt;/b>&lt;/noscript>&lt;/p></description></item><item><title>Web Doc - very good overview of Vitamin D</title><link>/posts/web-doc-very-good-overview-of-vitamin-d.html</link><pubDate>Thu, 01 Jul 2010 00:00:00 +0000</pubDate><guid>/posts/web-doc-very-good-overview-of-vitamin-d.html</guid><description>&lt;h1 class="firstHeading">&lt;a href="http://www.wikidoc.org/index.php/Vitamin_D">www.wikidoc.org/index.php/Vitamin_D&lt;/a>  July 2010&lt;br />
&lt;p>Vitamin D&lt;/h1>&lt;/p>
&lt;h3>You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.&lt;/h3>
&lt;div>Jump to: &lt;a href="http://www.wikidoc.org/index.php/Vitamin_D#column-one">navigation&lt;/a>, &lt;a href="http://www.wikidoc.org/index.php/Vitamin_D#searchInput">search&lt;/a>&lt;/div>
&lt;table class="infobox bordered" style="width:15em;text-align:left;font-size:90%;background:none repeat scroll 0% 0%;">&lt;tbody>&lt;tr>&lt;td colspan="1" style="text-align:center;background:none repeat scroll 0% 0%;">
&lt;p>&lt;b>Wiki&lt;i>Doc&lt;/i> Resources for&lt;/b>&lt;/p></description></item><item><title>Low vitamin D associated with hemodialysis problems</title><link>/posts/low-vitamin-d-associated-with-hemodialysis-problems.html</link><pubDate>Sat, 26 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/low-vitamin-d-associated-with-hemodialysis-problems.html</guid><description>&lt;h4 id="effects-of-vitamin-d3-on-selected-biochemical-parameters-of-nutritional-status-inflammation-and-cardiovascular-disease-in-patients-undergoing-long-term-hemodialysis">Effects of vitamin D3 on selected biochemical parameters of nutritional status, inflammation, and cardiovascular disease in patients undergoing long-term hemodialysis.&lt;/h4>
&lt;p>Pol Arch Med Wewn. 2010 May;120(5):167-74.&lt;/p>
&lt;p>Bednarek-Skublewska A, Smole? A, Jaroszy?ski A, Za?uska W, Ksiazek A.&lt;/p>
&lt;p>Department of Nephrology, Medical University of Lublin, Lublin, Poland. &lt;a href="mailto:anna.bednarek@diaverum.com">anna.bednarek@diaverum.com&lt;/a>&lt;/p>
&lt;p>INTRODUCTION: Vitamin D3 has diverse biological effects extending beyond the maintenance of calcium and phosphorus homeostasis and ensuring the proper functioning of the body.&lt;/p>
&lt;p>OBJECTIVES: This study evaluated the levels of vitamin D3 and its association with nutritional status, immunological activity, and selected markers of cardiovascular disease in patients on long-term hemodialysis (HD).&lt;/p></description></item><item><title>Cochrane review finds that Vitamin D helps with kidney</title><link>/posts/cochrane-review-finds-that-vitamin-d-helps-with-kidney.html</link><pubDate>Sun, 20 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/cochrane-review-finds-that-vitamin-d-helps-with-kidney.html</guid><description>&lt;h1 id="vitamin-d-compounds-for-people-with-chronic-kidney-disease-requiring-dialysis">Vitamin D compounds for people with chronic kidney disease requiring dialysis&lt;/h1>
&lt;p>People with reduced kidney function (chronic kidney disease; CKD) develop changes in circulating blood levels of calcium and phosphorus. The kidney gradually loses the ability to remove phosphorus from the blood and cannot activate adequate amounts of vitamin D, to maintain normal levels of calcium. The parathyroid gland senses these changes and compensates to increase calcium by elevating production and release of parathyroid hormone. These metabolic changes alter bone metabolism to release calcium and accordingly lead to bone abnormalities including altered bone production. Consequently bone deformation, bone pain, and altered risks of fracture may occur.&lt;/p></description></item><item><title>1000 IU vitamin D might prevent cardiovascular events</title><link>/posts/1000-iu-vitamin-d-might-prevent-cardiovascular-events.html</link><pubDate>Tue, 01 Jun 2010 00:00:00 +0000</pubDate><guid>/posts/1000-iu-vitamin-d-might-prevent-cardiovascular-events.html</guid><description>&lt;h1 id="systematic-review-vitamin-d-and-calcium-supplementation-in-prevention-of-cardiovascular-events">Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events.&lt;/h1>
&lt;p>by: Lu Wang, JoAnn E. Manson, Yiqing Song, Howard D. Sesso&lt;/p>
&lt;p>Annals of internal medicine, Vol. 152, No. 5. (2 March 2010), pp. 315-323.&lt;/p>
&lt;p>BACKGROUND: Vitamin D and calcium may affect the cardiovascular system independently and interactively. PURPOSE: To assess whether vitamin D and calcium supplements reduce the risk for cardiovascular events in adults.&lt;/p>
&lt;p>DATA SOURCES: Studies published in English from 1966 to July 2009 in MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials.&lt;/p></description></item><item><title>Hypercalcemia overview</title><link>/posts/hypercalcemia-overview.html</link><pubDate>Thu, 13 May 2010 00:00:00 +0000</pubDate><guid>/posts/hypercalcemia-overview.html</guid><description>&lt;table width="771" cellspacing="0" cellpadding="0" border="0">&lt;tbody>&lt;tr>&lt;td width="100%" valign="top">
&lt;table width="571" cellspacing="0" cellpadding="0" border="0">&lt;tbody>&lt;tr>&lt;td valign="top">&lt;span class="page-title">Table of Contents&lt;br />&lt;span style="color:rgb(255,0,0);">Downloaded from National Cancer Institute May 2010 - unknown date&lt;/span>&lt;br />
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages">http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages&lt;/a>&lt;/span>&lt;/p>
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_170">Purpose of This PDQ Summary&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_1">Overview&lt;/a>&lt;br />&lt;/p>&lt;table width="100%" cellspacing="0" cellpadding="0" border="0">&lt;tbody>&lt;tr>&lt;td>&lt;img src="http://www.cancer.gov/images/spacer.gif" alt="image" width="30" height="1">&lt;/td>
&lt;td width="100%">&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_3">Normal Calcium Homeostasis&lt;/a>&lt;br />
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_136">Hormonal influences &lt;/a>&lt;br />&lt;/p>
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_137">Renal function&lt;/a>&lt;br />&lt;/p>
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_138">Bone resorption&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_11">Mechanisms of Cancer-associated Hypercalcemia&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_15">Potentiating Factors&lt;/a>&lt;/td>&lt;/p>
&lt;/tr>&lt;/tbody>&lt;/table>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_19">Incidence by Cancer Type&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_23">Manifestations&lt;/a>&lt;br />&lt;table width="100%" cellspacing="0" cellpadding="0" border="0">&lt;tbody>&lt;tr>&lt;td>&lt;img src="http://www.cancer.gov/images/spacer.gif" alt="image" width="30" height="1">&lt;/td>
&lt;td width="100%">&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_30">Neurologic Symptoms&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_32">Cardiovascular Symptoms&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_34">Gastrointestinal Symptoms&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_36">Renal Symptoms&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_39">Bone Symptoms&lt;/a>&lt;/td>
&lt;/tr>&lt;/tbody>&lt;/table>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_41">Assessment&lt;/a>&lt;br />&lt;table width="100%" cellspacing="0" cellpadding="0" border="0">&lt;tbody>&lt;tr>&lt;td>&lt;img src="http://www.cancer.gov/images/spacer.gif" alt="image" width="30" height="1">&lt;/td>
&lt;td width="100%">&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_42">Laboratory Assessment&lt;/a>&lt;br />
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_139">Laboratory studies&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_51">Patient assessment&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_57">Decision to Treat Hypercalcemia&lt;/a>&lt;/td>&lt;/p>
&lt;/tr>&lt;/tbody>&lt;/table>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_59">Management&lt;/a>&lt;br />&lt;table width="100%" cellspacing="0" cellpadding="0" border="0">&lt;tbody>&lt;tr>&lt;td>&lt;img src="http://www.cancer.gov/images/spacer.gif" alt="image" width="30" height="1">&lt;/td>
&lt;td width="100%">&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_60">Prevention&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_63">Managing Hypercalcemia&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_69">Mild Hypercalcemia&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_73">Moderate to Severe Hypercalcemia&lt;/a>&lt;br />&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_78">Pharmacologic Inhibition of Osteoclastic Bone Resorption&lt;/a>&lt;br />
&lt;p>&lt;a href="http://www.cancer.gov/cancertopics/pdq/supportivecare/hypercalcemia/healthprofessional/allpages#Section_142">Bisphosphonates&lt;/a>&lt;br />&lt;/p></description></item><item><title>Vascular calcification in chronic kidney disease</title><link>/posts/vascular-calcification-in-chronic-kidney-disease.html</link><pubDate>Fri, 07 May 2010 00:00:00 +0000</pubDate><guid>/posts/vascular-calcification-in-chronic-kidney-disease.html</guid><description>&lt;p>Clin Sci (Lond). 2010 Apr 28;119(3):111-21.&lt;/p>
&lt;p>Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ.&lt;/p>
&lt;p>Clinic of Nephrology, C. I. Parhon University Hospital, Gr. T. Popa University of Medicine and Pharmacy, Bd. Carol I, Nr. 50, Iasi, Romania. &lt;a href="mailto:adrianccovic@gmail.com">adrianccovic@gmail.com&lt;/a>&lt;/p>
&lt;p>VC (vascular calcification) is highly prevalent in patients with CKD (chronic kidney disease), but its mechanism is multifactorial and incompletely understood. In addition to increased traditional risk factors, CKD patients also have a number of non-traditional cardiovascular risk factors, which may play a prominent role in the pathogenesis of arterial calcification, such as duration of dialysis and disorders of mineral metabolism. The transformation of vascular smooth muscle cells into chondrocytes or osteoblast-like cells seems to be a key element in VC pathogenesis, in the context of passive calcium and phosphate deposition due to abnormal bone metabolism and impaired renal excretion. The process may be favoured by the low levels of circulating and locally produced VC inhibitors. VC determines increased arterial stiffness, left ventricular hypertrophy, a decrease in coronary artery perfusion, myocardial ischaemia and increased cardiovascular morbidity and mortality.&lt;/p></description></item><item><title>NYT article on vitamin D has many comments</title><link>/posts/nyt-article-on-vitamin-d-has-many-comments.html</link><pubDate>Sun, 02 May 2010 00:00:00 +0000</pubDate><guid>/posts/nyt-article-on-vitamin-d-has-many-comments.html</guid><description>&lt;p>&lt;strong>Vitamin D Shows Heart Benefits in Study&lt;/strong>&lt;/p>
&lt;p>By RONI CARYN RABIN &lt;a href="http://well.blogs.nytimes.com/2009/11/16/vitamin-d-shows-heart-benefits-in-study/?src=twt&amp;amp;twt=nytimes&amp;amp;apage=1#comments">NYT Nov 16 2009&lt;/a>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">Henry’s notes Jan 3, 2009 of many of the comments&lt;/span>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">Many many interesting links, and the following quotes from the discussion forum&lt;/span>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">There are perhaps 200 different important metabolic processes that use vitamin D as a co-factor.”&lt;/span>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">It truly is the “wonder vitamin.”&lt;/span>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">leaves me just a bit skeptical&lt;/span>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">lab charged $230 for the test&lt;/span>&lt;/p>
&lt;p>&lt;span style="color:#ff0000;">beta-carotene or Vitamin E/selenium studies&lt;/span>&lt;/p></description></item><item><title>Vitamin D reduced CVD risk - systematic review 2010</title><link>/posts/vitamin-d-reduced-cvd-risk-systematic-review-2010.html</link><pubDate>Wed, 28 Apr 2010 00:00:00 +0000</pubDate><guid>/posts/vitamin-d-reduced-cvd-risk-systematic-review-2010.html</guid><description>&lt;h1 id="systematic-review-vitamin-d-and-calcium-supplementation-in-prevention-of-cardiovascular-events">Systematic Review: Vitamin D and Calcium Supplementation in Prevention of Cardiovascular Events&lt;/h1>
&lt;ol>
&lt;li>
&lt;p>Lu Wang, MD, PhD;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>JoAnn E. Manson, MD, DrPH;&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Yiqing Song, MD, ScD; and&lt;/p>
&lt;/li>
&lt;li>
&lt;p>Howard D. Sesso, ScD&lt;/p>
&lt;/li>
&lt;/ol>
&lt;p>From Brigham and Women&amp;rsquo;s Hospital and Harvard School of Public Health, Boston, Massachusetts.&lt;/p>
&lt;p>Background: Vitamin D and calcium may affect the cardiovascular system independently and interactively.&lt;/p>
&lt;p>Purpose: To assess whether vitamin D and calcium supplements reduce the risk for cardiovascular events in adults.&lt;/p></description></item><item><title>Potential for vitamin D receptor agonists in the treatment of cardiovascular disease</title><link>/posts/potential-for-vitamin-d-receptor-agonists-in-the-treatment-of-cardiovascular-disease.html</link><pubDate>Mon, 12 Apr 2010 00:00:00 +0000</pubDate><guid>/posts/potential-for-vitamin-d-receptor-agonists-in-the-treatment-of-cardiovascular-disease.html</guid><description>&lt;p>British Journal of Pharmacology Volume 158 Issue 2, Pages 395 - 412&lt;/p>
&lt;p>Special Issue: Themed Section: Advances in Nutritional Pharmacology: Guest Editor: CL Wainwright&lt;/p>
&lt;p>Published Online: 9 Apr 2009&lt;/p>
&lt;p>Journal compilation © 2010 The British Pharmacological Society&lt;/p>
&lt;p>THEMED SECTION: ADVANCES IN NUTRITIONAL PHARMACOLOGY&lt;/p>
&lt;p>REVIEW&lt;/p>
&lt;p>JR Wu-Wong Abbott, Abbott Park, IL, USA &lt;a href="mailto:ruth.wu-wong@abbott.com">ruth.wu-wong@abbott.com&lt;/a>&lt;/p>
&lt;p>Vitamin D3 is made in the skin and modified in the liver and kidney to form the active metabolite, 1,25-dihydroxyvitamin D3 (calcitriol). Calcitriol binds to a nuclear receptor, the vitamin D receptor (VDR), and activates VDR to recruit cofactors to form a transcriptional complex that binds to vitamin D response elements in the promoter region of target genes.&lt;/p></description></item><item><title>Genetics Determines Vitamin D Response</title><link>/posts/genetics-determines-vitamin-d-response.html</link><pubDate>Sun, 11 Apr 2010 00:00:00 +0000</pubDate><guid>/posts/genetics-determines-vitamin-d-response.html</guid><description>&lt;p>&lt;strong>Genetics, as well as dose, determine response to vitamin D supplements.&lt;/strong>&lt;/p>
&lt;p>&lt;strong>Vitamin D council newsletter March 13 2010&lt;/strong>&lt;/p>
&lt;p>Your vitamin D blood level depends entirely on how much you take or how often you sunbathe, right? Wrong. Prior studies of identical twins show that about 25 -50% of the variation of Vitamin D levels depends on genetics. In July, researchers at the University of Toronto discovered the heritability of 25(OH)D is probably mediated through the Vitamin D binding protein (VDBP).&lt;/p></description></item><item><title>Clinical Trials Vitamin D</title><link>/posts/clinical-trials-vitamin-d.html</link><pubDate>Sun, 28 Feb 2010 00:00:00 +0000</pubDate><guid>/posts/clinical-trials-vitamin-d.html</guid><description>&lt;h1 id="this-page-was-started-feb-2010">This page was started Feb 2010&lt;/h1>
&lt;p>Updates are on other pages&lt;/p>
&lt;ul>
&lt;li>
&lt;p>&lt;a href="/posts/clinical-trials-for-vitamin-d-2011">Clinical Trials for Vitamin D - 2011&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/vitamin-d-trials-studies-and-meta-analysis">Vitamin D trials, studies, and meta-analysis - Dec 2010&lt;/a>&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/clinical-trials-vitamin-d">Clinical Trials Vitamin D - Feb 2010&lt;/a> - full list of names - which can be searched&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/posts/clinical-trials-update">Clinical Trials update Sept 2010&lt;/a> includes grouping by some major diseases&lt;/p>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/tags/intervention-add-vitamin-d-and-see-what-happens.html">Intervention - add vitamin D and see what happens&lt;/a>&lt;/p>
&lt;ul>
&lt;li>includes Ultraviolet and world wide clinical trials&lt;/li>
&lt;/ul>
&lt;/li>
&lt;li>
&lt;p>&lt;a href="/tags/622-vitamin-d-clinical-trials-june-2010.html">622 vitamin D Clinical Trials - June 2010&lt;/a>&lt;/p></description></item></channel></rss>